data_2m67_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m67 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 N--CA 1.494 1.545 0 CA-C-O 120.865 0.277 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -64.2 -37.14 86.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.041 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -105.47 -24.37 12.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.982 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.65 -51.08 69.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.273 0.559 . . . . 0.0 110.33 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -9.87 35.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -20.49 62.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.51 -35.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' OG1' ' A' ' 15' ' ' THR . 8.1 t -61.27 -52.83 63.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.772 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.447 ' O ' ' OG1' ' A' ' 16' ' ' THR . 74.5 mt -60.41 -54.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.452 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.72 -41.2 91.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.561 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.46 -38.99 80.29 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 11' ' ' SER . 77.5 m -74.18 -16.46 60.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.987 0.423 . . . . 0.0 110.485 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 96.6 m -73.11 -45.24 58.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.261 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.8 mt -68.08 -45.09 74.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.73 -41.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.38 32.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.308 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD1' HH21 ' A' ' 64' ' ' ARG . 75.4 mt -65.39 -36.09 82.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 23' ' ' PHE . 46.8 t -64.93 -33.24 75.57 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.893 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -50.59 -2.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 21' ' ' SER . 63.2 m-85 -119.09 -25.53 6.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.434 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 91.5 m -47.52 -46.39 59.22 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.778 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 24' ' ' THR . 55.7 Cg_exo -47.44 -32.56 15.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.772 2.315 . . . . 0.0 112.682 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 5.9 p -49.15 -47.37 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.504 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 11.5 mt -64.13 -48.05 77.58 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.311 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.86 -42.78 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.56 -43.26 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.25 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -40.56 60.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.72 -40.74 89.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.09 -35.92 57.11 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -58.37 -51.72 67.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.411 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.73 -39.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.208 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.71 -36.93 93.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.1 -33.14 75.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 41' ' ' GLY . 50.2 m -56.64 -28.04 59.73 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.808 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.7 69.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.0 mm? -67.72 -58.99 3.69 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 40' ' ' THR . 2.1 t -75.99 -49.46 17.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.413 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 107.97 64.61 0.58 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 45' ' ' TYR . 3.0 m-85 -105.98 11.44 31.62 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 42' ' ' TYR . 4.4 mm? -31.67 -32.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.364 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 42' ' ' TYR . 24.4 t0 -71.37 -41.98 69.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.269 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 42' ' ' TYR . 23.8 t80 -92.73 53.05 1.96 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.593 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.3 -39.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.9 0.381 . . . . 0.0 110.484 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.16 -39.98 32.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.0 110.758 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 mp -60.04 -58.92 15.81 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 17.9 Cg_endo -58.13 -16.18 26.3 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.137 2.558 . . . . 0.0 112.365 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 -32.82 74.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.64 -24.79 15.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.533 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.35 58.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.414 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.52 -46.16 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.445 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.25 -45.08 89.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.95 -44.85 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.42 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 60' ' ' TYR . . . -66.96 -32.15 80.09 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tp -59.95 -41.21 91.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 110.513 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.6 p -65.69 -39.93 91.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.379 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.64 -50.13 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 5.9 m-30 -49.9 -29.87 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.55 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.577 0.227 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tp -62.44 -29.91 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 110.811 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.5 -40.77 89.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.519 HH21 ' CD1' ' A' ' 20' ' ' LEU . 14.5 mmt180 -76.02 -22.94 55.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.97 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -48.27 -47.72 36.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.188 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -72.75 -49.15 32.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.737 0.303 . . . . 0.0 110.669 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 83.5 mt-30 -53.84 -31.01 47.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.308 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' O ' ' OG ' ' A' ' 71' ' ' SER . . . -53.64 -53.53 50.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 110.227 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -70.59 -44.84 66.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.08 -32.65 66.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.215 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 87.5 p -71.39 -39.45 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.386 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -96.39 -79.93 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.569 ' C ' ' H ' ' A' ' 75' ' ' LYS . 11.7 m -39.27 101.83 0.24 Allowed Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 25.9 Cg_exo -60.55 31.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 123.027 2.485 . . . . 0.0 112.774 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 73' ' ' THR . 27.4 mttt -67.2 -44.42 79.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 38.7 p90 -57.92 -50.98 71.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 5.2 p-10 -78.58 -23.4 46.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.81 82.85 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.43 -43.76 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.331 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' LYS . 41.7 mmtm -54.42 -41.2 69.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' LYS . 13.1 tptt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.493 1.461 0 CA-C-O 120.76 0.233 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -74.47 -14.68 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -114.3 -27.66 7.53 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.899 0.38 . . . . 0.0 110.699 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.12 -55.77 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.58 80.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.362 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -61.67 -20.78 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.95 -35.43 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.713 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -55.8 -45.58 78.23 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.711 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.41 -45.56 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.045 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' OG1' ' A' ' 16' ' ' THR . 38.8 mm -64.09 -44.41 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 0.0 110.294 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -42.17 58.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.6 m -67.89 -21.56 65.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.672 0.273 . . . . 0.0 110.666 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 3.2 p -82.35 -35.7 27.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 110.371 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.77 -47.04 56.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.4 t -68.43 -41.31 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.168 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.43 58.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.559 0.695 . . . . 0.0 109.79 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.01 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.523 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.549 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 8.5 m -61.26 -23.06 65.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.17 0.51 . . . . 0.0 110.323 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.6 t -78.68 -11.47 59.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.9 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.555 ' CZ ' ' OE1' ' A' ' 63' ' ' GLN . 54.6 m-85 -108.68 -45.5 3.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.002 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.18 -50.28 11.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.321 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CD ' ' O ' ' A' ' 21' ' ' SER . 77.5 Cg_exo -44.84 -41.38 15.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.746 1.631 . . . . 0.0 112.157 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -48.18 -48.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.193 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.39 -53.75 50.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.499 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -33.53 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 121.229 -0.188 . . . . 0.0 111.309 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' GLY . 6.1 tt -42.84 -32.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.693 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.24 -30.28 1.18 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.07 -37.15 75.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.046 0.451 . . . . 0.0 109.949 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' ILE . . . -72.42 -52.79 9.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.501 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 ' CG2' ' N ' ' A' ' 34' ' ' VAL . 13.6 m -54.08 -44.45 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.607 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 37' ' ' SER . 14.2 p -71.28 -37.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.03 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.3 96.2 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.93 -26.62 68.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.667 ' HG ' ' N ' ' A' ' 38' ' ' ALA . 53.0 p -62.8 -41.41 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 110.355 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.667 ' N ' ' HG ' ' A' ' 37' ' ' SER . . . -55.15 -44.28 74.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.591 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.5 -73.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -79.54 -48.73 13.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 114.16 67.24 0.46 Allowed Glycine 0 N--CA 1.472 1.069 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 45' ' ' TYR . 64.1 m-85 -98.41 14.25 28.77 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -36.57 -43.49 0.4 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.978 0.418 . . . . 0.0 110.81 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.33 -36.21 82.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.108 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' TYR . 90.6 m-85 -107.35 46.8 0.92 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -120.31 -33.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 110.229 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -66.32 -40.45 89.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.6 mt -67.77 -59.88 6.15 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.691 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -40.62 -22.69 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.812 1.674 . . . . 0.0 113.51 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -70.36 -36.81 74.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.42 0.629 . . . . 0.0 110.333 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 10.3 mp -59.94 -26.01 65.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.692 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.88 81.45 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.37 -43.37 94.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.593 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -47.78 -39.8 19.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 109.865 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 55' ' ' ILE . 96.7 mt -60.81 -28.01 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.424 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.3 -38.04 67.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.63 -37.84 87.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.98 0.419 . . . . 0.0 110.581 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.649 ' HG1' ' N ' ' A' ' 59' ' ' ILE . 14.1 p -63.93 -52.58 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.444 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.649 ' N ' ' HG1' ' A' ' 58' ' ' THR . 17.4 tt -70.38 -39.88 77.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.81 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -53.57 -34.39 58.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.46 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.01 -40.06 79.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.663 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.62 -31.18 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.731 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.555 ' OE1' ' CZ ' ' A' ' 23' ' ' PHE . 27.7 mt-30 -67.05 -48.97 66.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.963 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -75.95 -22.79 55.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.857 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.71 -48.18 63.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.677 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 12.0 ptt180 -63.8 -48.68 75.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.265 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.446 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -54.29 -28.21 40.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 -178.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.54 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.345 0.593 . . . . 0.0 110.329 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 73' ' ' THR . 50.3 t0 -73.06 -40.89 64.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.57 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.98 -49.29 66.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.002 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -62.24 -42.55 99.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.729 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.9 p -73.89 -25.7 60.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' ASP . 26.1 m -132.9 81.74 57.21 Favored Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.531 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.85 125.63 18.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.299 1.999 . . . . 0.0 111.802 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.86 -28.84 35.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.1 m-85 -91.26 -59.57 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.557 ' N ' HD21 ' A' ' 77' ' ' ASN . 1.6 m120 -62.95 -25.76 68.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.5 -60.7 6.72 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.75 -42.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.066 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -77.13 -106.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.812 0.339 . . . . 0.0 110.344 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ASN . 2.4 mptm? . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.21 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 6' ' ' THR . 41.3 Cg_exo . . . . . 0 N--CA 1.495 1.58 0 CA-C-O 120.795 0.248 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -37.86 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.836 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' PRO . 73.4 p -124.12 -44.78 2.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.385 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 10.0 mp -56.29 -41.62 76.21 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.494 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 10' ' ' VAL . 1.8 tt -60.9 -76.88 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.296 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -45.42 -19.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 6' ' ' THR . 39.4 t -82.89 -55.99 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -60.89 -42.01 97.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.778 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.424 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 tp -51.79 -18.2 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.685 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.46 -43.68 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.806 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.06 -41.35 99.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -71.04 -19.85 62.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.567 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 15.1 m -67.26 -42.62 83.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 109.907 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -42.04 96.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.768 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 -44.71 96.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.28 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.43 65.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.573 0.702 . . . . 0.0 109.176 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.17 -36.93 83.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.9 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.2 t -51.99 -24.25 6.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.485 0.66 . . . . 0.0 110.603 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -77.86 -7.98 57.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.857 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -114.89 -54.22 2.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -66.06 -64.33 2.49 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.455 -177.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.46 -13.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.323 2.015 . . . . 0.0 113.469 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 24' ' ' THR . 52.4 t -59.34 -38.35 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.84 71.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.663 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.75 -41.57 93.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.338 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.05 -39.89 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.29 -37.05 71.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.57 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.65 -38.77 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -57.1 6.83 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.355 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -44.11 -32.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.58 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.89 -43.93 96.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.09 -33.25 85.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.2 tp -64.67 -34.45 78.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 0.0 110.255 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 41' ' ' GLY . 32.7 t -63.79 -33.37 75.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.406 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.39 -47.86 66.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 110.942 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.15 -60.45 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.067 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.554 ' HG1' ' N ' ' A' ' 41' ' ' GLY . 71.9 p -78.55 -45.77 21.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 89.59 107.01 1.18 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -112.52 117.17 31.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.218 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 3.7 mm? -83.66 -67.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.58 0.81 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.466 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.49 40.27 1.24 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.17 -25.55 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 110.289 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -84.97 -43.04 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -66.38 -49.22 54.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 46.0 Cg_endo -67.96 -15.57 43.77 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.724 1.616 . . . . 0.0 112.71 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.45 81.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.1 mm? -61.42 -25.68 67.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.67 90.33 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.99 -45.91 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -65.26 -43.13 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.528 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.85 -43.19 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 0.0 110.214 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.74 96.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 mp -62.73 -34.09 76.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.64 0.257 . . . . 0.0 111.167 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 m -64.5 -48.19 76.08 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 pt -71.5 -40.99 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.895 0.379 . . . . 0.0 111.943 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -55.35 -37.61 67.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.673 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.95 -26.76 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.19 -30.82 49.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.624 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -30.45 70.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -76.33 -22.01 55.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.823 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.16 -42.99 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.335 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -47.38 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.184 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -54.21 -28.34 40.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.725 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.432 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . -51.94 -52.3 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.827 0.823 . . . . 0.0 109.799 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 73' ' ' THR . 34.8 m-20 -70.05 -33.6 72.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.096 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.27 66.46 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.547 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.7 t -90.88 -31.95 16.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 7.9 m -83.22 -7.9 59.54 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.688 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.4 m -139.97 63.18 24.02 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 110.361 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.33 41.11 0.91 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 0.0 111.577 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -63.01 -41.82 99.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -53.9 -69.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -65.62 -30.57 71.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.84 -57.59 11.91 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.4 t -77.01 -55.36 10.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.35 . . . . 0.0 110.81 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -82.51 152.59 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.243 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.5 1.863 0 N-CA-C 112.44 0.131 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -69.4 -12.9 62.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.752 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -113.71 -51.77 2.78 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.802 0.334 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 10.4 mp -59.86 -51.35 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.85 -37.42 79.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.256 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -63.58 -18.3 63.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -67.79 -39.91 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.684 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' OG1' ' A' ' 15' ' ' THR . 4.0 t -59.58 -52.89 63.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 13' ' ' ILE . 2.0 tp -63.41 -46.14 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 78.0 mt -63.8 -44.12 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.377 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.1 -40.12 62.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 11' ' ' SER . 41.3 p -73.69 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 111.085 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 16' ' ' THR . 1.6 p -78.28 -39.78 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.411 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.05 -42.83 96.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.74 -40.72 81.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.57 -59.7 4.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.092 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.29 -34.83 75.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.328 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 23' ' ' PHE . 47.9 m -65.39 -32.94 74.83 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 110.69 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.7 p -50.49 -0.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.614 ' H ' ' C ' ' A' ' 21' ' ' SER . 7.4 m-85 -103.97 -20.71 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.73 0.3 . . . . 0.0 110.386 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.94 -47.39 53.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.152 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 24' ' ' THR . 71.5 Cg_exo -45.17 -26.63 2.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.518 2.145 . . . . 0.0 112.876 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 p -49.44 -23.96 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.884 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.87 -34.78 78.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 p -60.96 -39.62 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.342 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.0 mt -64.6 -44.46 96.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.289 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.91 -41.68 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.803 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.42 -42.24 98.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.47 85.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.49 -46.23 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.38 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.92 -46.97 94.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.254 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.62 90.22 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.36 -41.17 76.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 110.828 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' GLY . 62.5 m -70.88 -39.7 72.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.85 -49.19 40.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.483 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -62.74 -43.31 99.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.125 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -88.5 5.11 44.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 43.01 77.13 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' ASP . 59.9 t80 -166.92 35.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.827 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' TYR . 51.1 t0 -86.02 -28.27 24.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.571 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 76.8 t80 -99.56 48.71 0.94 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -116.19 -25.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.627 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.12 -37.13 24.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.506 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.85 -54.42 46.9 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.455 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.14 -37.14 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.922 1.748 . . . . 0.0 112.366 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.68 28.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.01 -41.78 98.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.106 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.95 91.5 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.946 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.95 -46.15 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.077 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -64.61 -44.96 88.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' O ' ' OG1' ' A' ' 58' ' ' THR . 97.9 mt -64.11 -43.29 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.95 -37.51 92.2 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.27 -45.24 88.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.543 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 17.2 p -55.19 -46.84 75.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.0 pt -70.55 -37.42 69.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 110.432 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -53.63 -35.09 60.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.693 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.55 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.597 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.94 -31.59 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.512 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.74 -42.54 73.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.134 0.492 . . . . 0.0 111.113 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -75.8 -23.19 55.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.498 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.53 -46.45 38.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.662 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -69.46 -45.94 67.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.646 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -56.29 -30.0 61.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.52 -42.21 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.006 -0.277 . . . . 0.0 110.649 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.95 -44.79 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.752 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.91 -52.41 17.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.466 ' HG ' ' N ' ' A' ' 72' ' ' SER . 78.6 p -59.32 -42.41 91.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.466 ' N ' ' HG ' ' A' ' 71' ' ' SER . 23.2 t -70.4 -76.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.62 117.85 8.7 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.27 114.58 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.766 1.644 . . . . 0.0 112.255 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -72.63 -33.47 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.003 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' A' ' 77' ' ' ASN . 23.9 p90 -67.28 -51.95 46.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 110.628 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.537 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 31.7 t30 -77.69 -33.02 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.52 50.48 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.906 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 80' ' ' LYS . 8.3 p -64.68 -40.48 89.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.468 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 61.8 tttm -61.76 -39.59 92.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.704 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.263 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 N--CA 1.494 1.512 0 CA-C-O 120.669 0.195 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.91 -8.79 59.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.041 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -105.73 -57.59 2.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.114 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.434 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 4.1 mm? -61.64 -45.7 92.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.794 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.66 -37.73 88.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.317 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -57.77 -32.28 67.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.316 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -41.82 -38.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.774 0.321 . . . . 0.0 111.432 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 15' ' ' THR . 58.7 p -60.42 -52.92 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.7 mp -62.05 -52.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.172 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 tp -66.28 -38.24 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -33.28 77.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 11' ' ' SER . 21.1 p -83.08 -15.55 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.9 m -65.32 -60.74 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -59.41 -41.47 89.57 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.549 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.94 -46.11 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.623 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -57.47 12.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.0 mm? -63.6 -36.93 85.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 23' ' ' PHE . 34.4 m -59.86 -27.1 66.38 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.63 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -49.98 -5.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.222 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 21' ' ' SER . 36.5 m-85 -111.65 -21.16 11.85 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.5 m -44.62 -57.27 6.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.533 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 29' ' ' ILE . 20.5 Cg_endo -57.84 -47.26 21.63 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.066 1.844 . . . . 0.0 111.974 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -47.48 -48.94 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.412 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.08 -50.57 15.97 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.35 -49.57 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.558 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 25' ' ' PRO . 6.8 tt -54.48 -32.71 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.521 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -37.59 72.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 109.977 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -66.39 -36.48 82.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.453 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -69.58 -62.39 3.89 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.786 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -39.86 -35.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.775 0.321 . . . . 0.0 110.613 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.5 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.137 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' GLY . . . -57.51 -30.13 61.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.31 -26.94 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.2 m -53.31 -24.91 13.0 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 110.097 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.81 -38.55 7.33 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 -56.78 4.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 p -78.82 -49.3 13.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.919 0.39 . . . . 0.0 111.608 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 93.65 -49.99 2.32 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.04 104.16 0.15 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.522 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.35 30.37 1.5 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.3 m-20 -83.34 -25.27 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.194 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 8.5 p90 -103.47 38.61 1.75 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.981 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.36 -24.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.674 0.273 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.21 -50.85 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.979 0.418 . . . . 0.0 110.611 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -62.3 -54.56 48.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 34.6 Cg_endo -63.17 -22.16 72.71 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.149 1.899 . . . . 0.0 112.708 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 110.769 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.41 -27.33 62.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.773 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.41 -32.73 57.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.72 -44.49 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.267 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -40.78 91.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.432 ' O ' ' OG1' ' A' ' 58' ' ' THR . 30.0 mm -62.8 -40.2 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.73 93.72 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.18 -39.56 89.82 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.347 -0.502 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 23.1 p -64.58 -51.87 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.466 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.6 -41.84 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.147 0.499 . . . . 0.0 110.54 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -53.6 -34.05 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.517 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.41 -30.38 60.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 111.355 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.483 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 1.7 mp -70.79 -30.87 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.655 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -67.35 -46.13 74.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.589 ' NH1' ' NE2' ' A' ' 67' ' ' GLN . 15.2 mmm180 -76.33 -22.59 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.976 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -49.06 -48.27 44.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -45.83 65.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.68 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.589 ' NE2' ' NH1' ' A' ' 64' ' ' ARG . 53.8 tt0 -55.36 -33.3 63.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.929 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.46 54.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.305 0.574 . . . . 0.0 110.662 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -72.55 -27.43 62.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 73' ' ' THR . . . -60.34 -49.26 78.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.254 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -76.6 -37.8 55.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 m -66.26 -43.28 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.283 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -40.85 131.42 1.86 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.85 -23.14 22.61 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.11 1.873 . . . . 0.0 112.143 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.61 -45.53 92.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.444 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.41 -46.85 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.614 ' N ' HD21 ' A' ' 77' ' ' ASN . 1.3 m120 -65.78 -36.51 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.659 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.33 -45.54 94.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.5 t -62.31 -44.08 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.369 . . . . 0.0 110.049 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -55.1 85.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.437 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 79' ' ' VAL . 39.0 tptt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.238 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.005 0.335 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -66.02 -5.59 10.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.999 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -51.48 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 111.031 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.54 -53.9 53.13 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.958 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.54 -35.19 79.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.649 0.261 . . . . 0.0 110.391 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.651 ' HE ' HD21 ' A' ' 77' ' ' ASN . 77.9 ttt-85 -62.22 -20.43 64.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.837 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.0 t -42.09 -29.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.902 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.429 ' O ' ' OG1' ' A' ' 15' ' ' THR . 45.7 t -62.99 -48.53 78.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.44 -53.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.491 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.452 ' O ' ' OG1' ' A' ' 16' ' ' THR . 12.1 pt -63.14 -38.73 82.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.631 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.63 -28.29 72.38 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 11' ' ' SER . 78.8 m -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.549 -0.325 . . . . 0.0 111.539 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 70.5 p -75.17 -32.35 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.332 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.2 mm? -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.294 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.21 -41.87 90.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.053 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -62.33 1.82 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.497 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.78 -36.08 83.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 23' ' ' PHE . 38.3 m -60.23 -31.4 70.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.061 0.458 . . . . 0.0 110.385 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -51.25 -3.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.36 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 21' ' ' SER . 3.1 m-85 -91.74 -29.66 16.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.736 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -62.73 -49.06 84.28 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.033 -178.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 24' ' ' THR . 46.4 Cg_exo -54.3 -25.47 38.99 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.08 2.52 . . . . 0.0 112.916 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.4 -49.38 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 110.299 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.86 -48.73 10.43 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.139 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.22 -51.51 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 25' ' ' PRO . 19.4 tt -65.94 -39.12 83.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.8 tp -59.4 -40.61 87.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.11 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.06 -37.43 87.54 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.744 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.55 -62.3 4.19 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.093 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -42.62 -33.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.922 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.414 ' O ' ' OG ' ' A' ' 37' ' ' SER . 41.2 t -63.11 -45.13 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.599 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -27.91 50.63 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -27.65 68.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.852 0.358 . . . . 0.0 110.597 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.2 p -60.1 -32.31 70.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.602 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.24 -42.85 14.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.688 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.3 m -81.94 -48.02 12.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.008 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.65 31.51 10.18 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -119.51 54.65 0.99 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.425 0.631 . . . . 0.0 110.965 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.26 9.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 42' ' ' TYR . 47.1 m-20 -73.37 -39.86 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.122 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.87 38.31 1.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.24 -16.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.17 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.67 -50.09 7.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.261 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -68.47 -46.48 36.77 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.039 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 48.8 Cg_exo -54.89 -36.47 91.75 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.43 2.087 . . . . 0.0 112.045 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.01 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.13 -29.3 57.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.48 96.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.3 mp -63.86 -44.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.115 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.42 -42.4 96.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.305 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.41 -42.99 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.03 -33.95 88.64 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 m -63.56 -49.42 73.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.652 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.09 -35.04 70.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -48.59 -34.06 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.678 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.27 -38.81 19.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 62' ' ' ILE . 47.6 mm -56.21 -31.05 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.801 0.334 . . . . 0.0 110.785 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -68.15 -42.95 79.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -76.87 -23.48 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -50.19 -43.52 52.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.075 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -70.57 -46.72 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.007 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.97 -30.39 59.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.5 74.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.422 0.63 . . . . 0.0 109.98 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -60.19 -48.83 80.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.56 -51.72 67.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -64.09 -39.39 93.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.9 p -60.48 -42.09 95.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 96.64 40.43 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.833 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.46 80.93 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.162 1.908 . . . . 0.0 112.489 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.17 -42.17 23.93 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.749 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CE2' ' OD1' ' A' ' 77' ' ' ASN . 5.2 p90 -52.18 -55.68 19.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.01 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.651 HD21 ' HE ' ' A' ' 9' ' ' ARG . 5.7 p-10 -79.02 -31.17 44.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 110.795 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.15 93.97 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.98 -40.05 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -44.39 -53.47 6.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.212 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 mttt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.549 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.493 1.441 0 CA-C-O 121.0 0.333 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 68.1 mttm -73.69 -9.34 58.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 t -115.26 -32.79 5.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.306 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.02 -53.02 7.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -36.54 80.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -56.76 -18.76 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.631 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 11' ' ' SER . 9.8 p -57.32 -40.68 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.422 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 58.1 m -48.72 -46.36 40.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.865 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OG1' ' A' ' 16' ' ' THR . 96.3 mt -67.08 -44.86 87.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.186 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 13' ' ' ILE . 96.7 mt -63.4 -44.63 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.056 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.81 93.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -68.01 -17.79 64.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 23.7 m -79.5 -35.47 40.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.992 0.425 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' O ' ' OG ' ' A' ' 21' ' ' SER . 5.7 tt -66.2 -44.59 83.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 18.9 m -73.46 -41.42 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.867 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -56.12 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.85 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.7 mm? -62.46 -39.44 93.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 23' ' ' PHE . 37.4 m -59.58 -29.39 67.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.674 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 59.7 p -51.38 -3.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.602 ' H ' ' C ' ' A' ' 21' ' ' SER . 31.6 m-85 -99.21 -25.62 14.45 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.495 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -60.45 -48.1 94.57 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.251 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 24' ' ' THR . 54.0 Cg_exo -45.8 -11.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.88 2.386 . . . . 0.0 112.796 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 24' ' ' THR . 10.2 m -71.74 -41.41 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 120.993 0.425 . . . . 0.0 110.969 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 84.7 mt -58.56 -30.83 67.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.017 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -57.42 -30.9 37.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.631 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 tt -56.14 -37.39 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.677 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.04 -41.62 98.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.963 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 31' ' ' LEU . 3.4 tm? -67.1 -47.54 70.89 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.58 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.93 -54.35 14.76 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.266 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 4.7 p -53.19 -41.46 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.837 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.462 ' O ' ' OG ' ' A' ' 37' ' ' SER . 48.2 t -69.33 -48.79 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.65 -35.16 85.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.97 -34.4 77.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.6 p -63.38 -36.52 83.97 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.991 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.8 -41.53 5.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.61 -44.7 93.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.608 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 p -85.63 -43.35 13.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.774 0.321 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.26 23.87 30.68 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.645 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -115.58 49.4 1.09 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -64.97 24.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.95 -0.469 . . . . 0.0 110.86 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 42' ' ' TYR . 41.5 t0 -80.81 -38.63 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.23 45.58 1.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.02 -14.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.88 -36.53 15.91 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 6.5 tp -69.65 -43.37 21.67 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.307 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.5 Cg_exo -66.38 -18.33 54.95 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.294 2.663 . . . . 0.0 111.801 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -33.17 73.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.158 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.55 -23.1 5.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.301 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.35 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -64.04 -44.37 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 53' ' ' ILE . 51.4 m-85 -66.38 -43.97 84.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.365 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 ' O ' ' OG1' ' A' ' 58' ' ' THR . 67.9 mt -63.7 -43.48 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.881 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.33 80.39 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.61 -34.73 74.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.981 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 11.9 p -67.01 -50.23 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.182 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.0 -37.87 79.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.326 0.584 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CD1' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -47.78 -34.66 8.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.28 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.95 -27.61 3.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.08 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.17 -31.31 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -68.37 -44.69 74.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.457 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -77.11 -23.08 51.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.999 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -50.34 -48.96 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.061 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.16 -47.56 42.85 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.027 -0.42 . . . . 0.0 110.637 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.81 -28.28 9.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.658 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.55 -36.46 45.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.235 0.54 . . . . 0.0 109.7 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.5 -42.16 95.99 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.17 84.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -69.5 -36.94 76.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p -82.13 24.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -139.92 70.98 35.87 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.94 -70.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.831 2.354 . . . . 0.0 112.078 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -76.04 -42.17 48.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -38.7 -71.38 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.676 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -72.78 -25.97 61.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.18 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . -55.08 -36.61 61.51 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 -35.74 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.071 0.462 . . . . 0.0 110.211 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -46.95 76.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.515 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.735 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.499 1.851 0 N-CA-C 112.745 0.248 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -70.36 -6.84 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.701 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -138.86 -57.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -51.12 71.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.33 -31.14 70.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.149 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.95 57.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.232 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.1 -40.19 62.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.09 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -52.47 -44.88 65.84 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 16' ' ' THR . 75.0 mt -67.72 -48.94 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.668 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.31 -43.88 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -42.76 93.71 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.3 m -66.45 -17.97 65.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.809 0.338 . . . . 0.0 110.422 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 9.5 m -68.06 -46.68 70.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.243 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.66 -44.13 87.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.238 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.96 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.21 -57.22 12.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 110.442 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -38.31 85.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.078 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 34.4 m -59.16 -19.74 47.63 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.87 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -61.23 -6.64 2.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.86 -30.87 4.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.902 0.382 . . . . 0.0 111.49 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 m -40.16 -56.24 3.51 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 24' ' ' THR . 11.0 Cg_endo -51.56 -39.59 65.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.878 2.386 . . . . 0.0 112.213 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -48.25 -51.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.798 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -67.48 -49.76 62.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.64 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.18 -47.52 89.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.51 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.59 -37.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.397 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.4 tp -49.99 -34.16 20.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.759 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.62 -29.3 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.985 0.421 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.07 -49.98 4.53 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.076 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 9.9 p -52.54 -41.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.456 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 27.0 m -66.0 -34.43 70.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.459 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 37' ' ' SER . . . -57.13 -30.95 61.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -44.42 -23.05 0.09 Allowed 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.406 ' N ' ' C ' ' A' ' 35' ' ' GLY . 13.7 m -41.78 -18.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.306 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -55.04 -50.85 68.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.991 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -76.64 -60.01 2.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.368 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.496 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 4.0 m -76.55 -49.83 15.43 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.692 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.49 28.58 73.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.517 ' C ' ' H ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -129.68 106.76 8.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.596 0.236 . . . . 0.0 110.436 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 10.5 mp -70.16 13.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.72 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 42' ' ' TYR . 20.7 p-10 -60.84 -44.07 97.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 78.3 t80 -111.07 48.29 0.94 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.077 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -129.2 -26.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.621 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.8 -40.27 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.545 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -62.01 -50.45 80.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 38.0 Cg_endo -67.02 -14.99 45.63 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.661 2.241 . . . . 0.0 112.78 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.11 82.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 0.0 110.57 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.31 -21.0 3.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.4 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 1.8 pt -71.43 -43.14 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.947 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 71.6 m-85 -67.45 -49.89 61.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.426 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 3.8 tp -62.22 -41.84 92.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.094 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . -66.37 -31.4 78.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.88 -30.7 61.94 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.727 -0.278 . . . . 0.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.523 0.202 . . . . 0.0 110.522 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.37 -41.46 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.175 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -47.04 -57.23 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.902 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.59 82.76 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.165 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.79 -49.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.581 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -68.4 -40.32 81.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -19.36 60.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.972 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -47.43 -48.32 26.51 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.709 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -74.04 -46.6 42.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.016 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -53.83 -33.93 57.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.415 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -52.27 -50.51 61.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.175 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.67 -31.64 72.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.644 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.46 70.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.21 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.7 m -86.36 -37.06 18.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.36 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 55.0 p -71.54 -7.56 48.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 75' ' ' LYS . 3.9 m -129.09 100.85 20.03 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.47 45.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 123.288 2.658 . . . . 0.0 112.856 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 73' ' ' THR . 84.8 tttt -64.78 -28.6 69.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.02 0.438 . . . . 0.0 110.394 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -59.34 -37.62 78.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -60.4 -43.32 96.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.4 96.16 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.22 -41.15 88.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -65.63 -37.51 86.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.563 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.556 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.492 1.434 0 CA-C-O 121.056 0.357 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.44 -8.44 19.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.01 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.1 m -135.8 -55.23 0.78 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.71 -48.82 80.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.739 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CD2' ' HZ2' ' A' ' 80' ' ' LYS . 5.2 tt -67.6 -33.53 75.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.98 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.675 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.97 -37.66 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.501 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.4 m -53.56 -46.37 70.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.663 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 70.2 mt -65.46 -47.96 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.389 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.94 -45.45 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.797 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.1 -38.97 94.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.8 m -70.58 -19.83 62.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 36.4 m -75.79 -44.41 41.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 17' ' ' LEU . 8.0 tt -63.75 -45.35 90.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.582 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -64.75 -36.5 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.11 -62.37 1.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.512 ' O ' ' OG1' ' A' ' 24' ' ' THR . 11.1 mp -50.3 -53.71 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 30.2 m -46.71 -31.34 2.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.274 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -62.57 -28.64 70.01 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.614 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.26 -33.79 4.87 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -43.74 -49.75 19.39 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' O ' ' A' ' 21' ' ' SER . 89.1 Cg_exo -41.87 -34.11 2.34 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.834 1.69 . . . . 0.0 112.576 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 27' ' ' LEU . 15.8 m -49.16 -45.11 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.605 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' H ' HG22 ' A' ' 26' ' ' VAL . 8.9 mt -73.95 -50.91 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.202 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.33 -47.48 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.232 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.72 -33.52 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.3 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.3 -39.04 72.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.373 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.89 -38.49 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.0 -40.69 50.87 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.95 -49.87 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.556 0.217 . . . . 0.0 111.012 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' A' ' 37' ' ' SER . 8.9 p -66.42 -43.24 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.98 93.7 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -65.95 -39.64 90.64 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' GLY . 91.1 p -63.15 -33.11 74.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.701 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 -40.76 7.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.343 0.592 . . . . 0.0 109.875 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.81 -45.69 92.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.297 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.86 -47.15 8.07 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -149.4 -169.15 15.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' C ' ' H ' ' A' ' 44' ' ' ASP . 75.8 m-85 -106.5 -143.31 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.9 mp -75.15 19.02 0.17 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 19.8 p-10 -67.86 -56.5 8.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 29.8 t80 -101.14 44.08 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.041 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.53 -16.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.6 -47.74 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.2 mm? -63.14 -58.17 17.38 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.948 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 36.1 Cg_endo -62.16 -18.28 61.19 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.121 1.88 . . . . 0.0 112.997 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.81 73.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -53.47 -24.38 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.05 10.93 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.979 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 54' ' ' PHE . 3.6 tp -61.09 -45.53 98.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.182 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.489 ' N ' ' CG2' ' A' ' 53' ' ' ILE . 54.7 t80 -63.65 -43.63 96.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.003 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.7 -43.77 98.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.927 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.4 81.68 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.53 -36.56 78.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 0.0 110.023 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 m -62.78 -40.05 96.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.44 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.8 -42.4 94.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -45.52 -52.13 10.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.249 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -61.35 -48.13 82.68 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.489 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.75 -50.31 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.86 -40.23 94.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.227 0.537 . . . . 0.0 110.385 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.75 -20.44 58.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.921 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' ALA . 10.7 tptp -53.78 -35.79 61.71 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.203 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.617 HH21 ' H ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -76.62 -52.96 8.71 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.283 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.404 ' NE2' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -54.47 -23.81 17.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.04 -50.73 46.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.658 0.742 . . . . 0.0 110.374 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -63.51 -45.19 91.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.396 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' H ' HH21 ' A' ' 66' ' ' ARG . . . -63.83 -34.59 78.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.991 0.424 . . . . 0.0 110.538 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.404 ' OG ' ' NE2' ' A' ' 67' ' ' GLN . 58.8 m -75.75 -28.22 58.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.515 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 p -99.44 -77.0 0.53 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 75' ' ' LYS . 2.1 m -33.84 97.71 0.12 Allowed Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 123.485 0.491 . . . . 0.0 111.283 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.79 -4.08 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.105 1.87 . . . . 0.0 112.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 73' ' ' THR . 64.6 tttm -60.54 -33.64 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 77' ' ' ASN . 2.1 p90 -56.05 -46.18 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.056 0.455 . . . . 0.0 110.108 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 18.1 t-20 -66.23 -34.14 77.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.616 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.97 93.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.75 -35.68 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.939 0.369 . . . . 0.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HZ2' ' CD2' ' A' ' 8' ' ' LEU . 59.1 mttm -78.46 -11.15 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.8 tptm . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.486 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.506 2.217 0 N-CA-C 113.064 0.371 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -77.1 -8.74 58.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.769 0.319 . . . . 0.0 110.661 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -27.58 8.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.487 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 6.9 mp -87.99 -56.12 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.617 0.246 . . . . 0.0 110.712 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.2 tp -62.56 -37.84 87.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.827 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.95 -17.66 10.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.84 0.352 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 7' ' ' LEU . 7.7 p -54.97 -35.46 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.537 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' OG1' ' A' ' 15' ' ' THR . 77.7 p -56.06 -47.87 77.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.056 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' OG1' ' A' ' 16' ' ' THR . 32.7 mm -66.3 -47.39 84.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.85 -45.9 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.752 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.33 93.68 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 11' ' ' SER . 98.1 m -64.83 -19.19 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.584 0.231 . . . . 0.0 110.84 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 9.0 m -85.74 -34.79 21.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.385 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 tp -71.46 -32.74 68.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.111 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.41 -56.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.331 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.91 76.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.96 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.34 -48.95 68.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.617 ' C ' ' H ' ' A' ' 23' ' ' PHE . 66.6 m -73.71 -38.16 64.94 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.215 0.531 . . . . 0.0 110.721 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -50.59 0.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.919 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.617 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.4 m-85 -102.2 -21.31 14.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -64.72 -45.85 75.83 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 24' ' ' THR . 51.3 Cg_exo -52.96 -14.39 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.592 2.195 . . . . 0.0 112.522 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.0 -42.68 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.554 0.692 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.55 -39.05 74.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.859 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 29' ' ' ILE . 3.4 m -65.28 -42.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.537 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 30.2 pt -67.92 -34.73 68.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.825 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.9 -41.62 96.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.05 -40.92 93.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.88 -46.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.307 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 37' ' ' SER . 59.6 t -68.92 -41.54 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.323 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.83 -36.36 86.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.65 -24.67 65.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 41' ' ' GLY . 95.2 p -50.33 -23.23 2.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.16 23.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.706 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.73 -58.76 3.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 m -76.1 -47.83 23.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.916 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 85.86 -54.37 4.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 44' ' ' ASP . 73.9 m-85 -52.04 106.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.573 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.759 ' H ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.33 21.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.737 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 42' ' ' TYR . 50.3 t0 -61.56 -44.27 97.34 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.943 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.56 47.75 0.89 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -118.88 -36.92 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.61 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.5 -39.43 17.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.696 0.284 . . . . 0.0 111.425 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -60.17 -50.71 84.81 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 53.5 Cg_exo -48.99 -44.88 31.06 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.115 1.877 . . . . 0.0 112.295 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.72 67.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.97 92.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.61 -44.88 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.76 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.29 -48.77 71.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.2 tt -66.43 -40.92 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.685 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.78 -38.09 94.06 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.11 -38.78 91.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.674 0.273 . . . . 0.0 111.366 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.0 m -61.67 -48.46 80.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.918 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 0.0 110.366 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -47.78 -32.25 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.262 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -49.52 -28.76 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 111.297 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.26 -30.51 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.807 0.337 . . . . 0.0 111.767 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.606 ' NE2' ' CE1' ' A' ' 60' ' ' TYR . 7.1 tt0 -68.03 -45.2 74.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -76.59 -22.94 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -28.7 6.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 9.7 ptt180 -74.55 -48.65 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.336 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -54.48 -27.34 37.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.006 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . -54.64 -48.59 72.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.305 0.574 . . . . 0.0 110.017 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -67.64 -35.5 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.311 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.65 98.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.358 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.8 m -86.13 -46.67 10.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.718 0.294 . . . . 0.0 111.189 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 79.4 p -64.95 -32.61 74.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.071 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 75' ' ' LYS . 34.8 p -139.57 79.24 24.89 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.128 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.81 77.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.575 2.184 . . . . 0.0 111.503 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.59 -42.14 95.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.558 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 27.9 p90 -55.6 -47.06 77.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.459 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.561 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.82 -28.34 67.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.88 52.64 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.51 -34.75 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.671 0.272 . . . . 0.0 111.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -67.02 -81.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 tptm . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.445 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mmm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -59.31 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 5' ' ' LYS . 5.1 t70 -50.9 137.42 25.87 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.948 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.86 -8.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.708 2.272 . . . . 0.0 112.499 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 3' ' ' ASP . 47.8 tttm -64.2 -37.14 86.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -105.47 -24.37 12.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.982 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.65 -51.08 69.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.273 0.559 . . . . 0.0 110.33 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -9.87 35.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -20.49 62.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.51 -35.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' OG1' ' A' ' 15' ' ' THR . 8.1 t -61.27 -52.83 63.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.772 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.447 ' O ' ' OG1' ' A' ' 16' ' ' THR . 74.5 mt -60.41 -54.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.452 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.72 -41.2 91.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.561 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.46 -38.99 80.29 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 11' ' ' SER . 77.5 m -74.18 -16.46 60.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.987 0.423 . . . . 0.0 110.485 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 96.6 m -73.11 -45.24 58.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.261 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.8 mt -68.08 -45.09 74.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.73 -41.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.38 32.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.308 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD1' HH21 ' A' ' 64' ' ' ARG . 75.4 mt -65.39 -36.09 82.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 23' ' ' PHE . 46.8 t -64.93 -33.24 75.57 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.893 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -50.59 -2.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 21' ' ' SER . 63.2 m-85 -119.09 -25.53 6.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.434 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 91.5 m -47.52 -46.39 59.22 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.778 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 24' ' ' THR . 55.7 Cg_exo -47.44 -32.56 15.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.772 2.315 . . . . 0.0 112.682 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 5.9 p -49.15 -47.37 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.504 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 11.5 mt -64.13 -48.05 77.58 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.311 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.86 -42.78 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.56 -43.26 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.25 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -40.56 60.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.72 -40.74 89.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.09 -35.92 57.11 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -58.37 -51.72 67.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.411 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.73 -39.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.208 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.71 -36.93 93.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.1 -33.14 75.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 41' ' ' GLY . 50.2 m -56.64 -28.04 59.73 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.808 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.7 69.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.0 mm? -67.72 -58.99 3.69 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 40' ' ' THR . 2.1 t -75.99 -49.46 17.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.413 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 107.97 64.61 0.58 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 45' ' ' TYR . 3.0 m-85 -105.98 11.44 31.62 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 42' ' ' TYR . 4.4 mm? -31.67 -32.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.364 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 42' ' ' TYR . 24.4 t0 -71.37 -41.98 69.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.269 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 42' ' ' TYR . 23.8 t80 -92.73 53.05 1.96 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.593 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.3 -39.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.9 0.381 . . . . 0.0 110.484 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.16 -39.98 32.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.0 110.758 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 mp -60.04 -58.92 15.81 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 17.9 Cg_endo -58.13 -16.18 26.3 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.137 2.558 . . . . 0.0 112.365 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 -32.82 74.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.64 -24.79 15.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.533 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.35 58.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.414 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.52 -46.16 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.445 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.25 -45.08 89.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.95 -44.85 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.42 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 60' ' ' TYR . . . -66.96 -32.15 80.09 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tp -59.95 -41.21 91.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 110.513 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.6 p -65.69 -39.93 91.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.379 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.64 -50.13 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 5.9 m-30 -49.9 -29.87 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.55 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.577 0.227 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tp -62.44 -29.91 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 110.811 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.5 -40.77 89.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.519 HH21 ' CD1' ' A' ' 20' ' ' LEU . 14.5 mmt180 -76.02 -22.94 55.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.97 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -48.27 -47.72 36.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.188 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 0.6 OUTLIER -72.75 -49.15 32.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.737 0.303 . . . . 0.0 110.669 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 83.5 mt-30 -53.84 -31.01 47.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.308 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' O ' ' OG ' ' A' ' 71' ' ' SER . . . -53.64 -53.53 50.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 110.227 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -70.59 -44.84 66.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.08 -32.65 66.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.215 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 87.5 p -71.39 -39.45 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.386 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -96.39 -79.93 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.569 ' C ' ' H ' ' A' ' 75' ' ' LYS . 11.7 m -39.27 101.83 0.24 Allowed Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 25.9 Cg_exo -60.55 31.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 123.027 2.485 . . . . 0.0 112.774 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 73' ' ' THR . 27.4 mttt -67.2 -44.42 79.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 38.7 p90 -57.92 -50.98 71.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 5.2 p-10 -78.58 -23.4 46.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.81 82.85 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.43 -43.76 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.331 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' LYS . 41.7 mmtm -54.42 -41.2 69.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' LYS . 13.1 tptt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -145.71 50.06 1.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.545 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -123.53 85.7 52.63 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.9 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.81 -18.93 13.59 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.564 2.176 . . . . 0.0 111.916 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -74.47 -14.68 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -114.3 -27.66 7.53 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.899 0.38 . . . . 0.0 110.699 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.12 -55.77 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.58 80.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.362 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -61.67 -20.78 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.95 -35.43 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.713 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -55.8 -45.58 78.23 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.711 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.41 -45.56 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.045 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' OG1' ' A' ' 16' ' ' THR . 38.8 mm -64.09 -44.41 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 0.0 110.294 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -42.17 58.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.6 m -67.89 -21.56 65.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.672 0.273 . . . . 0.0 110.666 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 3.2 p -82.35 -35.7 27.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 110.371 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.77 -47.04 56.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.4 t -68.43 -41.31 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.168 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.43 58.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.559 0.695 . . . . 0.0 109.79 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.01 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.523 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.549 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 8.5 m -61.26 -23.06 65.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.17 0.51 . . . . 0.0 110.323 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.6 t -78.68 -11.47 59.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.9 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.555 ' CZ ' ' OE1' ' A' ' 63' ' ' GLN . 54.6 m-85 -108.68 -45.5 3.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.002 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.18 -50.28 11.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.321 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CD ' ' O ' ' A' ' 21' ' ' SER . 77.5 Cg_exo -44.84 -41.38 15.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.746 1.631 . . . . 0.0 112.157 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -48.18 -48.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.193 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.39 -53.75 50.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.499 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -33.53 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 121.229 -0.188 . . . . 0.0 111.309 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 32' ' ' GLY . 6.1 tt -42.84 -32.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.693 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.24 -30.28 1.18 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.07 -37.15 75.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.046 0.451 . . . . 0.0 109.949 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' ILE . . . -72.42 -52.79 9.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.501 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 ' CG2' ' N ' ' A' ' 34' ' ' VAL . 13.6 m -54.08 -44.45 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.607 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 37' ' ' SER . 14.2 p -71.28 -37.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.03 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.3 96.2 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.93 -26.62 68.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.667 ' HG ' ' N ' ' A' ' 38' ' ' ALA . 53.0 p -62.8 -41.41 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 110.355 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.667 ' N ' ' HG ' ' A' ' 37' ' ' SER . . . -55.15 -44.28 74.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.591 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.5 -73.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -79.54 -48.73 13.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 114.16 67.24 0.46 Allowed Glycine 0 N--CA 1.472 1.069 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 45' ' ' TYR . 64.1 m-85 -98.41 14.25 28.77 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -36.57 -43.49 0.4 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.978 0.418 . . . . 0.0 110.81 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.33 -36.21 82.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.108 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' TYR . 90.6 m-85 -107.35 46.8 0.92 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -120.31 -33.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 110.229 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -66.32 -40.45 89.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.6 mt -67.77 -59.88 6.15 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.691 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -40.62 -22.69 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.812 1.674 . . . . 0.0 113.51 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -70.36 -36.81 74.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.42 0.629 . . . . 0.0 110.333 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 10.3 mp -59.94 -26.01 65.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.692 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.88 81.45 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.37 -43.37 94.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.593 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -47.78 -39.8 19.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 109.865 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 55' ' ' ILE . 96.7 mt -60.81 -28.01 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.424 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.3 -38.04 67.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.63 -37.84 87.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.98 0.419 . . . . 0.0 110.581 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.649 ' HG1' ' N ' ' A' ' 59' ' ' ILE . 14.1 p -63.93 -52.58 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.444 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.649 ' N ' ' HG1' ' A' ' 58' ' ' THR . 17.4 tt -70.38 -39.88 77.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.81 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -53.57 -34.39 58.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.46 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.01 -40.06 79.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.663 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.62 -31.18 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.731 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' OE1' ' CZ ' ' A' ' 23' ' ' PHE . 27.7 mt-30 -67.05 -48.97 66.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.963 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -75.95 -22.79 55.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.857 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.71 -48.18 63.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.677 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 12.0 ptt180 -63.8 -48.68 75.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.265 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.446 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -54.29 -28.21 40.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 -178.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.54 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.345 0.593 . . . . 0.0 110.329 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 73' ' ' THR . 50.3 t0 -73.06 -40.89 64.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.57 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.98 -49.29 66.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.002 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -62.24 -42.55 99.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.729 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.9 p -73.89 -25.7 60.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' ASP . 26.1 m -132.9 81.74 57.21 Favored Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.531 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.85 125.63 18.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.299 1.999 . . . . 0.0 111.802 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.86 -28.84 35.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.1 m-85 -91.26 -59.57 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.557 ' N ' HD21 ' A' ' 77' ' ' ASN . 1.6 m120 -62.95 -25.76 68.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.5 -60.7 6.72 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.75 -42.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.066 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -77.13 -106.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.812 0.339 . . . . 0.0 110.344 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ASN . 2.4 mptm? . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.21 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' CB ' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -148.15 -63.89 0.25 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.957 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.38 164.59 42.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.353 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 6' ' ' THR . 41.3 Cg_exo -51.78 -3.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.193 1.928 . . . . 0.0 112.6 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.555 ' H ' ' C ' ' A' ' 3' ' ' ASP . 5.0 ttpm? -37.86 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.836 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 4' ' ' PRO . 73.4 p -124.12 -44.78 2.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.385 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 10.0 mp -56.29 -41.62 76.21 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.494 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 10' ' ' VAL . 1.8 tt -60.9 -76.88 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.296 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -45.42 -19.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 6' ' ' THR . 39.4 t -82.89 -55.99 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -60.89 -42.01 97.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.778 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.424 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 tp -51.79 -18.2 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.685 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.46 -43.68 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.806 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.06 -41.35 99.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -71.04 -19.85 62.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.567 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 15.1 m -67.26 -42.62 83.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 109.907 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -42.04 96.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.768 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 -44.71 96.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.28 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.43 65.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.573 0.702 . . . . 0.0 109.176 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.17 -36.93 83.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.9 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.2 t -51.99 -24.25 6.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.485 0.66 . . . . 0.0 110.603 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -77.86 -7.98 57.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.857 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -114.89 -54.22 2.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -66.06 -64.33 2.49 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.455 -177.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.46 -13.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.323 2.015 . . . . 0.0 113.469 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 24' ' ' THR . 52.4 t -59.34 -38.35 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.84 71.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.663 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.75 -41.57 93.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.338 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.05 -39.89 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.29 -37.05 71.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.57 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.65 -38.77 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -57.1 6.83 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.355 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -44.11 -32.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.58 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.89 -43.93 96.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.09 -33.25 85.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.2 tp -64.67 -34.45 78.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 0.0 110.255 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 41' ' ' GLY . 32.7 t -63.79 -33.37 75.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.406 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.39 -47.86 66.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 110.942 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.15 -60.45 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.067 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.554 ' HG1' ' N ' ' A' ' 41' ' ' GLY . 71.9 p -78.55 -45.77 21.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 89.59 107.01 1.18 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -112.52 117.17 31.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.218 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 3.7 mm? -83.66 -67.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.58 0.81 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.466 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.49 40.27 1.24 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.17 -25.55 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 110.289 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -84.97 -43.04 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -66.38 -49.22 54.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 46.0 Cg_endo -67.96 -15.57 43.77 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.724 1.616 . . . . 0.0 112.71 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.45 81.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.1 mm? -61.42 -25.68 67.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.67 90.33 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.99 -45.91 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -65.26 -43.13 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.528 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.85 -43.19 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 0.0 110.214 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.74 96.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 mp -62.73 -34.09 76.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.64 0.257 . . . . 0.0 111.167 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 m -64.5 -48.19 76.08 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 pt -71.5 -40.99 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.895 0.379 . . . . 0.0 111.943 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -55.35 -37.61 67.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.673 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.95 -26.76 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 tt -62.19 -30.82 49.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.624 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -30.45 70.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -76.33 -22.01 55.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.823 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.16 -42.99 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.335 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -47.38 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.184 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -54.21 -28.34 40.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.725 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.432 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . -51.94 -52.3 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.827 0.823 . . . . 0.0 109.799 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 73' ' ' THR . 34.8 m-20 -70.05 -33.6 72.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.096 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.27 66.46 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.547 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.7 t -90.88 -31.95 16.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 7.9 m -83.22 -7.9 59.54 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.688 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.4 m -139.97 63.18 24.02 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 110.361 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.33 41.11 0.91 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 0.0 111.577 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -63.01 -41.82 99.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -53.9 -69.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -65.62 -30.57 71.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.84 -57.59 11.91 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.4 t -77.01 -55.36 10.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.35 . . . . 0.0 110.81 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -82.51 152.59 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.243 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -35.32 80.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 5' ' ' LYS . 41.3 m-20 -121.23 155.81 58.1 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.108 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.55 10.67 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.71 1.607 . . . . 0.0 112.44 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 3' ' ' ASP . 5.5 mtmp? -69.4 -12.9 62.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -113.71 -51.77 2.78 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.802 0.334 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 10.4 mp -59.86 -51.35 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.85 -37.42 79.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.256 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -63.58 -18.3 63.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -67.79 -39.91 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.684 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' OG1' ' A' ' 15' ' ' THR . 4.0 t -59.58 -52.89 63.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 13' ' ' ILE . 2.0 tp -63.41 -46.14 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 78.0 mt -63.8 -44.12 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.377 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.1 -40.12 62.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 11' ' ' SER . 41.3 p -73.69 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 111.085 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 16' ' ' THR . 1.6 p -78.28 -39.78 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.411 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.05 -42.83 96.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.74 -40.72 81.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.57 -59.7 4.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.092 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.29 -34.83 75.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.328 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 23' ' ' PHE . 47.9 m -65.39 -32.94 74.83 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 110.69 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.7 p -50.49 -0.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.614 ' H ' ' C ' ' A' ' 21' ' ' SER . 7.4 m-85 -103.97 -20.71 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.73 0.3 . . . . 0.0 110.386 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.94 -47.39 53.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.152 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 24' ' ' THR . 71.5 Cg_exo -45.17 -26.63 2.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.518 2.145 . . . . 0.0 112.876 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 p -49.44 -23.96 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.884 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.87 -34.78 78.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 p -60.96 -39.62 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.342 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.0 mt -64.6 -44.46 96.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.289 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.91 -41.68 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.803 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.42 -42.24 98.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.47 85.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.49 -46.23 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.38 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.92 -46.97 94.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.254 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.62 90.22 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.36 -41.17 76.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 110.828 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' GLY . 62.5 m -70.88 -39.7 72.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.85 -49.19 40.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.483 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -62.74 -43.31 99.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.125 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -88.5 5.11 44.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 43.01 77.13 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 44' ' ' ASP . 59.9 t80 -166.92 35.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.827 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 42' ' ' TYR . 51.1 t0 -86.02 -28.27 24.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.571 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 76.8 t80 -99.56 48.71 0.94 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -116.19 -25.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.627 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.12 -37.13 24.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.506 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.85 -54.42 46.9 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.455 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.14 -37.14 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.922 1.748 . . . . 0.0 112.366 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.68 28.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.01 -41.78 98.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.106 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.95 91.5 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.946 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.95 -46.15 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.077 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -64.61 -44.96 88.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' O ' ' OG1' ' A' ' 58' ' ' THR . 97.9 mt -64.11 -43.29 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.95 -37.51 92.2 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.27 -45.24 88.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.543 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 17.2 p -55.19 -46.84 75.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.0 pt -70.55 -37.42 69.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 110.432 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -53.63 -35.09 60.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.693 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.55 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.597 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.94 -31.59 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.512 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.74 -42.54 73.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.134 0.492 . . . . 0.0 111.113 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -75.8 -23.19 55.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.498 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.53 -46.45 38.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.662 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -69.46 -45.94 67.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.646 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -56.29 -30.0 61.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.52 -42.21 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.006 -0.277 . . . . 0.0 110.649 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.95 -44.79 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.752 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.91 -52.41 17.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.466 ' HG ' ' N ' ' A' ' 72' ' ' SER . 78.6 p -59.32 -42.41 91.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.466 ' N ' ' HG ' ' A' ' 71' ' ' SER . 23.2 t -70.4 -76.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.62 117.85 8.7 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.27 114.58 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.766 1.644 . . . . 0.0 112.255 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -72.63 -33.47 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.003 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' A' ' 77' ' ' ASN . 23.9 p90 -67.28 -51.95 46.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 110.628 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.537 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 31.7 t30 -77.69 -33.02 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.52 50.48 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.906 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 80' ' ' LYS . 8.3 p -64.68 -40.48 89.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.468 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 61.8 tttm -61.76 -39.59 92.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.704 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.263 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 105.64 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -139.11 145.69 46.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.472 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.5 -30.09 43.92 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.18 1.92 . . . . 0.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.91 -8.79 59.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.041 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -105.73 -57.59 2.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.114 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 4.1 mm? -61.64 -45.7 92.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.794 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.66 -37.73 88.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.317 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -57.77 -32.28 67.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.316 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -41.82 -38.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.774 0.321 . . . . 0.0 111.432 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 15' ' ' THR . 58.7 p -60.42 -52.92 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.7 mp -62.05 -52.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.172 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 tp -66.28 -38.24 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -33.28 77.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 11' ' ' SER . 21.1 p -83.08 -15.55 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.9 m -65.32 -60.74 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -59.41 -41.47 89.57 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.549 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.94 -46.11 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.623 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -57.47 12.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.0 mm? -63.6 -36.93 85.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 23' ' ' PHE . 34.4 m -59.86 -27.1 66.38 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.63 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -49.98 -5.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.222 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 21' ' ' SER . 36.5 m-85 -111.65 -21.16 11.85 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.5 m -44.62 -57.27 6.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.533 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 29' ' ' ILE . 20.5 Cg_endo -57.84 -47.26 21.63 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.066 1.844 . . . . 0.0 111.974 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -47.48 -48.94 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.412 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.08 -50.57 15.97 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.35 -49.57 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.558 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 25' ' ' PRO . 6.8 tt -54.48 -32.71 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.521 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -37.59 72.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 109.977 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -66.39 -36.48 82.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.453 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -69.58 -62.39 3.89 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.786 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -39.86 -35.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.775 0.321 . . . . 0.0 110.613 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.5 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.137 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' GLY . . . -57.51 -30.13 61.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.31 -26.94 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.2 m -53.31 -24.91 13.0 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 110.097 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.81 -38.55 7.33 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 -56.78 4.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 p -78.82 -49.3 13.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.919 0.39 . . . . 0.0 111.608 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 93.65 -49.99 2.32 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.04 104.16 0.15 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.522 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.35 30.37 1.5 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.3 m-20 -83.34 -25.27 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.194 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 8.5 p90 -103.47 38.61 1.75 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.981 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.36 -24.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.674 0.273 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.21 -50.85 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.979 0.418 . . . . 0.0 110.611 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -62.3 -54.56 48.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 34.6 Cg_endo -63.17 -22.16 72.71 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.149 1.899 . . . . 0.0 112.708 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 110.769 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.41 -27.33 62.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.773 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.41 -32.73 57.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.72 -44.49 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.267 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -40.78 91.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.432 ' O ' ' OG1' ' A' ' 58' ' ' THR . 30.0 mm -62.8 -40.2 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.73 93.72 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.18 -39.56 89.82 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.347 -0.502 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 23.1 p -64.58 -51.87 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.466 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.6 -41.84 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.147 0.499 . . . . 0.0 110.54 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -53.6 -34.05 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.517 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.41 -30.38 60.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 111.355 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.483 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 1.7 mp -70.79 -30.87 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.655 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -67.35 -46.13 74.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.589 ' NH1' ' NE2' ' A' ' 67' ' ' GLN . 15.2 mmm180 -76.33 -22.59 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.976 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -49.06 -48.27 44.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -45.83 65.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.68 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.589 ' NE2' ' NH1' ' A' ' 64' ' ' ARG . 53.8 tt0 -55.36 -33.3 63.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.929 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.46 54.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.305 0.574 . . . . 0.0 110.662 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -72.55 -27.43 62.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 73' ' ' THR . . . -60.34 -49.26 78.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.254 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -76.6 -37.8 55.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 m -66.26 -43.28 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.283 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -40.85 131.42 1.86 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.85 -23.14 22.61 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.11 1.873 . . . . 0.0 112.143 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.61 -45.53 92.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.444 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.41 -46.85 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.614 ' N ' HD21 ' A' ' 77' ' ' ASN . 1.3 m120 -65.78 -36.51 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.659 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.33 -45.54 94.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.5 t -62.31 -44.08 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.369 . . . . 0.0 110.049 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -55.1 85.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.437 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 79' ' ' VAL . 39.0 tptt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.238 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.49 26.68 6.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 66.29 76.37 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.43 -5.15 16.26 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.732 2.288 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -66.02 -5.59 10.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.999 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -51.48 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 111.031 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.54 -53.9 53.13 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.958 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.54 -35.19 79.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.649 0.261 . . . . 0.0 110.391 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.651 ' HE ' HD21 ' A' ' 77' ' ' ASN . 77.9 ttt-85 -62.22 -20.43 64.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.837 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.0 t -42.09 -29.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.902 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.429 ' O ' ' OG1' ' A' ' 15' ' ' THR . 45.7 t -62.99 -48.53 78.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.44 -53.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.491 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.452 ' O ' ' OG1' ' A' ' 16' ' ' THR . 12.1 pt -63.14 -38.73 82.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.631 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.63 -28.29 72.38 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 11' ' ' SER . 78.8 m -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.549 -0.325 . . . . 0.0 111.539 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 13' ' ' ILE . 70.5 p -75.17 -32.35 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.332 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.2 mm? -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.294 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.21 -41.87 90.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.053 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -62.33 1.82 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.497 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.78 -36.08 83.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 23' ' ' PHE . 38.3 m -60.23 -31.4 70.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.061 0.458 . . . . 0.0 110.385 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -51.25 -3.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.36 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 21' ' ' SER . 3.1 m-85 -91.74 -29.66 16.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.736 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -62.73 -49.06 84.28 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.033 -178.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 24' ' ' THR . 46.4 Cg_exo -54.3 -25.47 38.99 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.08 2.52 . . . . 0.0 112.916 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.4 -49.38 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 110.299 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.86 -48.73 10.43 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.139 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.22 -51.51 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 25' ' ' PRO . 19.4 tt -65.94 -39.12 83.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.8 tp -59.4 -40.61 87.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.11 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.06 -37.43 87.54 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.744 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.55 -62.3 4.19 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.093 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -42.62 -33.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.922 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' O ' ' OG ' ' A' ' 37' ' ' SER . 41.2 t -63.11 -45.13 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.599 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -27.91 50.63 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -27.65 68.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.852 0.358 . . . . 0.0 110.597 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.2 p -60.1 -32.31 70.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.602 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.24 -42.85 14.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.688 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.3 m -81.94 -48.02 12.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.008 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.65 31.51 10.18 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -119.51 54.65 0.99 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.425 0.631 . . . . 0.0 110.965 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.26 9.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 42' ' ' TYR . 47.1 m-20 -73.37 -39.86 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.122 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.87 38.31 1.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.24 -16.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.17 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.67 -50.09 7.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.261 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -68.47 -46.48 36.77 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.039 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 48.8 Cg_exo -54.89 -36.47 91.75 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.43 2.087 . . . . 0.0 112.045 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.01 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.13 -29.3 57.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.48 96.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.3 mp -63.86 -44.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.115 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.42 -42.4 96.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.305 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.41 -42.99 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.03 -33.95 88.64 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 m -63.56 -49.42 73.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.652 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.09 -35.04 70.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -48.59 -34.06 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.678 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.27 -38.81 19.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 62' ' ' ILE . 47.6 mm -56.21 -31.05 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.801 0.334 . . . . 0.0 110.785 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -68.15 -42.95 79.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -76.87 -23.48 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -50.19 -43.52 52.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.075 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -70.57 -46.72 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.007 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.97 -30.39 59.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.5 74.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.422 0.63 . . . . 0.0 109.98 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -60.19 -48.83 80.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.56 -51.72 67.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -64.09 -39.39 93.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.9 p -60.48 -42.09 95.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 96.64 40.43 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.833 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.46 80.93 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.162 1.908 . . . . 0.0 112.489 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -80.17 -42.17 23.93 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.749 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CE2' ' OD1' ' A' ' 77' ' ' ASN . 5.2 p90 -52.18 -55.68 19.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.01 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.651 HD21 ' HE ' ' A' ' 9' ' ' ARG . 5.7 p-10 -79.02 -31.17 44.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 110.795 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.15 93.97 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.98 -40.05 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 110.681 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -44.39 -53.47 6.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.212 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 mttt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.549 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mmm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -76.18 -16.5 59.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 23.5 p-10 -139.72 71.14 36.99 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -71.73 86.45 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.899 2.399 . . . . 0.0 111.558 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 68.1 mttm -73.69 -9.34 58.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 t -115.26 -32.79 5.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.306 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.02 -53.02 7.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.96 -36.54 80.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -56.76 -18.76 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.631 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 11' ' ' SER . 9.8 p -57.32 -40.68 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.422 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 58.1 m -48.72 -46.36 40.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.865 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OG1' ' A' ' 16' ' ' THR . 96.3 mt -67.08 -44.86 87.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.186 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 13' ' ' ILE . 96.7 mt -63.4 -44.63 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.056 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.81 93.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -68.01 -17.79 64.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 23.7 m -79.5 -35.47 40.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.992 0.425 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' O ' ' OG ' ' A' ' 21' ' ' SER . 5.7 tt -66.2 -44.59 83.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 18.9 m -73.46 -41.42 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.867 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' OG ' ' A' ' 22' ' ' SER . . . -56.12 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.85 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.7 mm? -62.46 -39.44 93.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 23' ' ' PHE . 37.4 m -59.58 -29.39 67.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.674 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 59.7 p -51.38 -3.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.602 ' H ' ' C ' ' A' ' 21' ' ' SER . 31.6 m-85 -99.21 -25.62 14.45 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.495 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -60.45 -48.1 94.57 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.251 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 24' ' ' THR . 54.0 Cg_exo -45.8 -11.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.88 2.386 . . . . 0.0 112.796 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 24' ' ' THR . 10.2 m -71.74 -41.41 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 120.993 0.425 . . . . 0.0 110.969 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 84.7 mt -58.56 -30.83 67.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.017 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -57.42 -30.9 37.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.631 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 tt -56.14 -37.39 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.677 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.04 -41.62 98.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.963 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 31' ' ' LEU . 3.4 tm? -67.1 -47.54 70.89 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.58 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.93 -54.35 14.76 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.266 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 4.7 p -53.19 -41.46 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.837 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.462 ' O ' ' OG ' ' A' ' 37' ' ' SER . 48.2 t -69.33 -48.79 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.65 -35.16 85.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.97 -34.4 77.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.6 p -63.38 -36.52 83.97 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.991 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.8 -41.53 5.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.61 -44.7 93.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.608 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 p -85.63 -43.35 13.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.774 0.321 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.26 23.87 30.68 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.645 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -115.58 49.4 1.09 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -64.97 24.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.95 -0.469 . . . . 0.0 110.86 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 42' ' ' TYR . 41.5 t0 -80.81 -38.63 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.23 45.58 1.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -126.02 -14.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.88 -36.53 15.91 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 6.5 tp -69.65 -43.37 21.67 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.307 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.5 Cg_exo -66.38 -18.33 54.95 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.294 2.663 . . . . 0.0 111.801 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -33.17 73.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.158 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.55 -23.1 5.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.301 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.35 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -64.04 -44.37 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 53' ' ' ILE . 51.4 m-85 -66.38 -43.97 84.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.365 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 ' O ' ' OG1' ' A' ' 58' ' ' THR . 67.9 mt -63.7 -43.48 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.881 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.33 80.39 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.61 -34.73 74.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.981 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 11.9 p -67.01 -50.23 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.182 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.0 -37.87 79.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.326 0.584 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CD1' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -47.78 -34.66 8.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.28 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.95 -27.61 3.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.08 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.17 -31.31 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -68.37 -44.69 74.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.457 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -77.11 -23.08 51.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.999 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -50.34 -48.96 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.061 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.16 -47.56 42.85 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.027 -0.42 . . . . 0.0 110.637 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.81 -28.28 9.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.658 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.55 -36.46 45.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.235 0.54 . . . . 0.0 109.7 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.5 -42.16 95.99 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.17 84.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -69.5 -36.94 76.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p -82.13 24.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -139.92 70.98 35.87 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.94 -70.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.831 2.354 . . . . 0.0 112.078 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -76.04 -42.17 48.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -38.7 -71.38 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.676 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -72.78 -25.97 61.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.18 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . -55.08 -36.61 61.51 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.82 -35.74 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.071 0.462 . . . . 0.0 110.211 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -46.95 76.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.515 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.735 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -145.27 62.51 1.29 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.781 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.63 93.44 46.26 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.417 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.47 -22.16 3.92 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.613 2.209 . . . . 0.0 112.745 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -70.36 -6.84 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.701 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -138.86 -57.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -51.12 71.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.33 -31.14 70.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.149 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -17.95 57.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.232 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.1 -40.19 62.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.09 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -52.47 -44.88 65.84 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 16' ' ' THR . 75.0 mt -67.72 -48.94 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.668 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.31 -43.88 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -42.76 93.71 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.3 m -66.45 -17.97 65.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.809 0.338 . . . . 0.0 110.422 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 9.5 m -68.06 -46.68 70.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.243 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.66 -44.13 87.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.238 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.96 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.21 -57.22 12.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 110.442 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -38.31 85.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.078 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 34.4 m -59.16 -19.74 47.63 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.87 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -61.23 -6.64 2.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.86 -30.87 4.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.902 0.382 . . . . 0.0 111.49 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 m -40.16 -56.24 3.51 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 24' ' ' THR . 11.0 Cg_endo -51.56 -39.59 65.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.878 2.386 . . . . 0.0 112.213 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -48.25 -51.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.798 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -67.48 -49.76 62.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.64 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.18 -47.52 89.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.51 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.59 -37.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.397 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.4 tp -49.99 -34.16 20.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.759 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.62 -29.3 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.985 0.421 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.07 -49.98 4.53 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.076 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 9.9 p -52.54 -41.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.456 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 27.0 m -66.0 -34.43 70.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.459 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 37' ' ' SER . . . -57.13 -30.95 61.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -44.42 -23.05 0.09 Allowed 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.406 ' N ' ' C ' ' A' ' 35' ' ' GLY . 13.7 m -41.78 -18.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.306 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -55.04 -50.85 68.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.991 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -76.64 -60.01 2.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.368 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.496 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 4.0 m -76.55 -49.83 15.43 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.692 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.49 28.58 73.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.517 ' C ' ' H ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -129.68 106.76 8.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.596 0.236 . . . . 0.0 110.436 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 10.5 mp -70.16 13.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.72 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 42' ' ' TYR . 20.7 p-10 -60.84 -44.07 97.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 78.3 t80 -111.07 48.29 0.94 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.077 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -129.2 -26.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.621 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.8 -40.27 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.545 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -62.01 -50.45 80.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 38.0 Cg_endo -67.02 -14.99 45.63 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.661 2.241 . . . . 0.0 112.78 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.11 82.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 0.0 110.57 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.31 -21.0 3.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.4 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 1.8 pt -71.43 -43.14 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.947 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 71.6 m-85 -67.45 -49.89 61.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.426 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 3.8 tp -62.22 -41.84 92.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.094 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . -66.37 -31.4 78.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.88 -30.7 61.94 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.727 -0.278 . . . . 0.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 t -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.523 0.202 . . . . 0.0 110.522 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.37 -41.46 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.175 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -47.04 -57.23 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.902 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.59 82.76 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.165 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.79 -49.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.581 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -68.4 -40.32 81.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -19.36 60.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.972 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -47.43 -48.32 26.51 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.709 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -74.04 -46.6 42.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.016 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -53.83 -33.93 57.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.415 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -52.27 -50.51 61.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.175 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.67 -31.64 72.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.644 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.46 70.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.21 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.7 m -86.36 -37.06 18.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.36 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 55.0 p -71.54 -7.56 48.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 75' ' ' LYS . 3.9 m -129.09 100.85 20.03 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.47 45.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 123.288 2.658 . . . . 0.0 112.856 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 73' ' ' THR . 84.8 tttt -64.78 -28.6 69.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.02 0.438 . . . . 0.0 110.394 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -59.34 -37.62 78.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -60.4 -43.32 96.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.4 96.16 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.22 -41.15 88.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -65.63 -37.51 86.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.563 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.556 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 13.4 ttt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -64.97 -16.01 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.798 0.332 . . . . 0.0 110.292 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -45.97 160.86 0.28 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.918 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.96 -8.77 24.49 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.423 2.082 . . . . 0.0 111.608 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.44 -8.44 19.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.01 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.1 m -135.8 -55.23 0.78 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.71 -48.82 80.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.739 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CD2' ' HZ2' ' A' ' 80' ' ' LYS . 5.2 tt -67.6 -33.53 75.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.98 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.675 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.97 -37.66 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.501 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.4 m -53.56 -46.37 70.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.663 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 70.2 mt -65.46 -47.96 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.389 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.94 -45.45 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.797 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.1 -38.97 94.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.8 m -70.58 -19.83 62.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 36.4 m -75.79 -44.41 41.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 17' ' ' LEU . 8.0 tt -63.75 -45.35 90.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.582 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -64.75 -36.5 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.11 -62.37 1.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.512 ' O ' ' OG1' ' A' ' 24' ' ' THR . 11.1 mp -50.3 -53.71 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 30.2 m -46.71 -31.34 2.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.274 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -62.57 -28.64 70.01 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.614 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.26 -33.79 4.87 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -43.74 -49.75 19.39 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' O ' ' A' ' 21' ' ' SER . 89.1 Cg_exo -41.87 -34.11 2.34 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.834 1.69 . . . . 0.0 112.576 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 27' ' ' LEU . 15.8 m -49.16 -45.11 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.605 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' H ' HG22 ' A' ' 26' ' ' VAL . 8.9 mt -73.95 -50.91 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.202 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.33 -47.48 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.232 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.0 tp -57.72 -33.52 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.3 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.3 -39.04 72.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.373 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.89 -38.49 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.0 -40.69 50.87 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.95 -49.87 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.556 0.217 . . . . 0.0 111.012 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' A' ' 37' ' ' SER . 8.9 p -66.42 -43.24 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.98 93.7 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -65.95 -39.64 90.64 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' GLY . 91.1 p -63.15 -33.11 74.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.701 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 -40.76 7.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.343 0.592 . . . . 0.0 109.875 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.81 -45.69 92.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.297 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.86 -47.15 8.07 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -149.4 -169.15 15.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' C ' ' H ' ' A' ' 44' ' ' ASP . 75.8 m-85 -106.5 -143.31 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.9 mp -75.15 19.02 0.17 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 19.8 p-10 -67.86 -56.5 8.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 29.8 t80 -101.14 44.08 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.041 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.53 -16.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.6 -47.74 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.2 mm? -63.14 -58.17 17.38 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.948 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 36.1 Cg_endo -62.16 -18.28 61.19 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.121 1.88 . . . . 0.0 112.997 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.81 73.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.49 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -53.47 -24.38 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.05 10.93 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.979 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 54' ' ' PHE . 3.6 tp -61.09 -45.53 98.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.182 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.489 ' N ' ' CG2' ' A' ' 53' ' ' ILE . 54.7 t80 -63.65 -43.63 96.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.003 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.7 -43.77 98.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.927 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.4 81.68 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.53 -36.56 78.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 0.0 110.023 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 m -62.78 -40.05 96.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.44 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.8 -42.4 94.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -45.52 -52.13 10.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.249 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -61.35 -48.13 82.68 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.489 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.75 -50.31 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.86 -40.23 94.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.227 0.537 . . . . 0.0 110.385 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.75 -20.44 58.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.921 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' ALA . 10.7 tptp -53.78 -35.79 61.71 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.203 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.617 HH21 ' H ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -76.62 -52.96 8.71 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.283 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.404 ' NE2' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -54.47 -23.81 17.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.04 -50.73 46.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.658 0.742 . . . . 0.0 110.374 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -63.51 -45.19 91.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.396 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' H ' HH21 ' A' ' 66' ' ' ARG . . . -63.83 -34.59 78.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.991 0.424 . . . . 0.0 110.538 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.404 ' OG ' ' NE2' ' A' ' 67' ' ' GLN . 58.8 m -75.75 -28.22 58.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.515 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 p -99.44 -77.0 0.53 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 75' ' ' LYS . 2.1 m -33.84 97.71 0.12 Allowed Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 123.485 0.491 . . . . 0.0 111.283 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.79 -4.08 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.105 1.87 . . . . 0.0 112.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 73' ' ' THR . 64.6 tttm -60.54 -33.64 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 77' ' ' ASN . 2.1 p90 -56.05 -46.18 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.056 0.455 . . . . 0.0 110.108 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 18.1 t-20 -66.23 -34.14 77.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.616 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.97 93.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.75 -35.68 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.939 0.369 . . . . 0.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HZ2' ' CD2' ' A' ' 8' ' ' LEU . 59.1 mttm -78.46 -11.15 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.8 tptm . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.486 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' CG ' ' H ' ' A' ' 3' ' ' ASP . 23.7 tptt -72.36 -139.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.866 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 5' ' ' LYS . 51.7 t0 -31.12 95.84 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.363 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.58 59.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 122.822 2.348 . . . . 0.0 113.064 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' ASP . 9.8 tptm -77.1 -8.74 58.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.769 0.319 . . . . 0.0 110.661 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -27.58 8.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.487 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 6.9 mp -87.99 -56.12 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.617 0.246 . . . . 0.0 110.712 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.2 tp -62.56 -37.84 87.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.827 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.95 -17.66 10.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.84 0.352 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 7' ' ' LEU . 7.7 p -54.97 -35.46 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.537 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' OG1' ' A' ' 15' ' ' THR . 77.7 p -56.06 -47.87 77.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.056 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' OG1' ' A' ' 16' ' ' THR . 32.7 mm -66.3 -47.39 84.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.85 -45.9 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.752 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.33 93.68 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 11' ' ' SER . 98.1 m -64.83 -19.19 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.584 0.231 . . . . 0.0 110.84 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 9.0 m -85.74 -34.79 21.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.385 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 tp -71.46 -32.74 68.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.111 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.41 -56.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.331 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.91 76.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.96 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.34 -48.95 68.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.617 ' C ' ' H ' ' A' ' 23' ' ' PHE . 66.6 m -73.71 -38.16 64.94 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.215 0.531 . . . . 0.0 110.721 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -50.59 0.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.919 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.617 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.4 m-85 -102.2 -21.31 14.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -64.72 -45.85 75.83 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 24' ' ' THR . 51.3 Cg_exo -52.96 -14.39 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.592 2.195 . . . . 0.0 112.522 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.0 -42.68 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.554 0.692 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.55 -39.05 74.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.859 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 29' ' ' ILE . 3.4 m -65.28 -42.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.537 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 30.2 pt -67.92 -34.73 68.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.825 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.9 -41.62 96.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.05 -40.92 93.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.88 -46.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.307 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 37' ' ' SER . 59.6 t -68.92 -41.54 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.323 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.83 -36.36 86.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.65 -24.67 65.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 41' ' ' GLY . 95.2 p -50.33 -23.23 2.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.16 23.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.706 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.73 -58.76 3.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 m -76.1 -47.83 23.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.916 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 85.86 -54.37 4.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 44' ' ' ASP . 73.9 m-85 -52.04 106.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.573 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.759 ' H ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.33 21.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.737 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 42' ' ' TYR . 50.3 t0 -61.56 -44.27 97.34 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.943 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.56 47.75 0.89 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -118.88 -36.92 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.61 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.5 -39.43 17.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.696 0.284 . . . . 0.0 111.425 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -60.17 -50.71 84.81 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 53.5 Cg_exo -48.99 -44.88 31.06 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.115 1.877 . . . . 0.0 112.295 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.72 67.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.97 92.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.61 -44.88 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.76 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.29 -48.77 71.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.2 tt -66.43 -40.92 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.685 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.78 -38.09 94.06 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.11 -38.78 91.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.674 0.273 . . . . 0.0 111.366 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.0 m -61.67 -48.46 80.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.918 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 0.0 110.366 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -47.78 -32.25 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.262 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -49.52 -28.76 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 111.297 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.26 -30.51 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.807 0.337 . . . . 0.0 111.767 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.606 ' NE2' ' CE1' ' A' ' 60' ' ' TYR . 7.1 tt0 -68.03 -45.2 74.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -76.59 -22.94 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -28.7 6.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 9.7 ptt180 -74.55 -48.65 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.336 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -54.48 -27.34 37.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.006 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . -54.64 -48.59 72.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.305 0.574 . . . . 0.0 110.017 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -67.64 -35.5 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.311 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.65 98.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.358 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.8 m -86.13 -46.67 10.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.718 0.294 . . . . 0.0 111.189 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 79.4 p -64.95 -32.61 74.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.071 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 75' ' ' LYS . 34.8 p -139.57 79.24 24.89 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.128 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.81 77.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.575 2.184 . . . . 0.0 111.503 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.59 -42.14 95.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.558 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 27.9 p90 -55.6 -47.06 77.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.459 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.561 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.82 -28.34 67.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.88 52.64 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.51 -34.75 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.671 0.272 . . . . 0.0 111.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -67.02 -81.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 tptm . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.445 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 N--CA 1.494 1.545 0 CA-C-O 120.865 0.277 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -64.2 -37.14 86.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.041 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -105.47 -24.37 12.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.982 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 7' ' ' LEU . 1.9 tt -61.65 -51.08 69.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.273 0.559 . . . . 0.0 110.33 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -9.87 35.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -20.49 62.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.51 -35.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -61.27 -52.83 63.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.772 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OG1' ' A' ' 16' ' ' THR . 74.5 mt -60.41 -54.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.452 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -64.72 -41.2 91.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -69.46 -38.99 80.29 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.5 m -74.18 -16.46 60.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.987 0.423 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 96.6 m -73.11 -45.24 58.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.261 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.8 mt -68.08 -45.09 74.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.73 -41.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.38 32.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.308 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HH21 ' A' ' 64' ' ' ARG . 75.4 mt -65.39 -36.09 82.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 23' ' ' PHE . 46.8 t -64.93 -33.24 75.57 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.893 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -50.59 -2.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 21' ' ' SER . 63.2 m-85 -119.09 -25.53 6.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.434 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 91.5 m -47.52 -46.39 59.22 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.778 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 24' ' ' THR . 55.7 Cg_exo -47.44 -32.56 15.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.772 2.315 . . . . 0.0 112.682 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 27' ' ' LEU . 5.9 p -49.15 -47.37 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.504 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' HG13 ' A' ' 26' ' ' VAL . 11.5 mt -64.13 -48.05 77.58 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.311 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.86 -42.78 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.56 -43.26 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.25 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -51.74 -40.56 60.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.8 tt -59.72 -40.74 89.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.09 -35.92 57.11 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -58.37 -51.72 67.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.411 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 35' ' ' GLY . 7.3 p -66.73 -39.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.208 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -62.71 -36.93 93.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.1 -33.14 75.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 41' ' ' GLY . 50.2 m -56.64 -28.04 59.73 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.808 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.7 69.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 39' ' ' LEU . 4.0 mm? -67.72 -58.99 3.69 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 41' ' ' GLY . 2.1 t -75.99 -49.46 17.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.413 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 107.97 64.61 0.58 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 45' ' ' TYR . 3.0 m-85 -105.98 11.44 31.62 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.4 mm? -31.67 -32.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.364 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 42' ' ' TYR . 24.4 t0 -71.37 -41.98 69.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.269 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 42' ' ' TYR . 23.8 t80 -92.73 53.05 1.96 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.593 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.2 m -126.3 -39.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.9 0.381 . . . . 0.0 110.484 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.7 tp -79.16 -39.98 32.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.0 110.758 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 mp -60.04 -58.92 15.81 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 17.9 Cg_endo -58.13 -16.18 26.3 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.137 2.558 . . . . 0.0 112.365 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 -32.82 74.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.64 -24.79 15.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.533 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.35 58.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.414 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.52 -46.16 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.445 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.25 -45.08 89.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.95 -44.85 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.42 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 60' ' ' TYR . . . -66.96 -32.15 80.09 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tp -59.95 -41.21 91.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 110.513 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.6 p -65.69 -39.93 91.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.379 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 62' ' ' ILE . 5.7 mm -68.64 -50.13 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 5.9 m-30 -49.9 -29.87 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.55 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.577 0.227 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 59' ' ' ILE . 4.3 tp -62.44 -29.91 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 110.811 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.5 -40.77 89.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 20' ' ' LEU . 14.5 mmt180 -76.02 -22.94 55.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.97 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -48.27 -47.72 36.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.188 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -72.75 -49.15 32.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.737 0.303 . . . . 0.0 110.669 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.84 -31.01 47.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.308 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.64 -53.53 50.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 110.227 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -70.59 -44.84 66.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.08 -32.65 66.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.215 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.5 p -71.39 -39.45 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -96.39 -79.93 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 75' ' ' LYS . 11.7 m -39.27 101.83 0.24 Allowed Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 25.9 Cg_exo -60.55 31.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 123.027 2.485 . . . . 0.0 112.774 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 73' ' ' THR . 27.4 mttt -67.2 -44.42 79.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 38.7 p90 -57.92 -50.98 71.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 5.2 p-10 -78.58 -23.4 46.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.81 82.85 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.43 -43.76 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.331 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' LYS . 41.7 mmtm -54.42 -41.2 69.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' LYS . 13.1 tptt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.493 1.461 0 CA-C-O 120.76 0.233 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HZ1' ' HD2' ' A' ' 80' ' ' LYS . 22.1 mmtm -74.47 -14.68 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -114.3 -27.66 7.53 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.899 0.38 . . . . 0.0 110.699 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 10' ' ' VAL . 4.5 mm? -87.12 -55.77 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.589 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.58 80.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.362 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -61.67 -20.78 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 7' ' ' LEU . 2.8 p -53.95 -35.43 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.713 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -55.8 -45.58 78.23 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.711 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 16' ' ' THR . 96.6 mt -65.41 -45.56 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.045 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.09 -44.41 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 0.0 110.294 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -42.17 58.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 73.6 m -67.89 -21.56 65.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.672 0.273 . . . . 0.0 110.666 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' ILE . 3.2 p -82.35 -35.7 27.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 110.371 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.77 -47.04 56.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.4 t -68.43 -41.31 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.168 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . -57.89 -53.43 58.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.559 0.695 . . . . 0.0 109.79 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.01 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.523 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.549 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 8.5 m -61.26 -23.06 65.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.17 0.51 . . . . 0.0 110.323 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.6 t -78.68 -11.47 59.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.9 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.555 ' CZ ' ' OE1' ' A' ' 63' ' ' GLN . 54.6 m-85 -108.68 -45.5 3.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.002 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.18 -50.28 11.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.321 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CD ' ' O ' ' A' ' 21' ' ' SER . 77.5 Cg_exo -44.84 -41.38 15.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.746 1.631 . . . . 0.0 112.157 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 29' ' ' ILE . 96.7 t -48.18 -48.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.193 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.39 -53.75 50.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.499 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -33.53 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 121.229 -0.188 . . . . 0.0 111.309 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.1 tt -42.84 -32.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.693 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -45.24 -30.28 1.18 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.693 HD23 ' O ' ' A' ' 31' ' ' LEU . 5.6 tt -70.07 -37.15 75.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.046 0.451 . . . . 0.0 109.949 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' ILE . . . -72.42 -52.79 9.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.501 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' VAL . 13.6 m -54.08 -44.45 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.607 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' VAL . 14.2 p -71.28 -37.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.03 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -63.34 -38.3 96.2 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.93 -26.62 68.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 42' ' ' TYR . 53.0 p -62.8 -41.41 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 110.355 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.28 74.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.591 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.5 -73.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -79.54 -48.73 13.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 114.16 67.24 0.46 Allowed Glycine 0 N--CA 1.472 1.069 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 46' ' ' VAL . 64.1 m-85 -98.41 14.25 28.77 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -36.57 -43.49 0.4 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.978 0.418 . . . . 0.0 110.81 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.33 -36.21 82.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.108 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' TYR . 90.6 m-85 -107.35 46.8 0.92 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 42' ' ' TYR . 25.4 t -120.31 -33.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -66.32 -40.45 89.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.6 mt -67.77 -59.88 6.15 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.691 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -40.62 -22.69 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.812 1.674 . . . . 0.0 113.51 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -70.36 -36.81 74.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.42 0.629 . . . . 0.0 110.333 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.3 mp -59.94 -26.01 65.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.692 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.88 81.45 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.8 mp -65.37 -43.37 94.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -47.78 -39.8 19.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 109.865 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.81 -28.01 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.424 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.3 -38.04 67.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.63 -37.84 87.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.98 0.419 . . . . 0.0 110.581 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 p -63.93 -52.58 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.444 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 60' ' ' TYR . 17.4 tt -70.38 -39.88 77.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.81 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 59' ' ' ILE . 47.8 t80 -53.57 -34.39 58.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.46 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.01 -40.06 79.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.663 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.62 -31.18 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.731 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.555 ' OE1' ' CZ ' ' A' ' 23' ' ' PHE . 27.7 mt-30 -67.05 -48.97 66.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.963 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -75.95 -22.79 55.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.857 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.71 -48.18 63.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.677 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.414 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 12.0 ptt180 -63.8 -48.68 75.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.265 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -54.29 -28.21 40.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 -178.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.54 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.345 0.593 . . . . 0.0 110.329 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 73' ' ' THR . 50.3 t0 -73.06 -40.89 64.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.57 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.98 -49.29 66.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.002 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -62.24 -42.55 99.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.729 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.9 p -73.89 -25.7 60.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' ASP . 26.1 m -132.9 81.74 57.21 Favored Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.531 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.85 125.63 18.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.299 1.999 . . . . 0.0 111.802 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.86 -28.84 35.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.1 m-85 -91.26 -59.57 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 81' ' ' LYS . 10.9 m-20 -62.95 -25.76 68.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.5 -60.7 6.72 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 80' ' ' LYS . 12.2 p -67.75 -42.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.066 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' N ' HG13 ' A' ' 79' ' ' VAL . 38.2 mtmt -77.13 -106.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.812 0.339 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ASN . 2.4 mptm? . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.21 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 6' ' ' THR . 41.3 Cg_exo . . . . . 0 N--CA 1.495 1.58 0 CA-C-O 120.795 0.248 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -37.86 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.836 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 p -124.12 -44.78 2.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.385 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.0 mp -56.29 -41.62 76.21 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.494 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 10' ' ' VAL . 1.8 tt -60.9 -76.88 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.296 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -45.42 -19.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 6' ' ' THR . 39.4 t -82.89 -55.99 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -60.89 -42.01 97.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.778 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.79 -18.2 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.685 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.46 -43.68 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.806 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.06 -41.35 99.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -71.04 -19.85 62.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.567 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 m -67.26 -42.62 83.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 109.907 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -60.68 -42.04 96.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.768 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 -44.71 96.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.28 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.43 65.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.573 0.702 . . . . 0.0 109.176 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.17 -36.93 83.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.9 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.2 t -51.99 -24.25 6.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.485 0.66 . . . . 0.0 110.603 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -77.86 -7.98 57.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.857 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -114.89 -54.22 2.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -66.06 -64.33 2.49 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.455 -177.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.46 -13.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.323 2.015 . . . . 0.0 113.469 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 24' ' ' THR . 52.4 t -59.34 -38.35 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -62.08 -30.84 71.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.663 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' H ' HD23 ' A' ' 27' ' ' LEU . 98.1 t -63.75 -41.57 93.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.338 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.8 mp -62.05 -39.89 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.29 -37.05 71.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.57 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.65 -38.77 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -57.1 6.83 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.355 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -44.11 -32.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.58 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.89 -43.93 96.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.09 -33.25 85.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.2 tp -64.67 -34.45 78.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 0.0 110.255 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 41' ' ' GLY . 32.7 t -63.79 -33.37 75.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.406 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.39 -47.86 66.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 110.942 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.15 -60.45 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.067 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.9 p -78.55 -45.77 21.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.069 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 89.59 107.01 1.18 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -112.52 117.17 31.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.218 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -83.66 -67.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.58 0.81 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.466 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.49 40.27 1.24 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.17 -25.55 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 110.289 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -84.97 -43.04 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -66.38 -49.22 54.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 46.0 Cg_endo -67.96 -15.57 43.77 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.724 1.616 . . . . 0.0 112.71 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.45 81.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.1 mm? -61.42 -25.68 67.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.67 90.33 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.99 -45.91 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -65.26 -43.13 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.528 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.85 -43.19 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 0.0 110.214 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.74 96.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 mp -62.73 -34.09 76.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.64 0.257 . . . . 0.0 111.167 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 m -64.5 -48.19 76.08 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 62' ' ' ILE . 16.7 pt -71.5 -40.99 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.895 0.379 . . . . 0.0 111.943 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -55.35 -37.61 67.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.673 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.95 -26.76 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 59' ' ' ILE . 5.4 tt -62.19 -30.82 49.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.624 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -30.45 70.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -76.33 -22.01 55.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.823 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.16 -42.99 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.335 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -47.38 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.184 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -54.21 -28.34 40.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.725 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.94 -52.3 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.827 0.823 . . . . 0.0 109.799 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 73' ' ' THR . 34.8 m-20 -70.05 -33.6 72.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.096 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.27 66.46 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.547 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.7 t -90.88 -31.95 16.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 m -83.22 -7.9 59.54 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.688 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.4 m -139.97 63.18 24.02 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 110.361 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.33 41.11 0.91 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 0.0 111.577 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -63.01 -41.82 99.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -53.9 -69.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -65.62 -30.57 71.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.84 -57.59 11.91 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.4 t -77.01 -55.36 10.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.35 . . . . 0.0 110.81 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -82.51 152.59 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.243 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.5 1.863 0 N-CA-C 112.44 0.131 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -69.4 -12.9 62.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.752 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -113.71 -51.77 2.78 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.802 0.334 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.4 mp -59.86 -51.35 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -68.85 -37.42 79.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.256 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -63.58 -18.3 63.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 7' ' ' LEU . 1.1 p -67.79 -39.91 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.684 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 15' ' ' THR . 4.0 t -59.58 -52.89 63.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 13' ' ' ILE . 2.0 tp -63.41 -46.14 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' N ' HG23 ' A' ' 12' ' ' ILE . 78.0 mt -63.8 -44.12 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.377 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.1 -40.12 62.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 11' ' ' SER . 41.3 p -73.69 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 111.085 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 12' ' ' ILE . 1.6 p -78.28 -39.78 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.411 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.05 -42.83 96.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.74 -40.72 81.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.57 -59.7 4.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.092 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.29 -34.83 75.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.328 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 23' ' ' PHE . 47.9 m -65.39 -32.94 74.83 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 110.69 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.7 p -50.49 -0.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.615 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.4 m-85 -103.97 -20.71 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.73 0.3 . . . . 0.0 110.386 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.94 -47.39 53.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.152 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 24' ' ' THR . 71.5 Cg_exo -45.17 -26.63 2.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.518 2.145 . . . . 0.0 112.876 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 23' ' ' PHE . 14.7 p -49.44 -23.96 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 26' ' ' VAL . 4.0 mm? -63.87 -34.78 78.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 25' ' ' PRO . 1.7 p -60.96 -39.62 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.342 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 33' ' ' VAL . 9.0 mt -64.6 -44.46 96.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.289 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.91 -41.68 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.803 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.42 -42.24 98.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.47 85.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.1 t -58.49 -46.23 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.38 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.92 -46.97 94.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.254 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.62 90.22 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.36 -41.17 76.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 110.828 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' GLY . 62.5 m -70.88 -39.7 72.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.85 -49.19 40.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.483 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -62.74 -43.31 99.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.125 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -88.5 5.11 44.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 43.01 77.13 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' H ' ' A' ' 44' ' ' ASP . 59.9 t80 -166.92 35.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.827 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.48 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 42' ' ' TYR . 51.1 t0 -86.02 -28.27 24.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.571 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 76.8 t80 -99.56 48.71 0.94 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -116.19 -25.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.627 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.4 mm? -83.12 -37.13 24.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.506 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.85 -54.42 46.9 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.455 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.14 -37.14 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.922 1.748 . . . . 0.0 112.366 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.68 28.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.01 -41.78 98.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.106 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.95 91.5 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.946 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.2 mp -63.95 -46.15 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -64.61 -44.96 88.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.424 ' O ' ' OG1' ' A' ' 58' ' ' THR . 97.9 mt -64.11 -43.29 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.95 -37.51 92.2 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.27 -45.24 88.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.543 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 17.2 p -55.19 -46.84 75.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.0 pt -70.55 -37.42 69.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 110.432 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -53.63 -35.09 60.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.693 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.55 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.597 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -54.94 -31.59 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.512 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.74 -42.54 73.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.134 0.492 . . . . 0.0 111.113 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -75.8 -23.19 55.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.498 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.53 -46.45 38.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.662 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -69.46 -45.94 67.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.646 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -56.29 -30.0 61.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.52 -42.21 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.006 -0.277 . . . . 0.0 110.649 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.95 -44.79 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.752 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.91 -52.41 17.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.6 p -59.32 -42.41 91.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 t -70.4 -76.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.62 117.85 8.7 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.27 114.58 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.766 1.644 . . . . 0.0 112.255 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.9 pttt -72.63 -33.47 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.003 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' A' ' 77' ' ' ASN . 23.9 p90 -67.28 -51.95 46.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 110.628 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.537 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 31.7 t30 -77.69 -33.02 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.52 50.48 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.906 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 75' ' ' LYS . 8.3 p -64.68 -40.48 89.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.468 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 79' ' ' VAL . 61.8 tttm -61.76 -39.59 92.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.704 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.263 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 N--CA 1.494 1.512 0 CA-C-O 120.669 0.195 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.91 -8.79 59.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.041 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -105.73 -57.59 2.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.114 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 7' ' ' LEU . 4.1 mm? -61.64 -45.7 92.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.794 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.6 tt -64.66 -37.73 88.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.317 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -57.77 -32.28 67.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.316 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -41.82 -38.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.774 0.321 . . . . 0.0 111.432 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' THR . 58.7 p -60.42 -52.92 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.7 mp -62.05 -52.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.172 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 tp -66.28 -38.24 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -33.28 77.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' SER . 21.1 p -83.08 -15.55 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.9 m -65.32 -60.74 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 -41.47 89.57 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.549 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.94 -46.11 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.623 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -57.47 12.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 20' ' ' LEU . 4.0 mm? -63.6 -36.93 85.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 23' ' ' PHE . 34.4 m -59.86 -27.1 66.38 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.63 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -49.98 -5.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.222 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 21' ' ' SER . 36.5 m-85 -111.65 -21.16 11.85 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.444 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -44.62 -57.27 6.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.533 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 29' ' ' ILE . 20.5 Cg_endo -57.84 -47.26 21.63 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.066 1.844 . . . . 0.0 111.974 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -47.48 -48.94 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.412 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.08 -50.57 15.97 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.35 -49.57 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.558 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' PRO . 6.8 tt -54.48 -32.71 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.521 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.3 -37.59 72.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 109.977 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -66.39 -36.48 82.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.453 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -69.58 -62.39 3.89 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.786 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -39.86 -35.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.775 0.321 . . . . 0.0 110.613 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.5 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.137 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' GLY . . . -57.51 -30.13 61.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.31 -26.94 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.2 m -53.31 -24.91 13.0 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 110.097 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.81 -38.55 7.33 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 -56.78 4.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 p -78.82 -49.3 13.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.919 0.39 . . . . 0.0 111.608 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 93.65 -49.99 2.32 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.04 104.16 0.15 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.522 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD21 ' OG ' ' A' ' 37' ' ' SER . 18.7 mt -92.35 30.37 1.5 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.3 m-20 -83.34 -25.27 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.194 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 8.5 p90 -103.47 38.61 1.75 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.981 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.36 -24.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.674 0.273 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -85.21 -50.85 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.979 0.418 . . . . 0.0 110.611 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -62.3 -54.56 48.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 34.6 Cg_endo -63.17 -22.16 72.71 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.149 1.899 . . . . 0.0 112.708 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 110.769 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.41 -27.33 62.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.773 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.41 -32.73 57.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 30' ' ' LEU . 96.5 mt -62.72 -44.49 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.267 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -40.78 91.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.407 ' O ' ' OG1' ' A' ' 58' ' ' THR . 30.0 mm -62.8 -40.2 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.73 93.72 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.18 -39.56 89.82 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.347 -0.502 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 23.1 p -64.58 -51.87 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.466 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 60' ' ' TYR . 2.2 pp -69.6 -41.84 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.147 0.499 . . . . 0.0 110.54 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.408 ' N ' HD12 ' A' ' 59' ' ' ILE . 78.6 t80 -53.6 -34.05 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.517 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.41 -30.38 60.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 111.355 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.7 mp -70.79 -30.87 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.655 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -67.35 -46.13 74.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.439 ' NH1' ' OE1' ' A' ' 67' ' ' GLN . 15.2 mmm180 -76.33 -22.59 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.976 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -49.06 -48.27 44.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -45.83 65.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.68 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.439 ' OE1' ' NH1' ' A' ' 64' ' ' ARG . 8.2 tt0 -55.36 -33.3 63.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.929 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.46 54.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.305 0.574 . . . . 0.0 110.662 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 p30 -72.55 -27.43 62.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 73' ' ' THR . . . -60.34 -49.26 78.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.254 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -76.6 -37.8 55.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 m -66.26 -43.28 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.283 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -40.85 131.42 1.86 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.85 -23.14 22.61 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.11 1.873 . . . . 0.0 112.143 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.61 -45.53 92.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.444 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.41 -46.85 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -65.78 -36.51 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.33 -45.54 94.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.5 t -62.31 -44.08 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.369 . . . . 0.0 110.049 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -55.1 85.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.437 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 79' ' ' VAL . 39.0 tptt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.238 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.005 0.335 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -66.02 -5.59 10.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.999 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -51.48 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 111.031 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.54 -53.9 53.13 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.958 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.54 -35.19 79.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.649 0.261 . . . . 0.0 110.391 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HE ' HD22 ' A' ' 77' ' ' ASN . 77.9 ttt-85 -62.22 -20.43 64.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.837 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.0 t -42.09 -29.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.902 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.7 t -62.99 -48.53 78.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 16' ' ' THR . 35.9 mm -61.44 -53.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.491 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.1 pt -63.14 -38.73 82.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.63 -28.29 72.38 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.8 m -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.549 -0.325 . . . . 0.0 111.539 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' ILE . 70.5 p -75.17 -32.35 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.332 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.2 mm? -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.294 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.21 -41.87 90.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.053 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -62.33 1.82 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.497 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.78 -36.08 83.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 23' ' ' PHE . 38.3 m -60.23 -31.4 70.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.061 0.458 . . . . 0.0 110.385 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -51.25 -3.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.36 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.559 ' H ' ' C ' ' A' ' 21' ' ' SER . 3.1 m-85 -91.74 -29.66 16.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.736 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -62.73 -49.06 84.28 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.033 -178.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.4 Cg_exo -54.3 -25.47 38.99 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.08 2.52 . . . . 0.0 112.916 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.4 -49.38 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 110.299 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.86 -48.73 10.43 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.139 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 24' ' ' THR . 74.0 t -47.22 -51.51 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 25' ' ' PRO . 19.4 tt -65.94 -39.12 83.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 34' ' ' VAL . 34.8 tp -59.4 -40.61 87.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.11 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.06 -37.43 87.54 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.744 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.55 -62.3 4.19 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.093 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -42.62 -33.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.922 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 30' ' ' LEU . 41.2 t -63.11 -45.13 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.599 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -27.91 50.63 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -61.21 -27.65 68.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.852 0.358 . . . . 0.0 110.597 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -60.1 -32.31 70.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.602 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.24 -42.85 14.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.688 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.3 m -81.94 -48.02 12.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.008 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.65 31.51 10.18 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -119.51 54.65 0.99 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.425 0.631 . . . . 0.0 110.965 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.26 9.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' TYR . 47.1 m-20 -73.37 -39.86 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.122 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.87 38.31 1.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.24 -16.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.17 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.67 -50.09 7.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.261 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -68.47 -46.48 36.77 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.039 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 48.8 Cg_exo -54.89 -36.47 91.75 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.43 2.087 . . . . 0.0 112.045 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.01 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.13 -29.3 57.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.48 96.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -63.86 -44.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.115 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.42 -42.4 96.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.305 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.41 -42.99 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.03 -33.95 88.64 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 m -63.56 -49.42 73.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.652 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.09 -35.04 70.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -48.59 -34.06 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.678 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.27 -38.81 19.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.21 -31.05 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.801 0.334 . . . . 0.0 110.785 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -68.15 -42.95 79.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -76.87 -23.48 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -50.19 -43.52 52.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.075 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -70.57 -46.72 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.007 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -30.39 59.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.5 74.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.422 0.63 . . . . 0.0 109.98 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -60.19 -48.83 80.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.56 -51.72 67.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -64.09 -39.39 93.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.9 p -60.48 -42.09 95.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 96.64 40.43 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.833 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 77' ' ' ASN . 59.6 Cg_endo -78.46 80.93 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.162 1.908 . . . . 0.0 112.489 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 mttt -80.17 -42.17 23.93 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.749 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CE2' ' OD1' ' A' ' 77' ' ' ASN . 5.2 p90 -52.18 -55.68 19.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.01 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.685 HD22 ' HE ' ' A' ' 9' ' ' ARG . 5.7 p-10 -79.02 -31.17 44.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 110.795 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.15 93.97 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' LYS . 52.1 t -67.98 -40.05 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 110.681 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -44.39 -53.47 6.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.212 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 mttt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.549 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.493 1.441 0 CA-C-O 121.0 0.333 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 68.1 mttm -73.69 -9.34 58.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 t -115.26 -32.79 5.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.306 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -78.02 -53.02 7.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -67.96 -36.54 80.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.594 ' NE ' HD12 ' A' ' 12' ' ' ILE . 2.7 mmp_? -56.76 -18.76 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 7' ' ' LEU . 9.8 p -57.32 -40.68 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 15' ' ' THR . 58.1 m -48.72 -46.36 40.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.865 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 HD12 ' NE ' ' A' ' 9' ' ' ARG . 96.3 mt -67.08 -44.86 87.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.186 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -44.63 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.81 93.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 11' ' ' SER . 27.2 p -68.01 -17.79 64.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 23.7 m -79.5 -35.47 40.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.992 0.425 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.2 -44.59 83.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 19' ' ' ALA . 18.9 m -73.46 -41.42 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.867 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -56.12 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.85 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.7 mm? -62.46 -39.44 93.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 23' ' ' PHE . 37.4 m -59.58 -29.39 67.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.674 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.7 p -51.38 -3.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.638 ' O ' HG22 ' A' ' 26' ' ' VAL . 31.6 m-85 -99.21 -25.62 14.45 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.495 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -60.45 -48.1 94.57 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.251 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 24' ' ' THR . 54.0 Cg_exo -45.8 -11.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.88 2.386 . . . . 0.0 112.796 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' PHE . 10.2 m -71.74 -41.41 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 120.993 0.425 . . . . 0.0 110.969 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' N ' HG23 ' A' ' 26' ' ' VAL . 84.7 mt -58.56 -30.83 67.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.017 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -57.42 -30.9 37.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.631 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 26' ' ' VAL . 7.5 tt -56.14 -37.39 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.04 -41.62 98.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.963 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.4 tm? -67.1 -47.54 70.89 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.58 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.93 -54.35 14.76 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.266 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 4.7 p -53.19 -41.46 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.837 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.436 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 48.2 t -69.33 -48.79 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.65 -35.16 85.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.97 -34.4 77.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.6 p -63.38 -36.52 83.97 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.991 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.8 -41.53 5.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.61 -44.7 93.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.608 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 p -85.63 -43.35 13.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.774 0.321 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.26 23.87 30.68 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.645 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -115.58 49.4 1.09 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -64.97 24.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.95 -0.469 . . . . 0.0 110.86 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 42' ' ' TYR . 41.5 t0 -80.81 -38.63 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.23 45.58 1.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.9 m -126.02 -14.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.88 -36.53 15.91 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 6.5 tp -69.65 -43.37 21.67 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.307 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.5 Cg_exo -66.38 -18.33 54.95 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.294 2.663 . . . . 0.0 111.801 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -33.17 73.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.158 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.55 -23.1 5.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.301 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.35 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -64.04 -44.37 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' N ' HG23 ' A' ' 53' ' ' ILE . 51.4 m-85 -66.38 -43.97 84.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.365 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.7 -43.48 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.881 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.33 80.39 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.61 -34.73 74.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.981 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -67.01 -50.23 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.182 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' ILE . 17.0 tt -68.0 -37.87 79.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.326 0.584 . . . . 0.0 110.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CD1' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -47.78 -34.66 8.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.28 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.95 -27.61 3.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.08 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -68.17 -31.31 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -68.37 -44.69 74.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.457 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -77.11 -23.08 51.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.999 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -50.34 -48.96 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.061 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.16 -47.56 42.85 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.027 -0.42 . . . . 0.0 110.637 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.81 -28.28 9.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.658 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.55 -36.46 45.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.235 0.54 . . . . 0.0 109.7 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.5 -42.16 95.99 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.17 84.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -69.5 -36.94 76.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p -82.13 24.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -139.92 70.98 35.87 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.94 -70.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.831 2.354 . . . . 0.0 112.078 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -76.04 -42.17 48.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.9 t80 -38.7 -71.38 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.676 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -72.78 -25.97 61.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.18 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . -55.08 -36.61 61.51 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 76' ' ' PHE . 5.1 p -58.82 -35.74 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.071 0.462 . . . . 0.0 110.211 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -46.95 76.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.515 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.735 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.499 1.851 0 N-CA-C 112.745 0.248 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -70.36 -6.84 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.701 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -138.86 -57.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -58.66 -51.12 71.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.33 -31.14 70.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.149 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -61.56 -17.95 57.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.232 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.1 -40.19 62.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.09 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -52.47 -44.88 65.84 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.72 -48.94 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.668 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.31 -43.88 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -42.76 93.71 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.3 m -66.45 -17.97 65.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.809 0.338 . . . . 0.0 110.422 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -68.06 -46.68 70.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.243 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.66 -44.13 87.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.238 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.96 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.21 -57.22 12.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 110.442 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.11 -38.31 85.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.078 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 34.4 m -59.16 -19.74 47.63 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.87 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -61.23 -6.64 2.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.86 -30.87 4.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.902 0.382 . . . . 0.0 111.49 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 m -40.16 -56.24 3.51 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 24' ' ' THR . 11.0 Cg_endo -51.56 -39.59 65.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.878 2.386 . . . . 0.0 112.213 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -48.25 -51.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.798 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -67.48 -49.76 62.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.64 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.18 -47.52 89.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.51 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.59 -37.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.397 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 34' ' ' VAL . 27.4 tp -49.99 -34.16 20.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.759 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -72.62 -29.3 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.985 0.421 . . . . 0.0 110.459 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.07 -49.98 4.53 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.076 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.84 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.9 p -52.54 -41.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.456 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' N ' HG13 ' A' ' 33' ' ' VAL . 27.0 m -66.0 -34.43 70.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.459 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 37' ' ' SER . . . -57.13 -30.95 61.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -44.42 -23.05 0.09 Allowed 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 36' ' ' LEU . 13.7 m -41.78 -18.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.306 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -55.04 -50.85 68.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.991 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -76.64 -60.01 2.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.368 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.503 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 4.0 m -76.55 -49.83 15.43 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.692 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.49 28.58 73.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -129.68 106.76 8.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.596 0.236 . . . . 0.0 110.436 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 43' ' ' LEU . 10.5 mp -70.16 13.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.72 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 20.7 p-10 -60.84 -44.07 97.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 78.3 t80 -111.07 48.29 0.94 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.077 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -129.2 -26.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.621 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.8 -40.27 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.545 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -62.01 -50.45 80.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 38.0 Cg_endo -67.02 -14.99 45.63 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.661 2.241 . . . . 0.0 112.78 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.11 82.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 0.0 110.57 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.31 -21.0 3.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.4 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 1.8 pt -71.43 -43.14 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.947 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 71.6 m-85 -67.45 -49.89 61.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.426 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' THR . 3.8 tp -62.22 -41.84 92.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.094 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -66.37 -31.4 78.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.88 -30.7 61.94 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.727 -0.278 . . . . 0.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 55' ' ' ILE . 1.3 t -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.523 0.202 . . . . 0.0 110.522 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.37 -41.46 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.175 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -47.04 -57.23 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.902 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.59 82.76 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.165 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.79 -49.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.581 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -68.4 -40.32 81.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -19.36 60.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.972 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -47.43 -48.32 26.51 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.709 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -74.04 -46.6 42.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.016 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.83 -33.93 57.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.415 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -52.27 -50.51 61.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.175 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.67 -31.64 72.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.644 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.46 70.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.21 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.7 m -86.36 -37.06 18.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.36 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 55.0 p -71.54 -7.56 48.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 75' ' ' LYS . 3.9 m -129.09 100.85 20.03 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.47 45.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 123.288 2.658 . . . . 0.0 112.856 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 73' ' ' THR . 84.8 tttt -64.78 -28.6 69.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.02 0.438 . . . . 0.0 110.394 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -59.34 -37.62 78.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.4 -43.32 96.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.4 96.16 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.22 -41.15 88.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -65.63 -37.51 86.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.563 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.556 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.492 1.434 0 CA-C-O 121.056 0.357 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.44 -8.44 19.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.01 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.1 m -135.8 -55.23 0.78 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.71 -48.82 80.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.739 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.2 tt -67.6 -33.53 75.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.98 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.675 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.97 -37.66 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.501 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.4 m -53.56 -46.37 70.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.663 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -65.46 -47.96 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.389 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.94 -45.45 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.797 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.1 -38.97 94.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.8 m -70.58 -19.83 62.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -75.79 -44.41 41.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 17' ' ' LEU . 8.0 tt -63.75 -45.35 90.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.582 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 19' ' ' ALA . 12.3 p -64.75 -36.5 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -51.11 -62.37 1.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.512 ' O ' ' OG1' ' A' ' 24' ' ' THR . 11.1 mp -50.3 -53.71 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 30.2 m -46.71 -31.34 2.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.274 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 22' ' ' SER . 1.4 m -62.57 -28.64 70.01 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.614 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' HG22 ' A' ' 26' ' ' VAL . 73.8 m-85 -116.26 -33.79 4.87 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -43.74 -49.75 19.39 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' O ' ' A' ' 21' ' ' SER . 89.1 Cg_exo -41.87 -34.11 2.34 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.834 1.69 . . . . 0.0 112.576 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 23' ' ' PHE . 15.8 m -49.16 -45.11 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.605 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' N ' HG23 ' A' ' 26' ' ' VAL . 8.9 mt -73.95 -50.91 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.202 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.33 -47.48 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.232 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 tp -57.72 -33.52 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.3 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.3 -39.04 72.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.373 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -61.89 -38.49 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.0 -40.69 50.87 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 29' ' ' ILE . 79.0 t -58.95 -49.87 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.556 0.217 . . . . 0.0 111.012 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 35' ' ' GLY . 8.9 p -66.42 -43.24 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -65.0 -36.98 93.7 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -65.95 -39.64 90.64 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' GLY . 91.1 p -63.15 -33.11 74.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.701 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 -40.76 7.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.343 0.592 . . . . 0.0 109.875 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.81 -45.69 92.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.297 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.86 -47.15 8.07 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -149.4 -169.15 15.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -106.5 -143.31 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 110.986 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 43' ' ' LEU . 7.9 mp -75.15 19.02 0.17 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 19.8 p-10 -67.86 -56.5 8.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.434 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 29.8 t80 -101.14 44.08 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.041 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.53 -16.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.6 -47.74 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.2 mm? -63.14 -58.17 17.38 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.948 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 36.1 Cg_endo -62.16 -18.28 61.19 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.121 1.88 . . . . 0.0 112.997 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . . . -64.13 -31.81 73.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.49 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -53.47 -24.38 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.05 10.93 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.979 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 54' ' ' PHE . 3.6 tp -61.09 -45.53 98.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.182 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 53' ' ' ILE . 54.7 t80 -63.65 -43.63 96.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.003 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.7 -43.77 98.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.927 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.4 81.68 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 57' ' ' LEU . 1.1 tt -60.53 -36.56 78.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 0.0 110.023 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 m -62.78 -40.05 96.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.44 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.8 -42.4 94.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -45.52 -52.13 10.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.249 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -61.35 -48.13 82.68 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.489 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.75 -50.31 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.86 -40.23 94.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.227 0.537 . . . . 0.0 110.385 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.75 -20.44 58.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.921 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' ALA . 10.7 tptp -53.78 -35.79 61.71 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.203 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.703 HH21 ' H ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -76.62 -52.96 8.71 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.283 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.404 ' NE2' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -54.47 -23.81 17.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.04 -50.73 46.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.658 0.742 . . . . 0.0 110.374 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -63.51 -45.19 91.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.396 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.703 ' H ' HH21 ' A' ' 66' ' ' ARG . . . -63.83 -34.59 78.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.991 0.424 . . . . 0.0 110.538 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.404 ' OG ' ' NE2' ' A' ' 67' ' ' GLN . 58.8 m -75.75 -28.22 58.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.515 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 p -99.44 -77.0 0.53 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 75' ' ' LYS . 2.1 m -33.84 97.71 0.12 Allowed Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 123.485 0.491 . . . . 0.0 111.283 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.79 -4.08 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.105 1.87 . . . . 0.0 112.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 73' ' ' THR . 64.6 tttm -60.54 -33.64 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 77' ' ' ASN . 2.1 p90 -56.05 -46.18 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.056 0.455 . . . . 0.0 110.108 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 18.1 t-20 -66.23 -34.14 77.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.616 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.97 93.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.75 -35.68 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.939 0.369 . . . . 0.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.46 -11.15 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.8 tptm . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.486 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.506 2.217 0 N-CA-C 113.064 0.371 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -77.1 -8.74 58.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.769 0.319 . . . . 0.0 110.661 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -27.58 8.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' O ' HG12 ' A' ' 10' ' ' VAL . 6.9 mp -87.99 -56.12 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.617 0.246 . . . . 0.0 110.712 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.2 tp -62.56 -37.84 87.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.827 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.95 -17.66 10.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.84 0.352 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 7' ' ' LEU . 7.7 p -54.97 -35.46 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.537 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -56.06 -47.87 77.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.056 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.3 -47.39 84.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.85 -45.9 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.752 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.33 93.68 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -64.83 -19.19 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.584 0.231 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 m -85.74 -34.79 21.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.385 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 tp -71.46 -32.74 68.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.111 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.41 -56.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.331 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.91 76.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.96 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.34 -48.95 68.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 23' ' ' PHE . 66.6 m -73.71 -38.16 64.94 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.215 0.531 . . . . 0.0 110.721 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -50.59 0.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.919 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.4 m-85 -102.2 -21.31 14.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -64.72 -45.85 75.83 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 24' ' ' THR . 51.3 Cg_exo -52.96 -14.39 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.592 2.195 . . . . 0.0 112.522 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.0 -42.68 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.554 0.692 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.55 -39.05 74.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.859 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 29' ' ' ILE . 3.4 m -65.28 -42.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.537 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' N ' HG23 ' A' ' 28' ' ' VAL . 30.2 pt -67.92 -34.73 68.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.825 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.9 -41.62 96.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.05 -40.92 93.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.8 t -58.88 -46.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.307 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.92 -41.54 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.323 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.83 -36.36 86.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.65 -24.67 65.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 41' ' ' GLY . 95.2 p -50.33 -23.23 2.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.16 23.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.706 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.73 -58.76 3.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 m -76.1 -47.83 23.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.916 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 85.86 -54.37 4.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 44' ' ' ASP . 73.9 m-85 -52.04 106.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.573 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.018 ' H ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.33 21.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.737 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 42' ' ' TYR . 50.3 t0 -61.56 -44.27 97.34 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.943 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.56 47.75 0.89 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -118.88 -36.92 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.61 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -85.5 -39.43 17.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.696 0.284 . . . . 0.0 111.425 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -60.17 -50.71 84.81 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 53.5 Cg_exo -48.99 -44.88 31.06 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.115 1.877 . . . . 0.0 112.295 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.72 67.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.97 92.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -67.61 -44.88 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.29 -48.77 71.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 56' ' ' GLY . 21.2 tt -66.43 -40.92 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.685 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -65.78 -38.09 94.06 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.11 -38.78 91.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.674 0.273 . . . . 0.0 111.366 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.0 m -61.67 -48.46 80.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.918 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.7 tp -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CE1' ' OE1' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -47.78 -32.25 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.262 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -49.52 -28.76 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 111.297 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 59' ' ' ILE . 8.9 tp -67.26 -30.51 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.807 0.337 . . . . 0.0 111.767 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.452 ' OE1' ' CE1' ' A' ' 60' ' ' TYR . 60.7 tt0 -68.03 -45.2 74.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -76.59 -22.94 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -28.7 6.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 9.7 ptt180 -74.55 -48.65 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.336 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -27.34 37.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.006 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.64 -48.59 72.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.305 0.574 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -67.64 -35.5 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.311 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.65 98.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.358 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.8 m -86.13 -46.67 10.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.718 0.294 . . . . 0.0 111.189 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.4 p -64.95 -32.61 74.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.071 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 75' ' ' LYS . 34.8 p -139.57 79.24 24.89 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.128 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.81 77.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.575 2.184 . . . . 0.0 111.503 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.59 -42.14 95.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.558 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 27.9 p90 -55.6 -47.06 77.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.459 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.561 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.82 -28.34 67.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.88 52.64 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.51 -34.75 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.671 0.272 . . . . 0.0 111.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -67.02 -81.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 tptm . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.445 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mmm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -59.31 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 5' ' ' LYS . 5.1 t70 -50.9 137.42 25.87 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.948 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.86 -8.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.708 2.272 . . . . 0.0 112.499 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 3' ' ' ASP . 47.8 tttm -64.2 -37.14 86.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -105.47 -24.37 12.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.982 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 7' ' ' LEU . 1.9 tt -61.65 -51.08 69.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.273 0.559 . . . . 0.0 110.33 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -9.87 35.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -20.49 62.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.51 -35.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -61.27 -52.83 63.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.772 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OG1' ' A' ' 16' ' ' THR . 74.5 mt -60.41 -54.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.452 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -64.72 -41.2 91.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -69.46 -38.99 80.29 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.5 m -74.18 -16.46 60.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.987 0.423 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 96.6 m -73.11 -45.24 58.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.261 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.8 mt -68.08 -45.09 74.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.73 -41.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.38 32.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.308 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HH21 ' A' ' 64' ' ' ARG . 75.4 mt -65.39 -36.09 82.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 23' ' ' PHE . 46.8 t -64.93 -33.24 75.57 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.893 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -50.59 -2.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 21' ' ' SER . 63.2 m-85 -119.09 -25.53 6.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.434 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 91.5 m -47.52 -46.39 59.22 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.778 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 24' ' ' THR . 55.7 Cg_exo -47.44 -32.56 15.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.772 2.315 . . . . 0.0 112.682 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 27' ' ' LEU . 5.9 p -49.15 -47.37 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.504 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' HG13 ' A' ' 26' ' ' VAL . 11.5 mt -64.13 -48.05 77.58 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.311 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.86 -42.78 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.56 -43.26 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.25 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -51.74 -40.56 60.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.8 tt -59.72 -40.74 89.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.09 -35.92 57.11 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -58.37 -51.72 67.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.411 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 35' ' ' GLY . 7.3 p -66.73 -39.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.208 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -62.71 -36.93 93.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.1 -33.14 75.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 41' ' ' GLY . 50.2 m -56.64 -28.04 59.73 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.808 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.7 69.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 39' ' ' LEU . 4.0 mm? -67.72 -58.99 3.69 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 41' ' ' GLY . 2.1 t -75.99 -49.46 17.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.413 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 107.97 64.61 0.58 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 45' ' ' TYR . 3.0 m-85 -105.98 11.44 31.62 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.4 mm? -31.67 -32.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.364 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 42' ' ' TYR . 24.4 t0 -71.37 -41.98 69.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.269 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 42' ' ' TYR . 23.8 t80 -92.73 53.05 1.96 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.593 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.2 m -126.3 -39.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.9 0.381 . . . . 0.0 110.484 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.7 tp -79.16 -39.98 32.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.0 110.758 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 mp -60.04 -58.92 15.81 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 17.9 Cg_endo -58.13 -16.18 26.3 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.137 2.558 . . . . 0.0 112.365 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 -32.82 74.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.64 -24.79 15.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.533 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.35 58.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.414 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.52 -46.16 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.445 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.25 -45.08 89.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.95 -44.85 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.42 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 60' ' ' TYR . . . -66.96 -32.15 80.09 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tp -59.95 -41.21 91.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 110.513 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.6 p -65.69 -39.93 91.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.379 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 62' ' ' ILE . 5.7 mm -68.64 -50.13 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 5.9 m-30 -49.9 -29.87 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.55 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.577 0.227 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 59' ' ' ILE . 4.3 tp -62.44 -29.91 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 110.811 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.5 -40.77 89.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 20' ' ' LEU . 14.5 mmt180 -76.02 -22.94 55.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.97 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -48.27 -47.72 36.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.188 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -72.75 -49.15 32.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.737 0.303 . . . . 0.0 110.669 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.84 -31.01 47.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.308 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.64 -53.53 50.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 110.227 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -70.59 -44.84 66.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.08 -32.65 66.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.215 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.5 p -71.39 -39.45 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -96.39 -79.93 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 75' ' ' LYS . 11.7 m -39.27 101.83 0.24 Allowed Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 25.9 Cg_exo -60.55 31.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 123.027 2.485 . . . . 0.0 112.774 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 73' ' ' THR . 27.4 mttt -67.2 -44.42 79.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 38.7 p90 -57.92 -50.98 71.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 5.2 p-10 -78.58 -23.4 46.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.81 82.85 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.43 -43.76 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.331 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' LYS . 41.7 mmtm -54.42 -41.2 69.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' LYS . 13.1 tptt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -145.71 50.06 1.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.545 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -123.53 85.7 52.63 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.9 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.81 -18.93 13.59 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.564 2.176 . . . . 0.0 111.916 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HZ1' ' HD2' ' A' ' 80' ' ' LYS . 22.1 mmtm -74.47 -14.68 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -114.3 -27.66 7.53 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.899 0.38 . . . . 0.0 110.699 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 10' ' ' VAL . 4.5 mm? -87.12 -55.77 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.589 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.58 80.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.362 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -61.67 -20.78 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 7' ' ' LEU . 2.8 p -53.95 -35.43 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.713 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -55.8 -45.58 78.23 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.711 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 16' ' ' THR . 96.6 mt -65.41 -45.56 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.045 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.09 -44.41 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 0.0 110.294 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -42.17 58.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 73.6 m -67.89 -21.56 65.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.672 0.273 . . . . 0.0 110.666 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' ILE . 3.2 p -82.35 -35.7 27.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 110.371 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.77 -47.04 56.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.4 t -68.43 -41.31 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.168 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . -57.89 -53.43 58.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.559 0.695 . . . . 0.0 109.79 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.01 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.523 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.549 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 8.5 m -61.26 -23.06 65.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.17 0.51 . . . . 0.0 110.323 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.6 t -78.68 -11.47 59.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.9 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.555 ' CZ ' ' OE1' ' A' ' 63' ' ' GLN . 54.6 m-85 -108.68 -45.5 3.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.002 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.18 -50.28 11.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.321 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CD ' ' O ' ' A' ' 21' ' ' SER . 77.5 Cg_exo -44.84 -41.38 15.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.746 1.631 . . . . 0.0 112.157 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 29' ' ' ILE . 96.7 t -48.18 -48.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.193 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.39 -53.75 50.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.499 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -33.53 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 121.229 -0.188 . . . . 0.0 111.309 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.1 tt -42.84 -32.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.693 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -45.24 -30.28 1.18 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.693 HD23 ' O ' ' A' ' 31' ' ' LEU . 5.6 tt -70.07 -37.15 75.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.046 0.451 . . . . 0.0 109.949 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' ILE . . . -72.42 -52.79 9.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.501 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' VAL . 13.6 m -54.08 -44.45 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.607 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' VAL . 14.2 p -71.28 -37.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.03 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -63.34 -38.3 96.2 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.93 -26.62 68.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 42' ' ' TYR . 53.0 p -62.8 -41.41 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 110.355 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.28 74.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.591 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.5 -73.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -79.54 -48.73 13.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 114.16 67.24 0.46 Allowed Glycine 0 N--CA 1.472 1.069 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 46' ' ' VAL . 64.1 m-85 -98.41 14.25 28.77 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -36.57 -43.49 0.4 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.978 0.418 . . . . 0.0 110.81 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.33 -36.21 82.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.108 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' TYR . 90.6 m-85 -107.35 46.8 0.92 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 42' ' ' TYR . 25.4 t -120.31 -33.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -66.32 -40.45 89.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.6 mt -67.77 -59.88 6.15 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.691 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -40.62 -22.69 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.812 1.674 . . . . 0.0 113.51 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -70.36 -36.81 74.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.42 0.629 . . . . 0.0 110.333 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.3 mp -59.94 -26.01 65.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.692 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.88 81.45 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.8 mp -65.37 -43.37 94.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -47.78 -39.8 19.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 109.865 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.81 -28.01 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.424 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.3 -38.04 67.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.63 -37.84 87.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.98 0.419 . . . . 0.0 110.581 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 p -63.93 -52.58 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.444 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 60' ' ' TYR . 17.4 tt -70.38 -39.88 77.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.81 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 59' ' ' ILE . 47.8 t80 -53.57 -34.39 58.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.46 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.01 -40.06 79.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.663 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.62 -31.18 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.731 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' OE1' ' CZ ' ' A' ' 23' ' ' PHE . 27.7 mt-30 -67.05 -48.97 66.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.963 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -75.95 -22.79 55.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.857 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.71 -48.18 63.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.677 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.414 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 12.0 ptt180 -63.8 -48.68 75.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.265 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -54.29 -28.21 40.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 -178.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.54 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.345 0.593 . . . . 0.0 110.329 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 73' ' ' THR . 50.3 t0 -73.06 -40.89 64.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.57 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.98 -49.29 66.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.002 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -62.24 -42.55 99.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.729 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.9 p -73.89 -25.7 60.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' ASP . 26.1 m -132.9 81.74 57.21 Favored Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.531 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.85 125.63 18.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.299 1.999 . . . . 0.0 111.802 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.86 -28.84 35.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.1 m-85 -91.26 -59.57 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 81' ' ' LYS . 10.9 m-20 -62.95 -25.76 68.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.5 -60.7 6.72 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 80' ' ' LYS . 12.2 p -67.75 -42.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.066 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' N ' HG13 ' A' ' 79' ' ' VAL . 38.2 mtmt -77.13 -106.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.812 0.339 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ASN . 2.4 mptm? . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.21 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' CB ' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -148.15 -63.89 0.25 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.957 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.38 164.59 42.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.353 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 6' ' ' THR . 41.3 Cg_exo -51.78 -3.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.193 1.928 . . . . 0.0 112.6 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' A' ' 3' ' ' ASP . 5.0 ttpm? -37.86 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.836 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 p -124.12 -44.78 2.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.385 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.0 mp -56.29 -41.62 76.21 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.494 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 10' ' ' VAL . 1.8 tt -60.9 -76.88 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.296 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -45.42 -19.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 6' ' ' THR . 39.4 t -82.89 -55.99 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -60.89 -42.01 97.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.778 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.79 -18.2 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.685 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.46 -43.68 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.806 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.06 -41.35 99.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -71.04 -19.85 62.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.567 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 m -67.26 -42.62 83.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 109.907 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -60.68 -42.04 96.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.768 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 -44.71 96.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.28 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.43 65.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.573 0.702 . . . . 0.0 109.176 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.17 -36.93 83.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.9 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.2 t -51.99 -24.25 6.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.485 0.66 . . . . 0.0 110.603 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -77.86 -7.98 57.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.857 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -114.89 -54.22 2.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -66.06 -64.33 2.49 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.455 -177.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.46 -13.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.323 2.015 . . . . 0.0 113.469 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 24' ' ' THR . 52.4 t -59.34 -38.35 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -62.08 -30.84 71.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.663 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' H ' HD23 ' A' ' 27' ' ' LEU . 98.1 t -63.75 -41.57 93.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.338 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.8 mp -62.05 -39.89 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.29 -37.05 71.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.57 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.65 -38.77 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -57.1 6.83 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.355 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -44.11 -32.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.58 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.89 -43.93 96.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.09 -33.25 85.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.2 tp -64.67 -34.45 78.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 0.0 110.255 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 41' ' ' GLY . 32.7 t -63.79 -33.37 75.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.406 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.39 -47.86 66.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 110.942 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.15 -60.45 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.067 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.9 p -78.55 -45.77 21.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.069 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 89.59 107.01 1.18 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -112.52 117.17 31.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.218 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -83.66 -67.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.58 0.81 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.466 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.49 40.27 1.24 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.17 -25.55 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 110.289 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -84.97 -43.04 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -66.38 -49.22 54.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 46.0 Cg_endo -67.96 -15.57 43.77 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.724 1.616 . . . . 0.0 112.71 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.45 81.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.1 mm? -61.42 -25.68 67.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.67 90.33 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.99 -45.91 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -65.26 -43.13 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.528 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.85 -43.19 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 0.0 110.214 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.74 96.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 mp -62.73 -34.09 76.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.64 0.257 . . . . 0.0 111.167 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 m -64.5 -48.19 76.08 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 62' ' ' ILE . 16.7 pt -71.5 -40.99 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.895 0.379 . . . . 0.0 111.943 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -55.35 -37.61 67.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.673 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.95 -26.76 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 59' ' ' ILE . 5.4 tt -62.19 -30.82 49.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.624 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -30.45 70.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -76.33 -22.01 55.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.823 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.16 -42.99 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.335 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -47.38 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.184 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -54.21 -28.34 40.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.725 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.94 -52.3 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.827 0.823 . . . . 0.0 109.799 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 73' ' ' THR . 34.8 m-20 -70.05 -33.6 72.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.096 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.27 66.46 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.547 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.7 t -90.88 -31.95 16.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 m -83.22 -7.9 59.54 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.688 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.4 m -139.97 63.18 24.02 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 110.361 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.33 41.11 0.91 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 0.0 111.577 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -63.01 -41.82 99.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -53.9 -69.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -65.62 -30.57 71.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.84 -57.59 11.91 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.4 t -77.01 -55.36 10.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.35 . . . . 0.0 110.81 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -82.51 152.59 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.243 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -35.32 80.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 5' ' ' LYS . 41.3 m-20 -121.23 155.81 58.1 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.108 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.55 10.67 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.71 1.607 . . . . 0.0 112.44 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 3' ' ' ASP . 5.5 mtmp? -69.4 -12.9 62.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -113.71 -51.77 2.78 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.802 0.334 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 7' ' ' LEU . 10.4 mp -59.86 -51.35 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -68.85 -37.42 79.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.256 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -63.58 -18.3 63.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 7' ' ' LEU . 1.1 p -67.79 -39.91 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.684 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 15' ' ' THR . 4.0 t -59.58 -52.89 63.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 13' ' ' ILE . 2.0 tp -63.41 -46.14 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' N ' HG23 ' A' ' 12' ' ' ILE . 78.0 mt -63.8 -44.12 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.377 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.1 -40.12 62.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 11' ' ' SER . 41.3 p -73.69 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 111.085 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 12' ' ' ILE . 1.6 p -78.28 -39.78 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.411 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.05 -42.83 96.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.74 -40.72 81.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.57 -59.7 4.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.092 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.29 -34.83 75.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.328 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 23' ' ' PHE . 47.9 m -65.39 -32.94 74.83 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 110.69 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.7 p -50.49 -0.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.615 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.4 m-85 -103.97 -20.71 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.73 0.3 . . . . 0.0 110.386 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.94 -47.39 53.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.152 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 24' ' ' THR . 71.5 Cg_exo -45.17 -26.63 2.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.518 2.145 . . . . 0.0 112.876 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 23' ' ' PHE . 14.7 p -49.44 -23.96 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 26' ' ' VAL . 4.0 mm? -63.87 -34.78 78.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 25' ' ' PRO . 1.7 p -60.96 -39.62 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.342 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 33' ' ' VAL . 9.0 mt -64.6 -44.46 96.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.289 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.91 -41.68 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.803 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.42 -42.24 98.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.47 85.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.1 t -58.49 -46.23 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.38 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.92 -46.97 94.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.254 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.62 90.22 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.36 -41.17 76.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 110.828 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' GLY . 62.5 m -70.88 -39.7 72.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.85 -49.19 40.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.483 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -62.74 -43.31 99.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.125 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -88.5 5.11 44.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 43.01 77.13 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' H ' ' A' ' 44' ' ' ASP . 59.9 t80 -166.92 35.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.827 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.48 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 42' ' ' TYR . 51.1 t0 -86.02 -28.27 24.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.571 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 76.8 t80 -99.56 48.71 0.94 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -116.19 -25.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.627 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.4 mm? -83.12 -37.13 24.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.506 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.85 -54.42 46.9 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.455 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.14 -37.14 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.922 1.748 . . . . 0.0 112.366 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.68 28.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.01 -41.78 98.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.106 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.95 91.5 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.946 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.2 mp -63.95 -46.15 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -64.61 -44.96 88.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.424 ' O ' ' OG1' ' A' ' 58' ' ' THR . 97.9 mt -64.11 -43.29 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.95 -37.51 92.2 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.27 -45.24 88.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.543 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 17.2 p -55.19 -46.84 75.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.0 pt -70.55 -37.42 69.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 110.432 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -53.63 -35.09 60.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.693 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.55 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.597 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -54.94 -31.59 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.512 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.74 -42.54 73.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.134 0.492 . . . . 0.0 111.113 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -75.8 -23.19 55.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.498 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.53 -46.45 38.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.662 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -69.46 -45.94 67.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.646 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -56.29 -30.0 61.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.52 -42.21 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.006 -0.277 . . . . 0.0 110.649 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.95 -44.79 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.752 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.91 -52.41 17.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.6 p -59.32 -42.41 91.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 t -70.4 -76.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.62 117.85 8.7 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.27 114.58 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.766 1.644 . . . . 0.0 112.255 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.9 pttt -72.63 -33.47 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.003 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' A' ' 77' ' ' ASN . 23.9 p90 -67.28 -51.95 46.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 110.628 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.537 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 31.7 t30 -77.69 -33.02 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.52 50.48 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.906 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 75' ' ' LYS . 8.3 p -64.68 -40.48 89.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.468 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 79' ' ' VAL . 61.8 tttm -61.76 -39.59 92.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.704 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.263 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 105.64 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -139.11 145.69 46.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.472 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.5 -30.09 43.92 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.18 1.92 . . . . 0.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.91 -8.79 59.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.041 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -105.73 -57.59 2.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.114 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 7' ' ' LEU . 4.1 mm? -61.64 -45.7 92.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.794 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.6 tt -64.66 -37.73 88.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.317 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -57.77 -32.28 67.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.316 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -41.82 -38.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.774 0.321 . . . . 0.0 111.432 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' THR . 58.7 p -60.42 -52.92 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.7 mp -62.05 -52.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.172 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 tp -66.28 -38.24 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -33.28 77.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' SER . 21.1 p -83.08 -15.55 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.9 m -65.32 -60.74 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 -41.47 89.57 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.549 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.94 -46.11 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.623 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -57.47 12.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 20' ' ' LEU . 4.0 mm? -63.6 -36.93 85.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 23' ' ' PHE . 34.4 m -59.86 -27.1 66.38 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.63 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -49.98 -5.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.222 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 21' ' ' SER . 36.5 m-85 -111.65 -21.16 11.85 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.444 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -44.62 -57.27 6.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.533 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 29' ' ' ILE . 20.5 Cg_endo -57.84 -47.26 21.63 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.066 1.844 . . . . 0.0 111.974 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -47.48 -48.94 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.412 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.08 -50.57 15.97 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.35 -49.57 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.558 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' PRO . 6.8 tt -54.48 -32.71 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.521 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.3 -37.59 72.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 109.977 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -66.39 -36.48 82.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.453 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -69.58 -62.39 3.89 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.786 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -39.86 -35.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.775 0.321 . . . . 0.0 110.613 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.5 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.137 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' GLY . . . -57.51 -30.13 61.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.31 -26.94 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.2 m -53.31 -24.91 13.0 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 110.097 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.81 -38.55 7.33 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 -56.78 4.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 p -78.82 -49.3 13.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.919 0.39 . . . . 0.0 111.608 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 93.65 -49.99 2.32 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.04 104.16 0.15 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.522 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD21 ' OG ' ' A' ' 37' ' ' SER . 18.7 mt -92.35 30.37 1.5 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.3 m-20 -83.34 -25.27 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.194 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 8.5 p90 -103.47 38.61 1.75 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.981 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.36 -24.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.674 0.273 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -85.21 -50.85 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.979 0.418 . . . . 0.0 110.611 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -62.3 -54.56 48.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 34.6 Cg_endo -63.17 -22.16 72.71 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.149 1.899 . . . . 0.0 112.708 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 110.769 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.41 -27.33 62.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.773 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.41 -32.73 57.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 30' ' ' LEU . 96.5 mt -62.72 -44.49 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.267 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -40.78 91.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.407 ' O ' ' OG1' ' A' ' 58' ' ' THR . 30.0 mm -62.8 -40.2 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.73 93.72 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.18 -39.56 89.82 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.347 -0.502 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 23.1 p -64.58 -51.87 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.466 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 60' ' ' TYR . 2.2 pp -69.6 -41.84 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.147 0.499 . . . . 0.0 110.54 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' N ' HD12 ' A' ' 59' ' ' ILE . 78.6 t80 -53.6 -34.05 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.517 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.41 -30.38 60.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 111.355 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.7 mp -70.79 -30.87 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.655 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -67.35 -46.13 74.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.439 ' NH1' ' OE1' ' A' ' 67' ' ' GLN . 15.2 mmm180 -76.33 -22.59 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.976 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -49.06 -48.27 44.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -45.83 65.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.68 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.439 ' OE1' ' NH1' ' A' ' 64' ' ' ARG . 8.2 tt0 -55.36 -33.3 63.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.929 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.46 54.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.305 0.574 . . . . 0.0 110.662 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 p30 -72.55 -27.43 62.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 73' ' ' THR . . . -60.34 -49.26 78.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.254 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -76.6 -37.8 55.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 m -66.26 -43.28 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.283 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -40.85 131.42 1.86 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.85 -23.14 22.61 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.11 1.873 . . . . 0.0 112.143 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.61 -45.53 92.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.444 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.41 -46.85 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -65.78 -36.51 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.33 -45.54 94.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.5 t -62.31 -44.08 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.369 . . . . 0.0 110.049 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -55.1 85.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.437 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 79' ' ' VAL . 39.0 tptt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.238 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.49 26.68 6.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 66.29 76.37 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.43 -5.15 16.26 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.732 2.288 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -66.02 -5.59 10.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.999 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -51.48 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 111.031 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.54 -53.9 53.13 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.958 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.54 -35.19 79.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.649 0.261 . . . . 0.0 110.391 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HE ' HD22 ' A' ' 77' ' ' ASN . 77.9 ttt-85 -62.22 -20.43 64.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.837 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.0 t -42.09 -29.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.902 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.7 t -62.99 -48.53 78.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 16' ' ' THR . 35.9 mm -61.44 -53.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.491 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.1 pt -63.14 -38.73 82.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.63 -28.29 72.38 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.8 m -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.549 -0.325 . . . . 0.0 111.539 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' ILE . 70.5 p -75.17 -32.35 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.332 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.2 mm? -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.294 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.21 -41.87 90.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.053 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -62.33 1.82 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.497 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.78 -36.08 83.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 23' ' ' PHE . 38.3 m -60.23 -31.4 70.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.061 0.458 . . . . 0.0 110.385 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -51.25 -3.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.36 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.559 ' H ' ' C ' ' A' ' 21' ' ' SER . 3.1 m-85 -91.74 -29.66 16.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.736 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -62.73 -49.06 84.28 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.033 -178.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.4 Cg_exo -54.3 -25.47 38.99 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.08 2.52 . . . . 0.0 112.916 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.4 -49.38 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 110.299 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.86 -48.73 10.43 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.139 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 24' ' ' THR . 74.0 t -47.22 -51.51 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 25' ' ' PRO . 19.4 tt -65.94 -39.12 83.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 34' ' ' VAL . 34.8 tp -59.4 -40.61 87.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.11 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.06 -37.43 87.54 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.744 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.55 -62.3 4.19 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.093 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -42.62 -33.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.922 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 30' ' ' LEU . 41.2 t -63.11 -45.13 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.599 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -27.91 50.63 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -61.21 -27.65 68.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.852 0.358 . . . . 0.0 110.597 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -60.1 -32.31 70.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.602 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.24 -42.85 14.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.688 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.3 m -81.94 -48.02 12.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.008 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.65 31.51 10.18 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -119.51 54.65 0.99 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.425 0.631 . . . . 0.0 110.965 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.26 9.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' TYR . 47.1 m-20 -73.37 -39.86 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.122 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.87 38.31 1.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.24 -16.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.17 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.67 -50.09 7.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.261 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -68.47 -46.48 36.77 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.039 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 48.8 Cg_exo -54.89 -36.47 91.75 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.43 2.087 . . . . 0.0 112.045 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.01 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.13 -29.3 57.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.48 96.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -63.86 -44.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.115 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.42 -42.4 96.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.305 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.41 -42.99 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.03 -33.95 88.64 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 m -63.56 -49.42 73.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.652 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.09 -35.04 70.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -48.59 -34.06 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.678 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.27 -38.81 19.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.21 -31.05 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.801 0.334 . . . . 0.0 110.785 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -68.15 -42.95 79.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -76.87 -23.48 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -50.19 -43.52 52.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.075 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -70.57 -46.72 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.007 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -30.39 59.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.5 74.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.422 0.63 . . . . 0.0 109.98 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -60.19 -48.83 80.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.56 -51.72 67.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -64.09 -39.39 93.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.9 p -60.48 -42.09 95.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 96.64 40.43 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.833 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 77' ' ' ASN . 59.6 Cg_endo -78.46 80.93 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.162 1.908 . . . . 0.0 112.489 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 mttt -80.17 -42.17 23.93 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.749 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CE2' ' OD1' ' A' ' 77' ' ' ASN . 5.2 p90 -52.18 -55.68 19.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.01 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.685 HD22 ' HE ' ' A' ' 9' ' ' ARG . 5.7 p-10 -79.02 -31.17 44.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 110.795 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.15 93.97 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' LYS . 52.1 t -67.98 -40.05 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 110.681 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -44.39 -53.47 6.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.212 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 mttt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.549 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mmm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -76.18 -16.5 59.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 23.5 p-10 -139.72 71.14 36.99 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -71.73 86.45 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.899 2.399 . . . . 0.0 111.558 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 68.1 mttm -73.69 -9.34 58.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 t -115.26 -32.79 5.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.306 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -78.02 -53.02 7.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -67.96 -36.54 80.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.594 ' NE ' HD12 ' A' ' 12' ' ' ILE . 2.7 mmp_? -56.76 -18.76 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 7' ' ' LEU . 9.8 p -57.32 -40.68 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 15' ' ' THR . 58.1 m -48.72 -46.36 40.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.865 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 HD12 ' NE ' ' A' ' 9' ' ' ARG . 96.3 mt -67.08 -44.86 87.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.186 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -44.63 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.81 93.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 11' ' ' SER . 27.2 p -68.01 -17.79 64.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 23.7 m -79.5 -35.47 40.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.992 0.425 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.2 -44.59 83.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 19' ' ' ALA . 18.9 m -73.46 -41.42 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.867 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -56.12 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.85 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 20' ' ' LEU . 3.7 mm? -62.46 -39.44 93.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 23' ' ' PHE . 37.4 m -59.58 -29.39 67.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.674 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.7 p -51.38 -3.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.638 ' O ' HG22 ' A' ' 26' ' ' VAL . 31.6 m-85 -99.21 -25.62 14.45 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.495 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -60.45 -48.1 94.57 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.251 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 24' ' ' THR . 54.0 Cg_exo -45.8 -11.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.88 2.386 . . . . 0.0 112.796 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' PHE . 10.2 m -71.74 -41.41 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 120.993 0.425 . . . . 0.0 110.969 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' N ' HG23 ' A' ' 26' ' ' VAL . 84.7 mt -58.56 -30.83 67.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.017 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -57.42 -30.9 37.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.631 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 26' ' ' VAL . 7.5 tt -56.14 -37.39 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.04 -41.62 98.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.963 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.4 tm? -67.1 -47.54 70.89 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.58 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.93 -54.35 14.76 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.266 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 4.7 p -53.19 -41.46 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.837 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.436 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 48.2 t -69.33 -48.79 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.65 -35.16 85.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.97 -34.4 77.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.6 p -63.38 -36.52 83.97 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.991 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.8 -41.53 5.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.61 -44.7 93.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.608 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 p -85.63 -43.35 13.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.774 0.321 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.26 23.87 30.68 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.645 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -115.58 49.4 1.09 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -64.97 24.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.95 -0.469 . . . . 0.0 110.86 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 42' ' ' TYR . 41.5 t0 -80.81 -38.63 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.23 45.58 1.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.9 m -126.02 -14.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.88 -36.53 15.91 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 6.5 tp -69.65 -43.37 21.67 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.307 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.5 Cg_exo -66.38 -18.33 54.95 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.294 2.663 . . . . 0.0 111.801 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -33.17 73.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.158 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.55 -23.1 5.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.301 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.35 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -64.04 -44.37 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' N ' HG23 ' A' ' 53' ' ' ILE . 51.4 m-85 -66.38 -43.97 84.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.365 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.7 -43.48 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.881 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.33 80.39 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.61 -34.73 74.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.981 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -67.01 -50.23 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.182 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' ILE . 17.0 tt -68.0 -37.87 79.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.326 0.584 . . . . 0.0 110.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CD1' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -47.78 -34.66 8.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.28 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.95 -27.61 3.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.08 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -68.17 -31.31 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -68.37 -44.69 74.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.457 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -77.11 -23.08 51.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.999 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -50.34 -48.96 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.061 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.16 -47.56 42.85 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.027 -0.42 . . . . 0.0 110.637 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.81 -28.28 9.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.658 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.55 -36.46 45.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.235 0.54 . . . . 0.0 109.7 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.5 -42.16 95.99 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.17 84.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -69.5 -36.94 76.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p -82.13 24.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -139.92 70.98 35.87 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.94 -70.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.831 2.354 . . . . 0.0 112.078 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -76.04 -42.17 48.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.9 t80 -38.7 -71.38 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.676 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -72.78 -25.97 61.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.18 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . -55.08 -36.61 61.51 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 76' ' ' PHE . 5.1 p -58.82 -35.74 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.071 0.462 . . . . 0.0 110.211 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -46.95 76.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.515 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.735 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -145.27 62.51 1.29 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.781 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.63 93.44 46.26 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.417 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.47 -22.16 3.92 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.613 2.209 . . . . 0.0 112.745 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -70.36 -6.84 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.701 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -138.86 -57.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.2 OUTLIER -58.66 -51.12 71.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.33 -31.14 70.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.149 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -61.56 -17.95 57.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.232 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.1 -40.19 62.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.09 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -52.47 -44.88 65.84 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.72 -48.94 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.668 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.31 -43.88 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -42.76 93.71 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.3 m -66.45 -17.97 65.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.809 0.338 . . . . 0.0 110.422 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -68.06 -46.68 70.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.243 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.66 -44.13 87.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.238 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.96 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.21 -57.22 12.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 110.442 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.11 -38.31 85.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.078 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 34.4 m -59.16 -19.74 47.63 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.87 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -61.23 -6.64 2.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.86 -30.87 4.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.902 0.382 . . . . 0.0 111.49 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 m -40.16 -56.24 3.51 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 24' ' ' THR . 11.0 Cg_endo -51.56 -39.59 65.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.878 2.386 . . . . 0.0 112.213 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -48.25 -51.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.798 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -67.48 -49.76 62.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.64 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.18 -47.52 89.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.51 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.59 -37.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.397 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 34' ' ' VAL . 27.4 tp -49.99 -34.16 20.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.759 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -72.62 -29.3 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.985 0.421 . . . . 0.0 110.459 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.07 -49.98 4.53 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.076 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.84 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.9 p -52.54 -41.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.456 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' N ' HG13 ' A' ' 33' ' ' VAL . 27.0 m -66.0 -34.43 70.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.459 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 37' ' ' SER . . . -57.13 -30.95 61.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -44.42 -23.05 0.09 Allowed 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 36' ' ' LEU . 13.7 m -41.78 -18.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.306 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -55.04 -50.85 68.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.991 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -76.64 -60.01 2.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.368 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.503 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 4.0 m -76.55 -49.83 15.43 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.692 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.49 28.58 73.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -129.68 106.76 8.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.596 0.236 . . . . 0.0 110.436 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 43' ' ' LEU . 10.5 mp -70.16 13.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.72 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 20.7 p-10 -60.84 -44.07 97.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 78.3 t80 -111.07 48.29 0.94 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.077 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -129.2 -26.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.621 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.8 -40.27 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.545 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -62.01 -50.45 80.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 38.0 Cg_endo -67.02 -14.99 45.63 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.661 2.241 . . . . 0.0 112.78 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.11 82.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 0.0 110.57 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.31 -21.0 3.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.4 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 1.8 pt -71.43 -43.14 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.947 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 71.6 m-85 -67.45 -49.89 61.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.426 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' THR . 3.8 tp -62.22 -41.84 92.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.094 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -66.37 -31.4 78.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.88 -30.7 61.94 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.727 -0.278 . . . . 0.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 55' ' ' ILE . 1.3 t -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.523 0.202 . . . . 0.0 110.522 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.37 -41.46 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.175 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -47.04 -57.23 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.902 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.59 82.76 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.165 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.79 -49.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.581 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -68.4 -40.32 81.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -19.36 60.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.972 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -47.43 -48.32 26.51 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.709 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -74.04 -46.6 42.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.016 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.83 -33.93 57.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.415 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -52.27 -50.51 61.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.175 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.67 -31.64 72.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.644 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.46 70.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.21 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.7 m -86.36 -37.06 18.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.36 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 55.0 p -71.54 -7.56 48.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 75' ' ' LYS . 3.9 m -129.09 100.85 20.03 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.47 45.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 123.288 2.658 . . . . 0.0 112.856 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 73' ' ' THR . 84.8 tttt -64.78 -28.6 69.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.02 0.438 . . . . 0.0 110.394 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -59.34 -37.62 78.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.4 -43.32 96.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.4 96.16 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.22 -41.15 88.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -65.63 -37.51 86.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.563 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.556 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 13.4 ttt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -64.97 -16.01 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.798 0.332 . . . . 0.0 110.292 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -45.97 160.86 0.28 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.918 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.96 -8.77 24.49 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.423 2.082 . . . . 0.0 111.608 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.44 -8.44 19.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.01 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.1 m -135.8 -55.23 0.78 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.71 -48.82 80.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.739 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.2 tt -67.6 -33.53 75.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.98 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.675 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.97 -37.66 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.501 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.4 m -53.56 -46.37 70.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.663 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -65.46 -47.96 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.389 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.94 -45.45 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.797 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.1 -38.97 94.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.8 m -70.58 -19.83 62.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -75.79 -44.41 41.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 17' ' ' LEU . 8.0 tt -63.75 -45.35 90.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.582 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 19' ' ' ALA . 12.3 p -64.75 -36.5 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -51.11 -62.37 1.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.512 ' O ' ' OG1' ' A' ' 24' ' ' THR . 11.1 mp -50.3 -53.71 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 30.2 m -46.71 -31.34 2.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.274 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 22' ' ' SER . 1.4 m -62.57 -28.64 70.01 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.614 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' HG22 ' A' ' 26' ' ' VAL . 73.8 m-85 -116.26 -33.79 4.87 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -43.74 -49.75 19.39 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' O ' ' A' ' 21' ' ' SER . 89.1 Cg_exo -41.87 -34.11 2.34 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.834 1.69 . . . . 0.0 112.576 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 23' ' ' PHE . 15.8 m -49.16 -45.11 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.605 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' N ' HG23 ' A' ' 26' ' ' VAL . 8.9 mt -73.95 -50.91 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.202 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.33 -47.48 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.232 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 tp -57.72 -33.52 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.3 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.3 -39.04 72.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.373 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp -61.89 -38.49 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.0 -40.69 50.87 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 29' ' ' ILE . 79.0 t -58.95 -49.87 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.556 0.217 . . . . 0.0 111.012 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 35' ' ' GLY . 8.9 p -66.42 -43.24 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -65.0 -36.98 93.7 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -65.95 -39.64 90.64 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' GLY . 91.1 p -63.15 -33.11 74.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.701 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 -40.76 7.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.343 0.592 . . . . 0.0 109.875 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.81 -45.69 92.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.297 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.86 -47.15 8.07 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -149.4 -169.15 15.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -106.5 -143.31 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 110.986 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 43' ' ' LEU . 7.9 mp -75.15 19.02 0.17 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 19.8 p-10 -67.86 -56.5 8.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.434 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 29.8 t80 -101.14 44.08 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.041 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.53 -16.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.6 -47.74 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.2 mm? -63.14 -58.17 17.38 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.948 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 36.1 Cg_endo -62.16 -18.28 61.19 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.121 1.88 . . . . 0.0 112.997 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . . . -64.13 -31.81 73.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.49 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -53.47 -24.38 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.05 10.93 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.979 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 54' ' ' PHE . 3.6 tp -61.09 -45.53 98.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.182 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 53' ' ' ILE . 54.7 t80 -63.65 -43.63 96.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.003 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.7 -43.77 98.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.927 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.4 81.68 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 57' ' ' LEU . 1.1 tt -60.53 -36.56 78.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 0.0 110.023 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 m -62.78 -40.05 96.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.44 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.8 -42.4 94.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -45.52 -52.13 10.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.249 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -61.35 -48.13 82.68 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.489 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.75 -50.31 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.86 -40.23 94.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.227 0.537 . . . . 0.0 110.385 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.75 -20.44 58.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.921 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' ALA . 10.7 tptp -53.78 -35.79 61.71 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.203 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.703 HH21 ' H ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -76.62 -52.96 8.71 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.283 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.404 ' NE2' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -54.47 -23.81 17.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.04 -50.73 46.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.658 0.742 . . . . 0.0 110.374 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -63.51 -45.19 91.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.396 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.703 ' H ' HH21 ' A' ' 66' ' ' ARG . . . -63.83 -34.59 78.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.991 0.424 . . . . 0.0 110.538 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.404 ' OG ' ' NE2' ' A' ' 67' ' ' GLN . 58.8 m -75.75 -28.22 58.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.515 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 p -99.44 -77.0 0.53 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 75' ' ' LYS . 2.1 m -33.84 97.71 0.12 Allowed Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 123.485 0.491 . . . . 0.0 111.283 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.79 -4.08 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.105 1.87 . . . . 0.0 112.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 73' ' ' THR . 64.6 tttm -60.54 -33.64 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 77' ' ' ASN . 2.1 p90 -56.05 -46.18 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.056 0.455 . . . . 0.0 110.108 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 18.1 t-20 -66.23 -34.14 77.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.616 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.97 93.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.75 -35.68 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.939 0.369 . . . . 0.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.46 -11.15 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.8 tptm . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.486 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CG ' ' H ' ' A' ' 3' ' ' ASP . 23.7 tptt -72.36 -139.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.866 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 5' ' ' LYS . 51.7 t0 -31.12 95.84 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.363 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.58 59.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 122.822 2.348 . . . . 0.0 113.064 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ASP . 9.8 tptm -77.1 -8.74 58.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.769 0.319 . . . . 0.0 110.661 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -27.58 8.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' O ' HG12 ' A' ' 10' ' ' VAL . 6.9 mp -87.99 -56.12 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.617 0.246 . . . . 0.0 110.712 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.2 tp -62.56 -37.84 87.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.827 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.95 -17.66 10.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.84 0.352 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 7' ' ' LEU . 7.7 p -54.97 -35.46 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.537 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -56.06 -47.87 77.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.056 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.3 -47.39 84.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.85 -45.9 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.752 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.33 93.68 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -64.83 -19.19 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.584 0.231 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 m -85.74 -34.79 21.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.385 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 tp -71.46 -32.74 68.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.111 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.41 -56.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.331 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.91 76.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.96 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.34 -48.95 68.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 23' ' ' PHE . 66.6 m -73.71 -38.16 64.94 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.215 0.531 . . . . 0.0 110.721 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -50.59 0.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.919 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.4 m-85 -102.2 -21.31 14.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -64.72 -45.85 75.83 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 24' ' ' THR . 51.3 Cg_exo -52.96 -14.39 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.592 2.195 . . . . 0.0 112.522 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.0 -42.68 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.554 0.692 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.55 -39.05 74.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.859 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 29' ' ' ILE . 3.4 m -65.28 -42.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.537 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' N ' HG23 ' A' ' 28' ' ' VAL . 30.2 pt -67.92 -34.73 68.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.825 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.9 -41.62 96.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.05 -40.92 93.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.8 t -58.88 -46.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.307 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.92 -41.54 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.323 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.83 -36.36 86.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.65 -24.67 65.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 41' ' ' GLY . 95.2 p -50.33 -23.23 2.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.16 23.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.706 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.73 -58.76 3.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 m -76.1 -47.83 23.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.916 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 85.86 -54.37 4.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 44' ' ' ASP . 73.9 m-85 -52.04 106.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.573 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.018 ' H ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.33 21.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.737 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 42' ' ' TYR . 50.3 t0 -61.56 -44.27 97.34 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.943 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.56 47.75 0.89 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -118.88 -36.92 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.61 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -85.5 -39.43 17.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.696 0.284 . . . . 0.0 111.425 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -60.17 -50.71 84.81 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 53.5 Cg_exo -48.99 -44.88 31.06 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.115 1.877 . . . . 0.0 112.295 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.72 67.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.97 92.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -67.61 -44.88 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.29 -48.77 71.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 56' ' ' GLY . 21.2 tt -66.43 -40.92 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.685 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -65.78 -38.09 94.06 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.11 -38.78 91.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.674 0.273 . . . . 0.0 111.366 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.0 m -61.67 -48.46 80.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.918 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.7 tp -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CE1' ' OE1' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -47.78 -32.25 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.262 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -49.52 -28.76 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 111.297 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 59' ' ' ILE . 8.9 tp -67.26 -30.51 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.807 0.337 . . . . 0.0 111.767 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.452 ' OE1' ' CE1' ' A' ' 60' ' ' TYR . 60.7 tt0 -68.03 -45.2 74.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -76.59 -22.94 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -28.7 6.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 9.7 ptt180 -74.55 -48.65 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.336 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -27.34 37.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.006 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.64 -48.59 72.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.305 0.574 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -67.64 -35.5 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.311 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.65 98.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.358 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.8 m -86.13 -46.67 10.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.718 0.294 . . . . 0.0 111.189 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.4 p -64.95 -32.61 74.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.071 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 75' ' ' LYS . 34.8 p -139.57 79.24 24.89 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.128 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.81 77.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.575 2.184 . . . . 0.0 111.503 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.59 -42.14 95.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.558 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 27.9 p90 -55.6 -47.06 77.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.459 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.561 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.82 -28.34 67.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.88 52.64 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.51 -34.75 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.671 0.272 . . . . 0.0 111.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -67.02 -81.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 tptm . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.445 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 N--CA 1.494 1.545 0 CA-C-O 120.865 0.277 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -64.2 -37.14 86.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.041 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -105.47 -24.37 12.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.982 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.9 tt -61.65 -51.08 69.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.273 0.559 . . . . 0.0 110.33 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -9.87 35.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -20.49 62.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.51 -35.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -61.27 -52.83 63.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.772 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OG1' ' A' ' 16' ' ' THR . 74.5 mt -60.41 -54.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.452 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -64.72 -41.2 91.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -69.46 -38.99 80.29 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.5 m -74.18 -16.46 60.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.987 0.423 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 96.6 m -73.11 -45.24 58.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.261 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.8 mt -68.08 -45.09 74.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.73 -41.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.38 32.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.308 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HH21 ' A' ' 64' ' ' ARG . 75.4 mt -65.39 -36.09 82.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 23' ' ' PHE . 46.8 t -64.93 -33.24 75.57 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.893 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -50.59 -2.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 21' ' ' SER . 63.2 m-85 -119.09 -25.53 6.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.434 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 91.5 m -47.52 -46.39 59.22 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.778 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 24' ' ' THR . 55.7 Cg_exo -47.44 -32.56 15.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.772 2.315 . . . . 0.0 112.682 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 27' ' ' LEU . 5.9 p -49.15 -47.37 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.504 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' HG13 ' A' ' 26' ' ' VAL . 11.5 mt -64.13 -48.05 77.58 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.311 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.86 -42.78 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.56 -43.26 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.25 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -51.74 -40.56 60.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.662 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.8 tt -59.72 -40.74 89.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.09 -35.92 57.11 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -58.37 -51.72 67.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.411 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 35' ' ' GLY . 7.3 p -66.73 -39.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.208 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -62.71 -36.93 93.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.1 -33.14 75.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 41' ' ' GLY . 50.2 m -56.64 -28.04 59.73 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.808 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.7 69.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.0 mm? -67.72 -58.99 3.69 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 41' ' ' GLY . 2.1 t -75.99 -49.46 17.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.413 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 107.97 64.61 0.58 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 45' ' ' TYR . 3.0 m-85 -105.98 11.44 31.62 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.4 mm? -31.67 -32.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.364 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 42' ' ' TYR . 24.4 t0 -71.37 -41.98 69.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.269 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 42' ' ' TYR . 23.8 t80 -92.73 53.05 1.96 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.593 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.2 m -126.3 -39.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.9 0.381 . . . . 0.0 110.484 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.7 tp -79.16 -39.98 32.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.0 110.758 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 mp -60.04 -58.92 15.81 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 17.9 Cg_endo -58.13 -16.18 26.3 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.137 2.558 . . . . 0.0 112.365 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 -32.82 74.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.64 -24.79 15.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.533 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.35 58.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.414 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.52 -46.16 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.445 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.25 -45.08 89.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.95 -44.85 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.42 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 60' ' ' TYR . . . -66.96 -32.15 80.09 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tp -59.95 -41.21 91.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 110.513 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.6 p -65.69 -39.93 91.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.379 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 62' ' ' ILE . 5.7 mm -68.64 -50.13 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 5.9 m-30 -49.9 -29.87 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.55 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.577 0.227 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 59' ' ' ILE . 4.3 tp -62.44 -29.91 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 110.811 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.5 -40.77 89.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 20' ' ' LEU . 14.5 mmt180 -76.02 -22.94 55.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.97 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -48.27 -47.72 36.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.188 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -72.75 -49.15 32.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.737 0.303 . . . . 0.0 110.669 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.84 -31.01 47.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.308 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.64 -53.53 50.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 110.227 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -70.59 -44.84 66.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.08 -32.65 66.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.215 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.5 p -71.39 -39.45 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -96.39 -79.93 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 75' ' ' LYS . 11.7 m -39.27 101.83 0.24 Allowed Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 25.9 Cg_exo -60.55 31.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 123.027 2.485 . . . . 0.0 112.774 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 73' ' ' THR . 27.4 mttt -67.2 -44.42 79.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 38.7 p90 -57.92 -50.98 71.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 5.2 p-10 -78.58 -23.4 46.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.81 82.85 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.43 -43.76 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.331 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' LYS . 41.7 mmtm -54.42 -41.2 69.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' LYS . 13.1 tptt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.493 1.461 0 CA-C-O 120.76 0.233 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HZ1' ' HD2' ' A' ' 80' ' ' LYS . 22.1 mmtm -74.47 -14.68 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -114.3 -27.66 7.53 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.899 0.38 . . . . 0.0 110.699 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 10' ' ' VAL . 4.5 mm? -87.12 -55.77 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.589 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.58 80.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.362 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -61.67 -20.78 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 7' ' ' LEU . 2.8 p -53.95 -35.43 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.713 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -55.8 -45.58 78.23 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.711 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 16' ' ' THR . 96.6 mt -65.41 -45.56 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.045 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.09 -44.41 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 0.0 110.294 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -42.17 58.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 73.6 m -67.89 -21.56 65.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.672 0.273 . . . . 0.0 110.666 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' ILE . 3.2 p -82.35 -35.7 27.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 110.371 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.77 -47.04 56.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.4 t -68.43 -41.31 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.168 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . -57.89 -53.43 58.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.559 0.695 . . . . 0.0 109.79 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.01 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.523 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.549 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 8.5 m -61.26 -23.06 65.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.17 0.51 . . . . 0.0 110.323 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.6 t -78.68 -11.47 59.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.9 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.555 ' CZ ' ' OE1' ' A' ' 63' ' ' GLN . 54.6 m-85 -108.68 -45.5 3.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.002 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.18 -50.28 11.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.321 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CD ' ' O ' ' A' ' 21' ' ' SER . 77.5 Cg_exo -44.84 -41.38 15.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.746 1.631 . . . . 0.0 112.157 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 29' ' ' ILE . 96.7 t -48.18 -48.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.193 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.39 -53.75 50.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.499 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -33.53 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 121.229 -0.188 . . . . 0.0 111.309 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.1 tt -42.84 -32.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.693 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -45.24 -30.28 1.18 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.693 ' O ' HD23 ' A' ' 31' ' ' LEU . 5.6 tt -70.07 -37.15 75.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.046 0.451 . . . . 0.0 109.949 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' ILE . . . -72.42 -52.79 9.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.501 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' VAL . 13.6 m -54.08 -44.45 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.607 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' VAL . 14.2 p -71.28 -37.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.03 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -63.34 -38.3 96.2 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.93 -26.62 68.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 42' ' ' TYR . 53.0 p -62.8 -41.41 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 110.355 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.28 74.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.591 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.5 -73.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -79.54 -48.73 13.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 114.16 67.24 0.46 Allowed Glycine 0 N--CA 1.472 1.069 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 46' ' ' VAL . 64.1 m-85 -98.41 14.25 28.77 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -36.57 -43.49 0.4 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.978 0.418 . . . . 0.0 110.81 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.33 -36.21 82.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.108 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' TYR . 90.6 m-85 -107.35 46.8 0.92 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 42' ' ' TYR . 25.4 t -120.31 -33.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -66.32 -40.45 89.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.6 mt -67.77 -59.88 6.15 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.691 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -40.62 -22.69 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.812 1.674 . . . . 0.0 113.51 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -70.36 -36.81 74.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.42 0.629 . . . . 0.0 110.333 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 51' ' ' LEU . 10.3 mp -59.94 -26.01 65.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.692 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.88 81.45 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.8 mp -65.37 -43.37 94.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -47.78 -39.8 19.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 109.865 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.81 -28.01 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.424 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.3 -38.04 67.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.63 -37.84 87.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.98 0.419 . . . . 0.0 110.581 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 p -63.93 -52.58 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.444 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 60' ' ' TYR . 17.4 tt -70.38 -39.88 77.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.81 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 59' ' ' ILE . 47.8 t80 -53.57 -34.39 58.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.46 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.01 -40.06 79.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.663 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.62 -31.18 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.731 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.555 ' OE1' ' CZ ' ' A' ' 23' ' ' PHE . 27.7 mt-30 -67.05 -48.97 66.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.963 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -75.95 -22.79 55.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.857 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.71 -48.18 63.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.677 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.414 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 12.0 ptt180 -63.8 -48.68 75.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.265 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -54.29 -28.21 40.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 -178.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.54 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.345 0.593 . . . . 0.0 110.329 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 73' ' ' THR . 50.3 t0 -73.06 -40.89 64.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.57 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.98 -49.29 66.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.002 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -62.24 -42.55 99.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.729 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.9 p -73.89 -25.7 60.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' ASP . 26.1 m -132.9 81.74 57.21 Favored Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.531 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.85 125.63 18.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.299 1.999 . . . . 0.0 111.802 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.86 -28.84 35.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.1 m-85 -91.26 -59.57 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 77' ' ' ASN . 1.6 m120 -62.95 -25.76 68.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.5 -60.7 6.72 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 80' ' ' LYS . 12.2 p -67.75 -42.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.066 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' N ' HG13 ' A' ' 79' ' ' VAL . 38.2 mtmt -77.13 -106.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.812 0.339 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ASN . 2.4 mptm? . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.21 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 6' ' ' THR . 41.3 Cg_exo . . . . . 0 N--CA 1.495 1.58 0 CA-C-O 120.795 0.248 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -37.86 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.836 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 p -124.12 -44.78 2.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.385 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.0 mp -56.29 -41.62 76.21 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.494 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 10' ' ' VAL . 1.8 tt -60.9 -76.88 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.296 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -45.42 -19.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 6' ' ' THR . 39.4 t -82.89 -55.99 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -60.89 -42.01 97.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.778 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.79 -18.2 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.685 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.46 -43.68 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.806 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.06 -41.35 99.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -71.04 -19.85 62.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.567 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 m -67.26 -42.62 83.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 109.907 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -60.68 -42.04 96.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.768 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 -44.71 96.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.28 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.43 65.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.573 0.702 . . . . 0.0 109.176 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.17 -36.93 83.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.9 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.2 t -51.99 -24.25 6.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.485 0.66 . . . . 0.0 110.603 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -77.86 -7.98 57.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.857 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -114.89 -54.22 2.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -66.06 -64.33 2.49 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.455 -177.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.46 -13.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.323 2.015 . . . . 0.0 113.469 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 24' ' ' THR . 52.4 t -59.34 -38.35 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -62.08 -30.84 71.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.663 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' H ' HD23 ' A' ' 27' ' ' LEU . 98.1 t -63.75 -41.57 93.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.338 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.8 mp -62.05 -39.89 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.29 -37.05 71.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.57 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.65 -38.77 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -57.1 6.83 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.355 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -44.11 -32.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.58 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.89 -43.93 96.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.09 -33.25 85.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.2 tp -64.67 -34.45 78.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 0.0 110.255 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 41' ' ' GLY . 32.7 t -63.79 -33.37 75.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.406 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.39 -47.86 66.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 110.942 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.15 -60.45 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.067 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.9 p -78.55 -45.77 21.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.069 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 89.59 107.01 1.18 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -112.52 117.17 31.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.218 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.7 mm? -83.66 -67.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.58 0.81 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.466 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.49 40.27 1.24 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.17 -25.55 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 110.289 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -84.97 -43.04 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -66.38 -49.22 54.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 46.0 Cg_endo -67.96 -15.57 43.77 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.724 1.616 . . . . 0.0 112.71 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.45 81.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.1 mm? -61.42 -25.68 67.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.67 90.33 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.99 -45.91 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -65.26 -43.13 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.528 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.85 -43.19 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 0.0 110.214 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.74 96.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 mp -62.73 -34.09 76.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.64 0.257 . . . . 0.0 111.167 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 m -64.5 -48.19 76.08 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 62' ' ' ILE . 16.7 pt -71.5 -40.99 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.895 0.379 . . . . 0.0 111.943 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -55.35 -37.61 67.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.673 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.95 -26.76 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 59' ' ' ILE . 5.4 tt -62.19 -30.82 49.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.624 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -30.45 70.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -76.33 -22.01 55.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.823 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.16 -42.99 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.335 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -47.38 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.184 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -54.21 -28.34 40.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.725 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.94 -52.3 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.827 0.823 . . . . 0.0 109.799 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 73' ' ' THR . 34.8 m-20 -70.05 -33.6 72.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.096 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.27 66.46 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.547 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.7 t -90.88 -31.95 16.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 m -83.22 -7.9 59.54 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.688 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.4 m -139.97 63.18 24.02 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 110.361 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.33 41.11 0.91 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 0.0 111.577 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -63.01 -41.82 99.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -53.9 -69.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -65.62 -30.57 71.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.84 -57.59 11.91 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.4 t -77.01 -55.36 10.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.35 . . . . 0.0 110.81 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -82.51 152.59 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.243 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.5 1.863 0 N-CA-C 112.44 0.131 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -69.4 -12.9 62.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.752 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -113.71 -51.77 2.78 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.802 0.334 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.4 mp -59.86 -51.35 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 8' ' ' LEU . 3.4 tm? -68.85 -37.42 79.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.256 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -63.58 -18.3 63.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 7' ' ' LEU . 1.1 p -67.79 -39.91 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.684 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 15' ' ' THR . 4.0 t -59.58 -52.89 63.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 13' ' ' ILE . 2.0 tp -63.41 -46.14 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' N ' HG23 ' A' ' 12' ' ' ILE . 78.0 mt -63.8 -44.12 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.377 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.1 -40.12 62.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 11' ' ' SER . 41.3 p -73.69 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 111.085 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 12' ' ' ILE . 1.6 p -78.28 -39.78 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.411 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.05 -42.83 96.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.74 -40.72 81.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.57 -59.7 4.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.092 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.29 -34.83 75.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.328 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 23' ' ' PHE . 47.9 m -65.39 -32.94 74.83 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 110.69 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.7 p -50.49 -0.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.615 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.4 m-85 -103.97 -20.71 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.73 0.3 . . . . 0.0 110.386 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.94 -47.39 53.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.152 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 24' ' ' THR . 71.5 Cg_exo -45.17 -26.63 2.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.518 2.145 . . . . 0.0 112.876 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 23' ' ' PHE . 14.7 p -49.44 -23.96 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 26' ' ' VAL . 4.0 mm? -63.87 -34.78 78.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 25' ' ' PRO . 1.7 p -60.96 -39.62 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.342 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 33' ' ' VAL . 9.0 mt -64.6 -44.46 96.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.289 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.91 -41.68 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.803 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.42 -42.24 98.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.47 85.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.1 t -58.49 -46.23 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.38 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.92 -46.97 94.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.254 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.62 90.22 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.36 -41.17 76.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 110.828 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' GLY . 62.5 m -70.88 -39.7 72.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.85 -49.19 40.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.483 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -62.74 -43.31 99.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.125 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -88.5 5.11 44.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 43.01 77.13 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' H ' ' A' ' 44' ' ' ASP . 59.9 t80 -166.92 35.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.827 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.48 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 42' ' ' TYR . 51.1 t0 -86.02 -28.27 24.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.571 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 76.8 t80 -99.56 48.71 0.94 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -116.19 -25.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.627 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.4 mm? -83.12 -37.13 24.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.506 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.85 -54.42 46.9 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.455 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.14 -37.14 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.922 1.748 . . . . 0.0 112.366 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.68 28.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.01 -41.78 98.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.106 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.95 91.5 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.946 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.2 mp -63.95 -46.15 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -64.61 -44.96 88.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.424 ' O ' ' OG1' ' A' ' 58' ' ' THR . 97.9 mt -64.11 -43.29 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.95 -37.51 92.2 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.27 -45.24 88.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.543 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 17.2 p -55.19 -46.84 75.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.0 pt -70.55 -37.42 69.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 110.432 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -53.63 -35.09 60.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.693 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.55 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.597 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -54.94 -31.59 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.512 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.74 -42.54 73.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.134 0.492 . . . . 0.0 111.113 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -75.8 -23.19 55.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.498 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.53 -46.45 38.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.662 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -69.46 -45.94 67.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.646 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -56.29 -30.0 61.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.52 -42.21 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.006 -0.277 . . . . 0.0 110.649 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.95 -44.79 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.752 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.91 -52.41 17.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.6 p -59.32 -42.41 91.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 t -70.4 -76.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.62 117.85 8.7 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.27 114.58 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.766 1.644 . . . . 0.0 112.255 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.9 pttt -72.63 -33.47 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.003 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' A' ' 77' ' ' ASN . 23.9 p90 -67.28 -51.95 46.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 110.628 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.537 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 31.7 t30 -77.69 -33.02 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.52 50.48 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.906 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 75' ' ' LYS . 8.3 p -64.68 -40.48 89.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.468 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 79' ' ' VAL . 61.8 tttm -61.76 -39.59 92.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.704 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.263 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 N--CA 1.494 1.512 0 CA-C-O 120.669 0.195 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.91 -8.79 59.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.041 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -105.73 -57.59 2.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.114 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 7' ' ' LEU . 4.1 mm? -61.64 -45.7 92.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.794 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.6 tt -64.66 -37.73 88.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.317 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -57.77 -32.28 67.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.316 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -41.82 -38.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.774 0.321 . . . . 0.0 111.432 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' THR . 58.7 p -60.42 -52.92 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 12' ' ' ILE . 1.7 mp -62.05 -52.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.172 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 tp -66.28 -38.24 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -33.28 77.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' SER . 21.1 p -83.08 -15.55 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.9 m -65.32 -60.74 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 -41.47 89.57 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.549 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.94 -46.11 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.623 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -57.47 12.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -63.6 -36.93 85.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 23' ' ' PHE . 34.4 m -59.86 -27.1 66.38 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.63 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -49.98 -5.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.222 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 21' ' ' SER . 36.5 m-85 -111.65 -21.16 11.85 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.444 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -44.62 -57.27 6.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.533 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 29' ' ' ILE . 20.5 Cg_endo -57.84 -47.26 21.63 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.066 1.844 . . . . 0.0 111.974 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -47.48 -48.94 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.412 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.08 -50.57 15.97 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.35 -49.57 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.558 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' PRO . 6.8 tt -54.48 -32.71 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.521 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.3 -37.59 72.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 109.977 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -66.39 -36.48 82.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.453 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -69.58 -62.39 3.89 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.786 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -39.86 -35.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.775 0.321 . . . . 0.0 110.613 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.5 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.137 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' GLY . . . -57.51 -30.13 61.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.31 -26.94 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.2 m -53.31 -24.91 13.0 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 110.097 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.81 -38.55 7.33 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 -56.78 4.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 p -78.82 -49.3 13.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.919 0.39 . . . . 0.0 111.608 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 93.65 -49.99 2.32 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.04 104.16 0.15 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.522 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD21 ' OG ' ' A' ' 37' ' ' SER . 18.7 mt -92.35 30.37 1.5 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.3 m-20 -83.34 -25.27 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.194 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 8.5 p90 -103.47 38.61 1.75 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.981 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.36 -24.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.674 0.273 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -85.21 -50.85 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.979 0.418 . . . . 0.0 110.611 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -62.3 -54.56 48.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 34.6 Cg_endo -63.17 -22.16 72.71 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.149 1.899 . . . . 0.0 112.708 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 110.769 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.41 -27.33 62.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.773 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.41 -32.73 57.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 30' ' ' LEU . 96.5 mt -62.72 -44.49 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.267 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -40.78 91.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.407 ' O ' ' OG1' ' A' ' 58' ' ' THR . 30.0 mm -62.8 -40.2 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.73 93.72 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.18 -39.56 89.82 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.347 -0.502 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 23.1 p -64.58 -51.87 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.466 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 60' ' ' TYR . 2.2 pp -69.6 -41.84 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.147 0.499 . . . . 0.0 110.54 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.408 ' N ' HD12 ' A' ' 59' ' ' ILE . 78.6 t80 -53.6 -34.05 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.517 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.41 -30.38 60.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 111.355 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.7 mp -70.79 -30.87 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.655 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -67.35 -46.13 74.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.589 ' NH1' ' NE2' ' A' ' 67' ' ' GLN . 15.2 mmm180 -76.33 -22.59 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.976 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -49.06 -48.27 44.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -45.83 65.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.68 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.589 ' NE2' ' NH1' ' A' ' 64' ' ' ARG . 53.8 tt0 -55.36 -33.3 63.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.929 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.46 54.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.305 0.574 . . . . 0.0 110.662 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 p30 -72.55 -27.43 62.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 73' ' ' THR . . . -60.34 -49.26 78.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.254 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -76.6 -37.8 55.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 m -66.26 -43.28 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.283 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -40.85 131.42 1.86 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.85 -23.14 22.61 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.11 1.873 . . . . 0.0 112.143 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.61 -45.53 92.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.444 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.41 -46.85 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.633 HD22 ' N ' ' A' ' 77' ' ' ASN . 1.3 m120 -65.78 -36.51 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.659 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.33 -45.54 94.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.5 t -62.31 -44.08 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.369 . . . . 0.0 110.049 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -55.1 85.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.437 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 79' ' ' VAL . 39.0 tptt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.238 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.005 0.335 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -66.02 -5.59 10.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.999 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -51.48 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 111.031 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.54 -53.9 53.13 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.958 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.54 -35.19 79.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.649 0.261 . . . . 0.0 110.391 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HE ' HD22 ' A' ' 77' ' ' ASN . 77.9 ttt-85 -62.22 -20.43 64.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.837 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.0 t -42.09 -29.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.902 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.7 t -62.99 -48.53 78.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 16' ' ' THR . 35.9 mm -61.44 -53.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.491 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.1 pt -63.14 -38.73 82.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.63 -28.29 72.38 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.8 m -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.549 -0.325 . . . . 0.0 111.539 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' ILE . 70.5 p -75.17 -32.35 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.332 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.2 mm? -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.294 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.21 -41.87 90.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.053 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -62.33 1.82 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.497 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.78 -36.08 83.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 23' ' ' PHE . 38.3 m -60.23 -31.4 70.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.061 0.458 . . . . 0.0 110.385 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -51.25 -3.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.36 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.559 ' H ' ' C ' ' A' ' 21' ' ' SER . 3.1 m-85 -91.74 -29.66 16.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.736 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -62.73 -49.06 84.28 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.033 -178.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.4 Cg_exo -54.3 -25.47 38.99 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.08 2.52 . . . . 0.0 112.916 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.4 -49.38 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 110.299 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.86 -48.73 10.43 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.139 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 24' ' ' THR . 74.0 t -47.22 -51.51 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 25' ' ' PRO . 19.4 tt -65.94 -39.12 83.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 34' ' ' VAL . 34.8 tp -59.4 -40.61 87.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.11 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.06 -37.43 87.54 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.744 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.55 -62.3 4.19 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.093 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -42.62 -33.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.922 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 30' ' ' LEU . 41.2 t -63.11 -45.13 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.599 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -27.91 50.63 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -61.21 -27.65 68.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.852 0.358 . . . . 0.0 110.597 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -60.1 -32.31 70.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.602 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.24 -42.85 14.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.688 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.3 m -81.94 -48.02 12.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.008 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.65 31.51 10.18 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -119.51 54.65 0.99 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.425 0.631 . . . . 0.0 110.965 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.26 9.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' TYR . 47.1 m-20 -73.37 -39.86 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.122 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.87 38.31 1.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.24 -16.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.17 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.67 -50.09 7.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.261 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -68.47 -46.48 36.77 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.039 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 48.8 Cg_exo -54.89 -36.47 91.75 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.43 2.087 . . . . 0.0 112.045 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.01 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.13 -29.3 57.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.48 96.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -63.86 -44.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.115 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.42 -42.4 96.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.305 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.41 -42.99 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.03 -33.95 88.64 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 m -63.56 -49.42 73.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.652 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.09 -35.04 70.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -48.59 -34.06 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.678 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.27 -38.81 19.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.21 -31.05 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.801 0.334 . . . . 0.0 110.785 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -68.15 -42.95 79.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -76.87 -23.48 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -50.19 -43.52 52.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.075 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -70.57 -46.72 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.007 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.97 -30.39 59.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.5 74.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.422 0.63 . . . . 0.0 109.98 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -60.19 -48.83 80.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.56 -51.72 67.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -64.09 -39.39 93.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.9 p -60.48 -42.09 95.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 96.64 40.43 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.833 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 77' ' ' ASN . 59.6 Cg_endo -78.46 80.93 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.162 1.908 . . . . 0.0 112.489 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 mttt -80.17 -42.17 23.93 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.749 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CE2' ' OD1' ' A' ' 77' ' ' ASN . 5.2 p90 -52.18 -55.68 19.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.01 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.685 HD22 ' HE ' ' A' ' 9' ' ' ARG . 5.7 p-10 -79.02 -31.17 44.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 110.795 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.15 93.97 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' LYS . 52.1 t -67.98 -40.05 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 110.681 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -44.39 -53.47 6.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.212 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 mttt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.549 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.493 1.441 0 CA-C-O 121.0 0.333 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 68.1 mttm -73.69 -9.34 58.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 t -115.26 -32.79 5.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.306 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -78.02 -53.02 7.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -67.96 -36.54 80.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.594 ' NE ' HD12 ' A' ' 12' ' ' ILE . 2.7 mmp_? -56.76 -18.76 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 7' ' ' LEU . 9.8 p -57.32 -40.68 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 15' ' ' THR . 58.1 m -48.72 -46.36 40.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.865 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 HD12 ' NE ' ' A' ' 9' ' ' ARG . 96.3 mt -67.08 -44.86 87.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.186 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -44.63 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.81 93.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 11' ' ' SER . 27.2 p -68.01 -17.79 64.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 23.7 m -79.5 -35.47 40.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.992 0.425 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.2 -44.59 83.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 19' ' ' ALA . 18.9 m -73.46 -41.42 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.867 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -56.12 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.85 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -62.46 -39.44 93.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 23' ' ' PHE . 37.4 m -59.58 -29.39 67.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.674 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.7 p -51.38 -3.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.638 ' O ' HG22 ' A' ' 26' ' ' VAL . 31.6 m-85 -99.21 -25.62 14.45 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.495 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -60.45 -48.1 94.57 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.251 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 24' ' ' THR . 54.0 Cg_exo -45.8 -11.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.88 2.386 . . . . 0.0 112.796 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' PHE . 10.2 m -71.74 -41.41 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 120.993 0.425 . . . . 0.0 110.969 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' N ' HG23 ' A' ' 26' ' ' VAL . 84.7 mt -58.56 -30.83 67.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.017 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -57.42 -30.9 37.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.631 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 26' ' ' VAL . 7.5 tt -56.14 -37.39 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.04 -41.62 98.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.963 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.4 tm? -67.1 -47.54 70.89 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.58 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.93 -54.35 14.76 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.266 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 4.7 p -53.19 -41.46 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.837 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.436 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 48.2 t -69.33 -48.79 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.65 -35.16 85.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.97 -34.4 77.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.6 p -63.38 -36.52 83.97 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.991 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.8 -41.53 5.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.61 -44.7 93.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.608 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 p -85.63 -43.35 13.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.774 0.321 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.26 23.87 30.68 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.645 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -115.58 49.4 1.09 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -64.97 24.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.95 -0.469 . . . . 0.0 110.86 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 42' ' ' TYR . 41.5 t0 -80.81 -38.63 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.23 45.58 1.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.9 m -126.02 -14.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.88 -36.53 15.91 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 6.5 tp -69.65 -43.37 21.67 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.307 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.5 Cg_exo -66.38 -18.33 54.95 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.294 2.663 . . . . 0.0 111.801 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -33.17 73.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.158 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.55 -23.1 5.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.301 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.35 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -64.04 -44.37 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' N ' HG23 ' A' ' 53' ' ' ILE . 51.4 m-85 -66.38 -43.97 84.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.365 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.7 -43.48 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.881 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.33 80.39 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.61 -34.73 74.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.981 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -67.01 -50.23 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.182 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' ILE . 17.0 tt -68.0 -37.87 79.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.326 0.584 . . . . 0.0 110.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CD1' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -47.78 -34.66 8.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.28 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.95 -27.61 3.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.08 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -68.17 -31.31 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -68.37 -44.69 74.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.457 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -77.11 -23.08 51.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.999 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -50.34 -48.96 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.061 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.16 -47.56 42.85 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.027 -0.42 . . . . 0.0 110.637 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.81 -28.28 9.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.658 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.55 -36.46 45.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.235 0.54 . . . . 0.0 109.7 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.5 -42.16 95.99 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.17 84.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -69.5 -36.94 76.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p -82.13 24.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -139.92 70.98 35.87 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.94 -70.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.831 2.354 . . . . 0.0 112.078 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -76.04 -42.17 48.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.9 t80 -38.7 -71.38 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.676 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -72.78 -25.97 61.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.18 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . -55.08 -36.61 61.51 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 76' ' ' PHE . 5.1 p -58.82 -35.74 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.071 0.462 . . . . 0.0 110.211 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -46.95 76.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.515 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.735 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.499 1.851 0 N-CA-C 112.745 0.248 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -70.36 -6.84 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.701 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -138.86 -57.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -58.66 -51.12 71.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.33 -31.14 70.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.149 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -61.56 -17.95 57.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.232 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.1 -40.19 62.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.09 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -52.47 -44.88 65.84 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.72 -48.94 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.668 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.31 -43.88 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -42.76 93.71 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.3 m -66.45 -17.97 65.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.809 0.338 . . . . 0.0 110.422 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -68.06 -46.68 70.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.243 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.66 -44.13 87.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.238 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.96 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.21 -57.22 12.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 110.442 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.11 -38.31 85.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.078 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 34.4 m -59.16 -19.74 47.63 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.87 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -61.23 -6.64 2.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.86 -30.87 4.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.902 0.382 . . . . 0.0 111.49 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 m -40.16 -56.24 3.51 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 24' ' ' THR . 11.0 Cg_endo -51.56 -39.59 65.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.878 2.386 . . . . 0.0 112.213 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -48.25 -51.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.798 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -67.48 -49.76 62.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.64 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.18 -47.52 89.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.51 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.59 -37.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.397 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 34' ' ' VAL . 27.4 tp -49.99 -34.16 20.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.759 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -72.62 -29.3 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.985 0.421 . . . . 0.0 110.459 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.07 -49.98 4.53 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.076 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.84 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.9 p -52.54 -41.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.456 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.483 ' N ' HG13 ' A' ' 33' ' ' VAL . 27.0 m -66.0 -34.43 70.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.459 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 37' ' ' SER . . . -57.13 -30.95 61.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -44.42 -23.05 0.09 Allowed 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 36' ' ' LEU . 13.7 m -41.78 -18.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.306 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -55.04 -50.85 68.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.991 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -76.64 -60.01 2.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.368 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.503 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 4.0 m -76.55 -49.83 15.43 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.692 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.49 28.58 73.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -129.68 106.76 8.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.596 0.236 . . . . 0.0 110.436 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 43' ' ' LEU . 10.5 mp -70.16 13.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.72 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 20.7 p-10 -60.84 -44.07 97.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 78.3 t80 -111.07 48.29 0.94 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.077 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -129.2 -26.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.621 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.8 -40.27 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.545 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -62.01 -50.45 80.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 38.0 Cg_endo -67.02 -14.99 45.63 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.661 2.241 . . . . 0.0 112.78 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.11 82.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 0.0 110.57 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.31 -21.0 3.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.4 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 1.8 pt -71.43 -43.14 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.947 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 71.6 m-85 -67.45 -49.89 61.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.426 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' THR . 3.8 tp -62.22 -41.84 92.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.094 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -66.37 -31.4 78.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.88 -30.7 61.94 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.727 -0.278 . . . . 0.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 55' ' ' ILE . 1.3 t -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.523 0.202 . . . . 0.0 110.522 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.37 -41.46 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.175 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -47.04 -57.23 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.902 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.59 82.76 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.165 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.79 -49.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.581 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -68.4 -40.32 81.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -19.36 60.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.972 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -47.43 -48.32 26.51 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.709 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -74.04 -46.6 42.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.016 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -53.83 -33.93 57.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.415 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -52.27 -50.51 61.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.175 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.67 -31.64 72.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.644 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.46 70.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.21 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.7 m -86.36 -37.06 18.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.36 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 55.0 p -71.54 -7.56 48.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 75' ' ' LYS . 3.9 m -129.09 100.85 20.03 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 77' ' ' ASN . 34.8 Cg_exo -58.47 45.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 123.288 2.658 . . . . 0.0 112.856 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 73' ' ' THR . 84.8 tttt -64.78 -28.6 69.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.02 0.438 . . . . 0.0 110.394 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -59.34 -37.62 78.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.428 HD22 ' HB3' ' A' ' 74' ' ' PRO . 57.4 m-80 -60.4 -43.32 96.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.4 96.16 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.22 -41.15 88.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -65.63 -37.51 86.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.563 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.556 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.492 1.434 0 CA-C-O 121.056 0.357 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.44 -8.44 19.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.01 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.1 m -135.8 -55.23 0.78 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.71 -48.82 80.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.739 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.2 tt -67.6 -33.53 75.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.98 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.675 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.97 -37.66 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.501 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.4 m -53.56 -46.37 70.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.663 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -65.46 -47.96 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.389 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.94 -45.45 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.797 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.1 -38.97 94.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.8 m -70.58 -19.83 62.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -75.79 -44.41 41.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.662 ' C ' HD23 ' A' ' 17' ' ' LEU . 8.0 tt -63.75 -45.35 90.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.582 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 19' ' ' ALA . 12.3 p -64.75 -36.5 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -51.11 -62.37 1.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.512 ' O ' ' OG1' ' A' ' 24' ' ' THR . 11.1 mp -50.3 -53.71 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 30.2 m -46.71 -31.34 2.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.274 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 22' ' ' SER . 1.4 m -62.57 -28.64 70.01 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.614 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' HG22 ' A' ' 26' ' ' VAL . 73.8 m-85 -116.26 -33.79 4.87 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -43.74 -49.75 19.39 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' O ' ' A' ' 21' ' ' SER . 89.1 Cg_exo -41.87 -34.11 2.34 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.834 1.69 . . . . 0.0 112.576 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 23' ' ' PHE . 15.8 m -49.16 -45.11 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.605 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' N ' HG23 ' A' ' 26' ' ' VAL . 8.9 mt -73.95 -50.91 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.202 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.33 -47.48 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.232 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 tp -57.72 -33.52 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.3 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.3 -39.04 72.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.373 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.9 mp -61.89 -38.49 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.0 -40.69 50.87 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 29' ' ' ILE . 79.0 t -58.95 -49.87 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.556 0.217 . . . . 0.0 111.012 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 35' ' ' GLY . 8.9 p -66.42 -43.24 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -65.0 -36.98 93.7 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -65.95 -39.64 90.64 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' GLY . 91.1 p -63.15 -33.11 74.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.701 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 -40.76 7.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.343 0.592 . . . . 0.0 109.875 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.81 -45.69 92.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.297 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.86 -47.15 8.07 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -149.4 -169.15 15.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -106.5 -143.31 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 110.986 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.9 mp -75.15 19.02 0.17 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.8 p-10 -67.86 -56.5 8.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.434 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 29.8 t80 -101.14 44.08 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.041 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.53 -16.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.6 -47.74 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.2 mm? -63.14 -58.17 17.38 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.948 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 36.1 Cg_endo -62.16 -18.28 61.19 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.121 1.88 . . . . 0.0 112.997 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . . . -64.13 -31.81 73.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.49 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -53.47 -24.38 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.05 10.93 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.979 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 54' ' ' PHE . 3.6 tp -61.09 -45.53 98.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.182 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 53' ' ' ILE . 54.7 t80 -63.65 -43.63 96.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.003 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.7 -43.77 98.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.927 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.4 81.68 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 57' ' ' LEU . 1.1 tt -60.53 -36.56 78.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 0.0 110.023 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 m -62.78 -40.05 96.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.44 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.8 -42.4 94.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -45.52 -52.13 10.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.249 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -61.35 -48.13 82.68 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.489 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.75 -50.31 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.86 -40.23 94.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.227 0.537 . . . . 0.0 110.385 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.75 -20.44 58.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.921 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' ALA . 10.7 tptp -53.78 -35.79 61.71 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.203 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.703 HH21 ' H ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -76.62 -52.96 8.71 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.283 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.404 ' NE2' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -54.47 -23.81 17.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.04 -50.73 46.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.658 0.742 . . . . 0.0 110.374 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -63.51 -45.19 91.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.396 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.703 ' H ' HH21 ' A' ' 66' ' ' ARG . . . -63.83 -34.59 78.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.991 0.424 . . . . 0.0 110.538 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.404 ' OG ' ' NE2' ' A' ' 67' ' ' GLN . 58.8 m -75.75 -28.22 58.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.515 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 p -99.44 -77.0 0.53 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 75' ' ' LYS . 2.1 m -33.84 97.71 0.12 Allowed Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 123.485 0.491 . . . . 0.0 111.283 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.79 -4.08 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.105 1.87 . . . . 0.0 112.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 73' ' ' THR . 64.6 tttm -60.54 -33.64 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 77' ' ' ASN . 2.1 p90 -56.05 -46.18 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.056 0.455 . . . . 0.0 110.108 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 18.1 t-20 -66.23 -34.14 77.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.616 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.97 93.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.75 -35.68 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.939 0.369 . . . . 0.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.46 -11.15 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.8 tptm . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.486 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.506 2.217 0 N-CA-C 113.064 0.371 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -77.1 -8.74 58.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.769 0.319 . . . . 0.0 110.661 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -27.58 8.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' O ' HG12 ' A' ' 10' ' ' VAL . 6.9 mp -87.99 -56.12 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.617 0.246 . . . . 0.0 110.712 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.2 tp -62.56 -37.84 87.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.827 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.95 -17.66 10.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.84 0.352 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 7' ' ' LEU . 7.7 p -54.97 -35.46 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.537 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -56.06 -47.87 77.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.056 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.3 -47.39 84.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.85 -45.9 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.752 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.33 93.68 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -64.83 -19.19 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.584 0.231 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 m -85.74 -34.79 21.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.385 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 tp -71.46 -32.74 68.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.111 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.41 -56.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.331 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.91 76.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.96 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.34 -48.95 68.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 23' ' ' PHE . 66.6 m -73.71 -38.16 64.94 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.215 0.531 . . . . 0.0 110.721 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -50.59 0.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.919 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.4 m-85 -102.2 -21.31 14.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -64.72 -45.85 75.83 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 24' ' ' THR . 51.3 Cg_exo -52.96 -14.39 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.592 2.195 . . . . 0.0 112.522 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.0 -42.68 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.554 0.692 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.55 -39.05 74.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.859 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 29' ' ' ILE . 3.4 m -65.28 -42.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.537 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' N ' HG23 ' A' ' 28' ' ' VAL . 30.2 pt -67.92 -34.73 68.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.825 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.9 -41.62 96.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.05 -40.92 93.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.8 t -58.88 -46.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.307 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.92 -41.54 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.323 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.83 -36.36 86.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.65 -24.67 65.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 41' ' ' GLY . 95.2 p -50.33 -23.23 2.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.16 23.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.706 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.73 -58.76 3.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 m -76.1 -47.83 23.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.916 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 85.86 -54.37 4.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 44' ' ' ASP . 73.9 m-85 -52.04 106.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.573 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.018 HD13 ' H ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.33 21.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.737 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 42' ' ' TYR . 50.3 t0 -61.56 -44.27 97.34 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.943 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.56 47.75 0.89 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -118.88 -36.92 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.61 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -85.5 -39.43 17.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.696 0.284 . . . . 0.0 111.425 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -60.17 -50.71 84.81 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 53.5 Cg_exo -48.99 -44.88 31.06 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.115 1.877 . . . . 0.0 112.295 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.72 67.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.97 92.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -67.61 -44.88 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.29 -48.77 71.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 56' ' ' GLY . 21.2 tt -66.43 -40.92 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.685 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -65.78 -38.09 94.06 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.11 -38.78 91.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.674 0.273 . . . . 0.0 111.366 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.0 m -61.67 -48.46 80.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.918 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.7 tp -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -47.78 -32.25 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.262 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -49.52 -28.76 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 111.297 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 59' ' ' ILE . 8.9 tp -67.26 -30.51 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.807 0.337 . . . . 0.0 111.767 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.606 ' NE2' ' CE1' ' A' ' 60' ' ' TYR . 7.1 tt0 -68.03 -45.2 74.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -76.59 -22.94 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -28.7 6.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 9.7 ptt180 -74.55 -48.65 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.336 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.48 -27.34 37.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.006 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.64 -48.59 72.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.305 0.574 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -67.64 -35.5 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.311 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.65 98.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.358 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.8 m -86.13 -46.67 10.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.718 0.294 . . . . 0.0 111.189 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.4 p -64.95 -32.61 74.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.071 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 75' ' ' LYS . 34.8 p -139.57 79.24 24.89 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.128 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.81 77.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.575 2.184 . . . . 0.0 111.503 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.59 -42.14 95.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.558 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 27.9 p90 -55.6 -47.06 77.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.459 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.561 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.82 -28.34 67.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.88 52.64 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.51 -34.75 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.671 0.272 . . . . 0.0 111.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -67.02 -81.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 tptm . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.445 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mmm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -59.31 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.58 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 5' ' ' LYS . 5.1 t70 -50.9 137.42 25.87 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.948 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.86 -8.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.708 2.272 . . . . 0.0 112.499 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 3' ' ' ASP . 47.8 tttm -64.2 -37.14 86.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -105.47 -24.37 12.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.982 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.9 tt -61.65 -51.08 69.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.273 0.559 . . . . 0.0 110.33 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.07 -9.87 35.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.08 -20.49 62.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.697 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.9 t -49.51 -35.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -61.27 -52.83 63.09 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.772 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OG1' ' A' ' 16' ' ' THR . 74.5 mt -60.41 -54.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.452 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -64.72 -41.2 91.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -69.46 -38.99 80.29 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.5 m -74.18 -16.46 60.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.987 0.423 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 96.6 m -73.11 -45.24 58.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.261 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.8 mt -68.08 -45.09 74.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.73 -41.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.38 32.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.308 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' HH21 ' A' ' 64' ' ' ARG . 75.4 mt -65.39 -36.09 82.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 23' ' ' PHE . 46.8 t -64.93 -33.24 75.57 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.893 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -50.59 -2.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 21' ' ' SER . 63.2 m-85 -119.09 -25.53 6.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.434 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 91.5 m -47.52 -46.39 59.22 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.778 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 24' ' ' THR . 55.7 Cg_exo -47.44 -32.56 15.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.772 2.315 . . . . 0.0 112.682 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 27' ' ' LEU . 5.9 p -49.15 -47.37 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.504 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' HG13 ' A' ' 26' ' ' VAL . 11.5 mt -64.13 -48.05 77.58 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.311 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.86 -42.78 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.56 -43.26 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.25 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -51.74 -40.56 60.46 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.662 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.8 tt -59.72 -40.74 89.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.09 -35.92 57.11 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -58.37 -51.72 67.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.411 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 35' ' ' GLY . 7.3 p -66.73 -39.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.208 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -62.71 -36.93 93.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.1 -33.14 75.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.697 0.284 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 41' ' ' GLY . 50.2 m -56.64 -28.04 59.73 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.808 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.7 69.4 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.0 mm? -67.72 -58.99 3.69 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.708 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 41' ' ' GLY . 2.1 t -75.99 -49.46 17.58 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.413 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 107.97 64.61 0.58 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 45' ' ' TYR . 3.0 m-85 -105.98 11.44 31.62 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.4 mm? -31.67 -32.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.364 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 42' ' ' TYR . 24.4 t0 -71.37 -41.98 69.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.269 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 42' ' ' TYR . 23.8 t80 -92.73 53.05 1.96 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.593 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.2 m -126.3 -39.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.9 0.381 . . . . 0.0 110.484 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.7 tp -79.16 -39.98 32.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.0 110.758 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 mp -60.04 -58.92 15.81 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.987 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 17.9 Cg_endo -58.13 -16.18 26.3 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.137 2.558 . . . . 0.0 112.365 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 -32.82 74.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.64 -24.79 15.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.533 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.35 58.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.414 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -63.52 -46.16 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.445 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.25 -45.08 89.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mm -62.95 -44.85 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.42 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 60' ' ' TYR . . . -66.96 -32.15 80.09 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tp -59.95 -41.21 91.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 110.513 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.6 p -65.69 -39.93 91.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.379 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 62' ' ' ILE . 5.7 mm -68.64 -50.13 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 56' ' ' GLY . 5.9 m-30 -49.9 -29.87 9.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.55 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.577 0.227 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 59' ' ' ILE . 4.3 tp -62.44 -29.91 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 110.811 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.5 -40.77 89.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 20' ' ' LEU . 14.5 mmt180 -76.02 -22.94 55.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.97 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -48.27 -47.72 36.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.188 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -72.75 -49.15 32.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.737 0.303 . . . . 0.0 110.669 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -53.84 -31.01 47.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.308 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.64 -53.53 50.53 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 110.227 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -70.59 -44.84 66.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.126 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.08 -32.65 66.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.215 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.5 p -71.39 -39.45 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.0 m -96.39 -79.93 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.708 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 75' ' ' LYS . 11.7 m -39.27 101.83 0.24 Allowed Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 25.9 Cg_exo -60.55 31.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 123.027 2.485 . . . . 0.0 112.774 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 73' ' ' THR . 27.4 mttt -67.2 -44.42 79.65 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.802 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.555 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 38.7 p90 -57.92 -50.98 71.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 5.2 p-10 -78.58 -23.4 46.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.81 82.85 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.43 -43.76 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.331 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' LYS . 41.7 mmtm -54.42 -41.2 69.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.475 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' LYS . 13.1 tptt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -145.71 50.06 1.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.545 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -123.53 85.7 52.63 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.9 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.81 -18.93 13.59 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.564 2.176 . . . . 0.0 111.916 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HZ1' ' HD2' ' A' ' 80' ' ' LYS . 22.1 mmtm -74.47 -14.68 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -114.3 -27.66 7.53 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.899 0.38 . . . . 0.0 110.699 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 10' ' ' VAL . 4.5 mm? -87.12 -55.77 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.589 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.58 80.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.362 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -61.67 -20.78 63.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.219 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 7' ' ' LEU . 2.8 p -53.95 -35.43 28.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.713 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.9 t -55.8 -45.58 78.23 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.711 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 16' ' ' THR . 96.6 mt -65.41 -45.56 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.045 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.09 -44.41 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 0.0 110.294 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -42.17 58.8 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 73.6 m -67.89 -21.56 65.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.672 0.273 . . . . 0.0 110.666 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' ILE . 3.2 p -82.35 -35.7 27.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 110.371 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.2 tt -71.77 -47.04 56.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.218 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.4 t -68.43 -41.31 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.168 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . -57.89 -53.43 58.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.559 0.695 . . . . 0.0 109.79 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.01 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.523 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.549 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 8.5 m -61.26 -23.06 65.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.17 0.51 . . . . 0.0 110.323 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.6 t -78.68 -11.47 59.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.9 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.555 ' CZ ' ' OE1' ' A' ' 63' ' ' GLN . 54.6 m-85 -108.68 -45.5 3.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.002 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.18 -50.28 11.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.321 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CD ' ' O ' ' A' ' 21' ' ' SER . 77.5 Cg_exo -44.84 -41.38 15.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.746 1.631 . . . . 0.0 112.157 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 29' ' ' ILE . 96.7 t -48.18 -48.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.193 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.39 -53.75 50.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.499 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -33.53 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 121.229 -0.188 . . . . 0.0 111.309 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 26' ' ' VAL . 6.1 tt -42.84 -32.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.693 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -45.24 -30.28 1.18 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.693 ' O ' HD23 ' A' ' 31' ' ' LEU . 5.6 tt -70.07 -37.15 75.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.046 0.451 . . . . 0.0 109.949 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' ILE . . . -72.42 -52.79 9.69 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.501 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' VAL . 13.6 m -54.08 -44.45 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.607 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' VAL . 14.2 p -71.28 -37.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 111.03 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -63.34 -38.3 96.2 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.93 -26.62 68.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' A' ' 42' ' ' TYR . 53.0 p -62.8 -41.41 99.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 110.355 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -44.28 74.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.591 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.5 -73.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.228 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -79.54 -48.73 13.35 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 114.16 67.24 0.46 Allowed Glycine 0 N--CA 1.472 1.069 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 46' ' ' VAL . 64.1 m-85 -98.41 14.25 28.77 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -36.57 -43.49 0.4 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.978 0.418 . . . . 0.0 110.81 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.33 -36.21 82.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.108 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' TYR . 90.6 m-85 -107.35 46.8 0.92 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 42' ' ' TYR . 25.4 t -120.31 -33.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -66.32 -40.45 89.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.6 mt -67.77 -59.88 6.15 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.691 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -40.62 -22.69 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.812 1.674 . . . . 0.0 113.51 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -70.36 -36.81 74.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.42 0.629 . . . . 0.0 110.333 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 51' ' ' LEU . 10.3 mp -59.94 -26.01 65.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.692 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.88 81.45 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.453 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' H ' ' A' ' 53' ' ' ILE . 3.8 mp -65.37 -43.37 94.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -47.78 -39.8 19.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.625 0.726 . . . . 0.0 109.865 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.81 -28.01 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.424 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.3 -38.04 67.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.63 -37.84 87.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.98 0.419 . . . . 0.0 110.581 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 p -63.93 -52.58 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.444 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 60' ' ' TYR . 17.4 tt -70.38 -39.88 77.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.81 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 59' ' ' ILE . 47.8 t80 -53.57 -34.39 58.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.46 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.01 -40.06 79.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.663 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.62 -31.18 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.731 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' OE1' ' CZ ' ' A' ' 23' ' ' PHE . 27.7 mt-30 -67.05 -48.97 66.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.963 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -75.95 -22.79 55.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.857 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.71 -48.18 63.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.677 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.414 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 12.0 ptt180 -63.8 -48.68 75.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.265 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -54.29 -28.21 40.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 -178.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.54 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.345 0.593 . . . . 0.0 110.329 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 73' ' ' THR . 50.3 t0 -73.06 -40.89 64.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.57 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.98 -49.29 66.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.002 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -62.24 -42.55 99.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.729 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.9 p -73.89 -25.7 60.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' ASP . 26.1 m -132.9 81.74 57.21 Favored Pre-proline 0 N--CA 1.465 0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.531 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.85 125.63 18.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.299 1.999 . . . . 0.0 111.802 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.86 -28.84 35.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.1 m-85 -91.26 -59.57 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.817 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 77' ' ' ASN . 1.6 m120 -62.95 -25.76 68.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.5 -60.7 6.72 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 80' ' ' LYS . 12.2 p -67.75 -42.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.066 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' N ' HG13 ' A' ' 79' ' ' VAL . 38.2 mtmt -77.13 -106.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.812 0.339 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ASN . 2.4 mptm? . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.21 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' NZ ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -148.15 -63.89 0.25 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.957 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.38 164.59 42.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.353 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 6' ' ' THR . 41.3 Cg_exo -51.78 -3.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.193 1.928 . . . . 0.0 112.6 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' A' ' 3' ' ' ASP . 5.0 ttpm? -37.86 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.836 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 p -124.12 -44.78 2.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.385 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.0 mp -56.29 -41.62 76.21 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.494 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 10' ' ' VAL . 1.8 tt -60.9 -76.88 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.296 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -45.42 -19.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 6' ' ' THR . 39.4 t -82.89 -55.99 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -60.89 -42.01 97.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.778 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 tp -51.79 -18.2 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.685 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.46 -43.68 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.806 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.06 -41.35 99.84 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -71.04 -19.85 62.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.567 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 m -67.26 -42.62 83.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 109.907 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -60.68 -42.04 96.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.768 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 -44.71 96.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.28 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.43 65.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.573 0.702 . . . . 0.0 109.176 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.17 -36.93 83.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.9 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.2 t -51.99 -24.25 6.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.485 0.66 . . . . 0.0 110.603 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -77.86 -7.98 57.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.857 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -114.89 -54.22 2.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -66.06 -64.33 2.49 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.455 -177.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.46 -13.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.323 2.015 . . . . 0.0 113.469 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 24' ' ' THR . 52.4 t -59.34 -38.35 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -62.08 -30.84 71.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.663 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' H ' HD23 ' A' ' 27' ' ' LEU . 98.1 t -63.75 -41.57 93.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 0.0 110.338 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.8 mp -62.05 -39.89 85.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.29 -37.05 71.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.971 0.415 . . . . 0.0 110.57 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.65 -38.77 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.57 -57.1 6.83 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.355 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -44.11 -32.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.58 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.89 -43.93 96.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.09 -33.25 85.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.2 tp -64.67 -34.45 78.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 0.0 110.255 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 41' ' ' GLY . 32.7 t -63.79 -33.37 75.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.406 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.39 -47.86 66.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.034 0.445 . . . . 0.0 110.942 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.15 -60.45 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.067 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.9 p -78.55 -45.77 21.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.069 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 89.59 107.01 1.18 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -112.52 117.17 31.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.218 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.7 mm? -83.66 -67.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.58 0.81 48.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.466 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.49 40.27 1.24 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.17 -25.55 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 0.0 110.289 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -84.97 -43.04 14.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -66.38 -49.22 54.31 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 46.0 Cg_endo -67.96 -15.57 43.77 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.724 1.616 . . . . 0.0 112.71 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.45 81.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.844 0.354 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.1 mm? -61.42 -25.68 67.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.67 90.33 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.99 -45.91 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -65.26 -43.13 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.528 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.85 -43.19 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 0.0 110.214 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.74 96.76 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 mp -62.73 -34.09 76.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.64 0.257 . . . . 0.0 111.167 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 m -64.5 -48.19 76.08 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 62' ' ' ILE . 16.7 pt -71.5 -40.99 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.895 0.379 . . . . 0.0 111.943 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -55.35 -37.61 67.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.673 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -52.95 -26.76 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 111.147 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 59' ' ' ILE . 5.4 tt -62.19 -30.82 49.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.624 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -30.45 70.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -76.33 -22.01 55.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.823 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -51.16 -42.99 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.335 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -47.38 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.184 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -54.21 -28.34 40.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.725 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.94 -52.3 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.827 0.823 . . . . 0.0 109.799 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 73' ' ' THR . 34.8 m-20 -70.05 -33.6 72.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.096 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.27 66.46 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.547 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.7 t -90.88 -31.95 16.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.189 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.9 m -83.22 -7.9 59.54 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.688 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.4 m -139.97 63.18 24.02 Favored Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 120.81 0.338 . . . . 0.0 110.361 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.33 41.11 0.91 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 0.0 111.577 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -63.01 -41.82 99.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -53.9 -69.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.216 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -65.62 -30.57 71.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.84 -57.59 11.91 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.931 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.4 t -77.01 -55.36 10.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.834 0.35 . . . . 0.0 110.81 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -82.51 152.59 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.243 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -35.32 80.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 5' ' ' LYS . 41.3 m-20 -121.23 155.81 58.1 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.108 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.55 10.67 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.71 1.607 . . . . 0.0 112.44 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 3' ' ' ASP . 5.5 mtmp? -69.4 -12.9 62.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.752 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 m -113.71 -51.77 2.78 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.802 0.334 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 7' ' ' LEU . 10.4 mp -59.86 -51.35 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.383 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 8' ' ' LEU . 3.4 tm? -68.85 -37.42 79.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.256 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -63.58 -18.3 63.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 7' ' ' LEU . 1.1 p -67.79 -39.91 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.684 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 15' ' ' THR . 4.0 t -59.58 -52.89 63.6 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 13' ' ' ILE . 2.0 tp -63.41 -46.14 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' N ' HG23 ' A' ' 12' ' ' ILE . 78.0 mt -63.8 -44.12 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.377 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.1 -40.12 62.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 11' ' ' SER . 41.3 p -73.69 -18.75 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 111.085 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 12' ' ' ILE . 1.6 p -78.28 -39.78 38.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.411 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.05 -42.83 96.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.74 -40.72 81.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.57 -59.7 4.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.092 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.29 -34.83 75.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.328 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 23' ' ' PHE . 47.9 m -65.39 -32.94 74.83 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 110.69 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.7 p -50.49 -0.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.615 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.4 m-85 -103.97 -20.71 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.73 0.3 . . . . 0.0 110.386 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.94 -47.39 53.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.152 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 24' ' ' THR . 71.5 Cg_exo -45.17 -26.63 2.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.518 2.145 . . . . 0.0 112.876 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 23' ' ' PHE . 14.7 p -49.44 -23.96 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD22 HG13 ' A' ' 26' ' ' VAL . 4.0 mm? -63.87 -34.78 78.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.93 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 25' ' ' PRO . 1.7 p -60.96 -39.62 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.342 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 33' ' ' VAL . 9.0 mt -64.6 -44.46 96.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.289 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.91 -41.68 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.803 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 mt -63.42 -42.24 98.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.47 85.99 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.1 t -58.49 -46.23 89.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.38 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.92 -46.97 94.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.254 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.62 90.22 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.36 -41.17 76.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 110.828 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 41' ' ' GLY . 62.5 m -70.88 -39.7 72.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.096 0.474 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.85 -49.19 40.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.483 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -62.74 -43.31 99.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.125 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -88.5 5.11 44.09 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 110.669 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 43.01 77.13 0.09 OUTLIER Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' H ' ' A' ' 44' ' ' ASP . 59.9 t80 -166.92 35.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.827 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.48 31.84 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 42' ' ' TYR . 51.1 t0 -86.02 -28.27 24.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.571 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 76.8 t80 -99.56 48.71 0.94 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.005 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -116.19 -25.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.627 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 47' ' ' LEU . 4.4 mm? -83.12 -37.13 24.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.506 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.85 -54.42 46.9 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.455 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.14 -37.14 1.7 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.922 1.748 . . . . 0.0 112.366 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.68 28.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.691 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.01 -41.78 98.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.106 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.95 91.5 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.946 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.2 mp -63.95 -46.15 94.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.077 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -64.61 -44.96 88.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.089 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.424 ' O ' ' OG1' ' A' ' 58' ' ' THR . 97.9 mt -64.11 -43.29 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.95 -37.51 92.2 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.27 -45.24 88.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.543 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 17.2 p -55.19 -46.84 75.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.0 pt -70.55 -37.42 69.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.29 0.567 . . . . 0.0 110.432 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -53.63 -35.09 60.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.693 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.55 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.597 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -54.94 -31.59 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.512 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.74 -42.54 73.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.134 0.492 . . . . 0.0 111.113 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -75.8 -23.19 55.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.498 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.53 -46.45 38.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.662 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -69.46 -45.94 67.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.646 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -56.29 -30.0 61.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.52 -42.21 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.006 -0.277 . . . . 0.0 110.649 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.95 -44.79 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.752 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.91 -52.41 17.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 110.972 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.6 p -59.32 -42.41 91.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 t -70.4 -76.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.62 117.85 8.7 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.831 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.27 114.58 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.766 1.644 . . . . 0.0 112.255 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.9 pttt -72.63 -33.47 66.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.003 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' A' ' 77' ' ' ASN . 23.9 p90 -67.28 -51.95 46.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 110.628 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.537 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 31.7 t30 -77.69 -33.02 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.23 -50.52 50.48 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.906 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 75' ' ' LYS . 8.3 p -64.68 -40.48 89.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.468 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 79' ' ' VAL . 61.8 tttm -61.76 -39.59 92.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.704 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.263 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 105.64 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -139.11 145.69 46.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.472 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.5 -30.09 43.92 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.18 1.92 . . . . 0.0 111.931 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.91 -8.79 59.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.041 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -105.73 -57.59 2.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.114 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 7' ' ' LEU . 4.1 mm? -61.64 -45.7 92.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.794 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.6 tt -64.66 -37.73 88.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.317 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -57.77 -32.28 67.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.316 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -41.82 -38.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.774 0.321 . . . . 0.0 111.432 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' THR . 58.7 p -60.42 -52.92 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 12' ' ' ILE . 1.7 mp -62.05 -52.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.172 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 tp -66.28 -38.24 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -33.28 77.67 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' SER . 21.1 p -83.08 -15.55 50.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 111.067 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.9 m -65.32 -60.74 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.407 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.41 -41.47 89.57 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.549 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.94 -46.11 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.623 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.59 -57.47 12.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -63.6 -36.93 85.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 23' ' ' PHE . 34.4 m -59.86 -27.1 66.38 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.63 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.8 m -49.98 -5.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.222 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 21' ' ' SER . 36.5 m-85 -111.65 -21.16 11.85 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.444 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.5 m -44.62 -57.27 6.97 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.533 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 29' ' ' ILE . 20.5 Cg_endo -57.84 -47.26 21.63 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.066 1.844 . . . . 0.0 111.974 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -47.48 -48.94 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.412 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.2 tp -75.08 -50.57 15.97 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.8 t -61.35 -49.57 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.558 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' PRO . 6.8 tt -54.48 -32.71 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.521 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.3 -37.59 72.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 109.977 -178.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.1 mm? -66.39 -36.48 82.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.453 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -69.58 -62.39 3.89 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.786 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -39.86 -35.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.775 0.321 . . . . 0.0 110.613 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -61.5 -44.37 98.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.137 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 32' ' ' GLY . . . -57.51 -30.13 61.62 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.31 -26.94 68.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 41' ' ' GLY . 13.2 m -53.31 -24.91 13.0 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 110.097 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.81 -38.55 7.33 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 -56.78 4.4 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 p -78.82 -49.3 13.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.919 0.39 . . . . 0.0 111.608 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 93.65 -49.99 2.32 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -57.04 104.16 0.15 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.522 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD21 ' OG ' ' A' ' 37' ' ' SER . 18.7 mt -92.35 30.37 1.5 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.3 m-20 -83.34 -25.27 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.194 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 8.5 p90 -103.47 38.61 1.75 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.981 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.36 -24.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.674 0.273 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -85.21 -50.85 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.979 0.418 . . . . 0.0 110.611 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -62.3 -54.56 48.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 34.6 Cg_endo -63.17 -22.16 72.71 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.149 1.899 . . . . 0.0 112.708 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 110.769 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.6 mt -57.41 -27.33 62.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.773 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.41 -32.73 57.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 30' ' ' LEU . 96.5 mt -62.72 -44.49 99.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.267 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -40.78 91.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.407 ' O ' ' OG1' ' A' ' 58' ' ' THR . 30.0 mm -62.8 -40.2 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.73 93.72 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.18 -39.56 89.82 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.347 -0.502 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 23.1 p -64.58 -51.87 60.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.466 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 60' ' ' TYR . 2.2 pp -69.6 -41.84 80.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.147 0.499 . . . . 0.0 110.54 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' N ' HD12 ' A' ' 59' ' ' ILE . 78.6 t80 -53.6 -34.05 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.517 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.41 -30.38 60.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.69 0.281 . . . . 0.0 111.355 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.7 mp -70.79 -30.87 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.655 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -67.35 -46.13 74.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.589 ' NH1' ' NE2' ' A' ' 67' ' ' GLN . 15.2 mmm180 -76.33 -22.59 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.976 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -49.06 -48.27 44.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -45.83 65.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.68 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.589 ' NE2' ' NH1' ' A' ' 64' ' ' ARG . 53.8 tt0 -55.36 -33.3 63.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.929 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.65 -53.46 54.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.305 0.574 . . . . 0.0 110.662 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 p30 -72.55 -27.43 62.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 73' ' ' THR . . . -60.34 -49.26 78.28 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.254 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -76.6 -37.8 55.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.0 m -66.26 -43.28 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.283 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -40.85 131.42 1.86 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.85 -23.14 22.61 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.11 1.873 . . . . 0.0 112.143 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.61 -45.53 92.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.444 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.41 -46.85 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.633 HD22 ' N ' ' A' ' 77' ' ' ASN . 1.3 m120 -65.78 -36.51 83.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.659 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.33 -45.54 94.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.5 t -62.31 -44.08 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.369 . . . . 0.0 110.049 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -55.1 85.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.437 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 79' ' ' VAL . 39.0 tptt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.238 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.49 26.68 6.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 66.29 76.37 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.43 -5.15 16.26 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.732 2.288 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -66.02 -5.59 10.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.999 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -51.48 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 111.031 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.54 -53.9 53.13 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.958 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.54 -35.19 79.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.649 0.261 . . . . 0.0 110.391 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HE ' HD22 ' A' ' 77' ' ' ASN . 77.9 ttt-85 -62.22 -20.43 64.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.837 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.0 t -42.09 -29.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.902 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.7 t -62.99 -48.53 78.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 16' ' ' THR . 35.9 mm -61.44 -53.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.491 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.1 pt -63.14 -38.73 82.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.63 -28.29 72.38 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.8 m -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.549 -0.325 . . . . 0.0 111.539 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' ILE . 70.5 p -75.17 -32.35 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.332 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.2 mm? -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.294 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.21 -41.87 90.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.053 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -62.33 1.82 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.497 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.78 -36.08 83.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 23' ' ' PHE . 38.3 m -60.23 -31.4 70.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.061 0.458 . . . . 0.0 110.385 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -51.25 -3.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.36 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.559 ' H ' ' C ' ' A' ' 21' ' ' SER . 3.1 m-85 -91.74 -29.66 16.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.736 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -62.73 -49.06 84.28 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.033 -178.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.4 Cg_exo -54.3 -25.47 38.99 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.08 2.52 . . . . 0.0 112.916 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.4 -49.38 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.272 0.558 . . . . 0.0 110.299 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.86 -48.73 10.43 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.139 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 24' ' ' THR . 74.0 t -47.22 -51.51 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 25' ' ' PRO . 19.4 tt -65.94 -39.12 83.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.645 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 34' ' ' VAL . 34.8 tp -59.4 -40.61 87.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.11 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.06 -37.43 87.54 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.744 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.55 -62.3 4.19 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.093 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -42.62 -33.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.922 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 30' ' ' LEU . 41.2 t -63.11 -45.13 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.599 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -27.91 50.63 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -61.21 -27.65 68.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.852 0.358 . . . . 0.0 110.597 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.2 p -60.1 -32.31 70.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.602 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.24 -42.85 14.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.073 0.463 . . . . 0.0 110.512 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.688 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.3 m -81.94 -48.02 12.01 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.008 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.65 31.51 10.18 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.648 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -119.51 54.65 0.99 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.425 0.631 . . . . 0.0 110.965 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.26 9.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 42' ' ' TYR . 47.1 m-20 -73.37 -39.86 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.122 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.87 38.31 1.57 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.24 -16.07 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.17 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.67 -50.09 7.95 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.261 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.5 OUTLIER -68.47 -46.48 36.77 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.039 -179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 48.8 Cg_exo -54.89 -36.47 91.75 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.43 2.087 . . . . 0.0 112.045 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.01 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.665 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.13 -29.3 57.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.48 96.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.3 mp -63.86 -44.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.115 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -64.42 -42.4 96.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.305 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -63.41 -42.99 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.107 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.03 -33.95 88.64 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 m -63.56 -49.42 73.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.652 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.09 -35.04 70.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -48.59 -34.06 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.678 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.27 -38.81 19.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.21 -31.05 31.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.801 0.334 . . . . 0.0 110.785 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -68.15 -42.95 79.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.796 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -76.87 -23.48 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -50.19 -43.52 52.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.075 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -70.57 -46.72 62.98 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.007 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.97 -30.39 59.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.819 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.5 74.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.422 0.63 . . . . 0.0 109.98 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -60.19 -48.83 80.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.56 -51.72 67.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -64.09 -39.39 93.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.397 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.9 p -60.48 -42.09 95.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.69 96.64 40.43 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.833 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HB2' HD21 ' A' ' 77' ' ' ASN . 59.6 Cg_endo -78.46 80.93 2.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.162 1.908 . . . . 0.0 112.489 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 79' ' ' VAL . 97.1 mttt -80.17 -42.17 23.93 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.749 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CE2' ' OD1' ' A' ' 77' ' ' ASN . 5.2 p90 -52.18 -55.68 19.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.01 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.685 HD22 ' HE ' ' A' ' 9' ' ' ARG . 5.7 p-10 -79.02 -31.17 44.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 110.795 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.15 93.97 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 75' ' ' LYS . 52.1 t -67.98 -40.05 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 110.681 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -44.39 -53.47 6.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.212 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 mttt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.549 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.7 mmm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -76.18 -16.5 59.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 23.5 p-10 -139.72 71.14 36.99 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -71.73 86.45 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.899 2.399 . . . . 0.0 111.558 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 68.1 mttm -73.69 -9.34 58.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 t -115.26 -32.79 5.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.306 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -78.02 -53.02 7.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -67.96 -36.54 80.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.594 ' NE ' HD12 ' A' ' 12' ' ' ILE . 2.7 mmp_? -56.76 -18.76 13.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 7' ' ' LEU . 9.8 p -57.32 -40.68 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.664 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 15' ' ' THR . 58.1 m -48.72 -46.36 40.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.865 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 HD12 ' NE ' ' A' ' 9' ' ' ARG . 96.3 mt -67.08 -44.86 87.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.186 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -44.63 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.056 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.81 93.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 11' ' ' SER . 27.2 p -68.01 -17.79 64.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 23.7 m -79.5 -35.47 40.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.992 0.425 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.2 -44.59 83.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 19' ' ' ALA . 18.9 m -73.46 -41.42 56.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.867 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.515 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -56.12 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.85 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.7 mm? -62.46 -39.44 93.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 23' ' ' PHE . 37.4 m -59.58 -29.39 67.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.674 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.7 p -51.38 -3.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.638 ' O ' HG22 ' A' ' 26' ' ' VAL . 31.6 m-85 -99.21 -25.62 14.45 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.495 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -60.45 -48.1 94.57 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.251 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 24' ' ' THR . 54.0 Cg_exo -45.8 -11.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.88 2.386 . . . . 0.0 112.796 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 23' ' ' PHE . 10.2 m -71.74 -41.41 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 120.993 0.425 . . . . 0.0 110.969 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' N ' HG23 ' A' ' 26' ' ' VAL . 84.7 mt -58.56 -30.83 67.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.017 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -57.42 -30.9 37.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.631 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 26' ' ' VAL . 7.5 tt -56.14 -37.39 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.786 0.327 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.04 -41.62 98.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 110.963 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.4 tm? -67.1 -47.54 70.89 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.58 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.93 -54.35 14.76 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.266 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 4.7 p -53.19 -41.46 42.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.837 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.436 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 48.2 t -69.33 -48.79 65.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.65 -35.16 85.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.97 -34.4 77.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 34' ' ' VAL . 82.6 p -63.38 -36.52 83.97 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.991 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.8 -41.53 5.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.61 -44.7 93.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.608 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 p -85.63 -43.35 13.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.774 0.321 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.26 23.87 30.68 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.645 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -115.58 49.4 1.09 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.179 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -64.97 24.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.95 -0.469 . . . . 0.0 110.86 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 42' ' ' TYR . 41.5 t0 -80.81 -38.63 28.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.23 45.58 1.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.673 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 43' ' ' LEU . 12.9 m -126.02 -14.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.88 -36.53 15.91 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 6.5 tp -69.65 -43.37 21.67 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.307 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 19.5 Cg_exo -66.38 -18.33 54.95 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 123.294 2.663 . . . . 0.0 111.801 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -33.17 73.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.158 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.55 -23.1 5.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.301 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.07 -29.35 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -64.04 -44.37 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' N ' HG23 ' A' ' 53' ' ' ILE . 51.4 m-85 -66.38 -43.97 84.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.365 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.7 -43.48 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.881 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.33 80.39 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.61 -34.73 74.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.981 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -67.01 -50.23 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.182 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' ILE . 17.0 tt -68.0 -37.87 79.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.326 0.584 . . . . 0.0 110.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CD1' ' CE2' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -47.78 -34.66 8.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.28 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -48.95 -27.61 3.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.08 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 59' ' ' ILE . 1.5 tp -68.17 -31.31 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -68.37 -44.69 74.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.457 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -77.11 -23.08 51.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.999 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -50.34 -48.96 55.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.061 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.16 -47.56 42.85 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.027 -0.42 . . . . 0.0 110.637 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.81 -28.28 9.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.658 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.55 -36.46 45.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.235 0.54 . . . . 0.0 109.7 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.5 -42.16 95.99 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.409 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.17 84.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -69.5 -36.94 76.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.8 p -82.13 24.75 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.905 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 p -139.92 70.98 35.87 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.94 -70.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.831 2.354 . . . . 0.0 112.078 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -76.04 -42.17 48.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.9 t80 -38.7 -71.38 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.676 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -72.78 -25.97 61.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.18 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . . . -55.08 -36.61 61.51 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 76' ' ' PHE . 5.1 p -58.82 -35.74 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.071 0.462 . . . . 0.0 110.211 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -46.95 76.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.515 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.735 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -145.27 62.51 1.29 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.781 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.63 93.44 46.26 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.417 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.47 -22.16 3.92 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.613 2.209 . . . . 0.0 112.745 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -70.36 -6.84 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.701 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -138.86 -57.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -58.66 -51.12 71.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.33 -31.14 70.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 110.149 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -61.56 -17.95 57.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.232 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.1 -40.19 62.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.09 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -52.47 -44.88 65.84 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.72 -48.94 74.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.668 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.31 -43.88 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -42.76 93.71 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.3 m -66.45 -17.97 65.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.809 0.338 . . . . 0.0 110.422 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -68.06 -46.68 70.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.243 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.66 -44.13 87.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.238 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.96 -44.83 99.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.21 -57.22 12.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 110.442 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.11 -38.31 85.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.078 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 34.4 m -59.16 -19.74 47.63 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.87 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -61.23 -6.64 2.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.86 -30.87 4.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.902 0.382 . . . . 0.0 111.49 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 m -40.16 -56.24 3.51 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 24' ' ' THR . 11.0 Cg_endo -51.56 -39.59 65.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.878 2.386 . . . . 0.0 112.213 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -48.25 -51.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.798 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.8 mm? -67.48 -49.76 62.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.64 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.18 -47.52 89.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.51 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.59 -37.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.397 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 34' ' ' VAL . 27.4 tp -49.99 -34.16 20.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.759 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -72.62 -29.3 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.985 0.421 . . . . 0.0 110.459 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.07 -49.98 4.53 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.076 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.84 ' O ' HD22 ' A' ' 36' ' ' LEU . 9.9 p -52.54 -41.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.456 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.483 ' N ' HG13 ' A' ' 33' ' ' VAL . 27.0 m -66.0 -34.43 70.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.459 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 37' ' ' SER . . . -57.13 -30.95 61.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -44.42 -23.05 0.09 Allowed 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.798 ' N ' HD23 ' A' ' 36' ' ' LEU . 13.7 m -41.78 -18.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.306 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -55.04 -50.85 68.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.991 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -76.64 -60.01 2.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.368 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.503 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 4.0 m -76.55 -49.83 15.43 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.692 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.49 28.58 73.34 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -129.68 106.76 8.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.596 0.236 . . . . 0.0 110.436 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 43' ' ' LEU . 10.5 mp -70.16 13.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.72 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 20.7 p-10 -60.84 -44.07 97.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 78.3 t80 -111.07 48.29 0.94 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.077 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -129.2 -26.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.621 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.8 -40.27 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.545 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -62.01 -50.45 80.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 38.0 Cg_endo -67.02 -14.99 45.63 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.661 2.241 . . . . 0.0 112.78 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.11 82.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 0.0 110.57 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 tp -52.31 -21.0 3.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.4 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 54' ' ' PHE . 1.8 pt -71.43 -43.14 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.98 0.419 . . . . 0.0 110.947 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' N ' ' CG1' ' A' ' 53' ' ' ILE . 71.6 m-85 -67.45 -49.89 61.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.426 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 58' ' ' THR . 3.8 tp -62.22 -41.84 92.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.094 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -66.37 -31.4 78.81 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.88 -30.7 61.94 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.727 -0.278 . . . . 0.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 55' ' ' ILE . 1.3 t -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.523 0.202 . . . . 0.0 110.522 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.37 -41.46 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.175 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -47.04 -57.23 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.902 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.59 82.76 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.165 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.79 -49.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.581 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -68.4 -40.32 81.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.116 0.484 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -19.36 60.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.972 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -47.43 -48.32 26.51 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.709 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -74.04 -46.6 42.26 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.016 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -53.83 -33.93 57.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.415 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -52.27 -50.51 61.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.175 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.67 -31.64 72.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.644 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.46 70.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.21 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.7 m -86.36 -37.06 18.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.36 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 55.0 p -71.54 -7.56 48.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 75' ' ' LYS . 3.9 m -129.09 100.85 20.03 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 77' ' ' ASN . 34.8 Cg_exo -58.47 45.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 123.288 2.658 . . . . 0.0 112.856 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 73' ' ' THR . 84.8 tttt -64.78 -28.6 69.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.02 0.438 . . . . 0.0 110.394 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -59.34 -37.62 78.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.428 HD22 ' HB3' ' A' ' 74' ' ' PRO . 57.4 m-80 -60.4 -43.32 96.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.631 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.4 96.16 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.22 -41.15 88.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -65.63 -37.51 86.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.563 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.556 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 13.4 ttt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -64.97 -16.01 62.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.798 0.332 . . . . 0.0 110.292 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -45.97 160.86 0.28 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.918 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.96 -8.77 24.49 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.423 2.082 . . . . 0.0 111.608 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.44 -8.44 19.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.01 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.1 m -135.8 -55.23 0.78 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.71 -48.82 80.09 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.739 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 8' ' ' LEU . 5.2 tt -67.6 -33.53 75.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -34.98 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.675 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.97 -37.66 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.501 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.4 m -53.56 -46.37 70.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.663 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -65.46 -47.96 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.389 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.94 -45.45 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.797 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.1 -38.97 94.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.8 m -70.58 -19.83 62.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.4 m -75.79 -44.41 41.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.662 ' C ' HD23 ' A' ' 17' ' ' LEU . 8.0 tt -63.75 -45.35 90.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.582 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 19' ' ' ALA . 12.3 p -64.75 -36.5 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -51.11 -62.37 1.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.512 ' O ' ' OG1' ' A' ' 24' ' ' THR . 11.1 mp -50.3 -53.71 26.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 30.2 m -46.71 -31.34 2.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.274 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 22' ' ' SER . 1.4 m -62.57 -28.64 70.01 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.614 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' HG22 ' A' ' 26' ' ' VAL . 73.8 m-85 -116.26 -33.79 4.87 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -43.74 -49.75 19.39 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' O ' ' A' ' 21' ' ' SER . 89.1 Cg_exo -41.87 -34.11 2.34 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.834 1.69 . . . . 0.0 112.576 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 23' ' ' PHE . 15.8 m -49.16 -45.11 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.605 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' N ' HG23 ' A' ' 26' ' ' VAL . 8.9 mt -73.95 -50.91 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.202 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.33 -47.48 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.232 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 tp -57.72 -33.52 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.3 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.3 -39.04 72.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.373 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.9 mp -61.89 -38.49 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.0 -40.69 50.87 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 29' ' ' ILE . 79.0 t -58.95 -49.87 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.556 0.217 . . . . 0.0 111.012 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 35' ' ' GLY . 8.9 p -66.42 -43.24 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.496 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -65.0 -36.98 93.7 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 tp -65.95 -39.64 90.64 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' GLY . 91.1 p -63.15 -33.11 74.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.701 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 -40.76 7.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.343 0.592 . . . . 0.0 109.875 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -61.81 -45.69 92.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.297 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.86 -47.15 8.07 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -149.4 -169.15 15.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -106.5 -143.31 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.74 0.305 . . . . 0.0 110.986 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.9 mp -75.15 19.02 0.17 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.8 p-10 -67.86 -56.5 8.87 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.434 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 29.8 t80 -101.14 44.08 1.03 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.041 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.53 -16.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.52 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.6 -47.74 11.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.2 mm? -63.14 -58.17 17.38 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.948 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 36.1 Cg_endo -62.16 -18.28 61.19 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.121 1.88 . . . . 0.0 112.997 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . . . -64.13 -31.81 73.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.49 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.3 mm? -53.47 -24.38 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.05 10.93 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.979 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 54' ' ' PHE . 3.6 tp -61.09 -45.53 98.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.182 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 53' ' ' ILE . 54.7 t80 -63.65 -43.63 96.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.003 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.7 -43.77 98.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.927 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.4 81.68 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 57' ' ' LEU . 1.1 tt -60.53 -36.56 78.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 0.0 110.023 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 m -62.78 -40.05 96.1 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.44 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.8 -42.4 94.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -45.52 -52.13 10.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.249 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -61.35 -48.13 82.68 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.489 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.75 -50.31 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.86 -40.23 94.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.227 0.537 . . . . 0.0 110.385 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.75 -20.44 58.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.921 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' ALA . 10.7 tptp -53.78 -35.79 61.71 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.203 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.703 HH21 ' H ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -76.62 -52.96 8.71 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.283 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.404 ' NE2' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -54.47 -23.81 17.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.04 -50.73 46.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.658 0.742 . . . . 0.0 110.374 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -63.51 -45.19 91.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.396 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.703 ' H ' HH21 ' A' ' 66' ' ' ARG . . . -63.83 -34.59 78.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.991 0.424 . . . . 0.0 110.538 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.404 ' OG ' ' NE2' ' A' ' 67' ' ' GLN . 58.8 m -75.75 -28.22 58.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.515 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 p -99.44 -77.0 0.53 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 75' ' ' LYS . 2.1 m -33.84 97.71 0.12 Allowed Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 123.485 0.491 . . . . 0.0 111.283 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.79 -4.08 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.105 1.87 . . . . 0.0 112.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 73' ' ' THR . 64.6 tttm -60.54 -33.64 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 77' ' ' ASN . 2.1 p90 -56.05 -46.18 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.056 0.455 . . . . 0.0 110.108 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 18.1 t-20 -66.23 -34.14 77.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.616 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.97 93.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 m -77.75 -35.68 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.939 0.369 . . . . 0.0 110.467 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.46 -11.15 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.8 tptm . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.486 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' CG ' ' H ' ' A' ' 3' ' ' ASP . 23.7 tptt -72.36 -139.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.866 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 5' ' ' LYS . 51.7 t0 -31.12 95.84 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.363 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.58 59.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 122.822 2.348 . . . . 0.0 113.064 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 3' ' ' ASP . 9.8 tptm -77.1 -8.74 58.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.769 0.319 . . . . 0.0 110.661 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -27.58 8.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' O ' HG12 ' A' ' 10' ' ' VAL . 6.9 mp -87.99 -56.12 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.617 0.246 . . . . 0.0 110.712 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.2 tp -62.56 -37.84 87.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.827 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -56.95 -17.66 10.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.84 0.352 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 7' ' ' LEU . 7.7 p -54.97 -35.46 34.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.537 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -56.06 -47.87 77.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.056 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.7 mm -66.3 -47.39 84.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.85 -45.9 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.752 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.33 93.68 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -64.83 -19.19 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.584 0.231 . . . . 0.0 110.84 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 m -85.74 -34.79 21.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.385 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 tp -71.46 -32.74 68.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.111 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.41 -56.07 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.331 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.96 -33.91 76.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.96 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.34 -48.95 68.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 23' ' ' PHE . 66.6 m -73.71 -38.16 64.94 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 121.215 0.531 . . . . 0.0 110.721 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -50.59 0.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.919 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.4 m-85 -102.2 -21.31 14.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.637 0.256 . . . . 0.0 110.658 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -64.72 -45.85 75.83 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 24' ' ' THR . 51.3 Cg_exo -52.96 -14.39 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.592 2.195 . . . . 0.0 112.522 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -73.0 -42.68 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.554 0.692 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.55 -39.05 74.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.859 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 29' ' ' ILE . 3.4 m -65.28 -42.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.537 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' N ' HG23 ' A' ' 28' ' ' VAL . 30.2 pt -67.92 -34.73 68.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.825 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.9 -41.62 96.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.05 -40.92 93.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.8 t -58.88 -46.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.307 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.92 -41.54 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.323 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.83 -36.36 86.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.65 -24.67 65.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 41' ' ' GLY . 95.2 p -50.33 -23.23 2.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.16 23.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.706 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.73 -58.76 3.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 m -76.1 -47.83 23.02 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.916 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 85.86 -54.37 4.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 44' ' ' ASP . 73.9 m-85 -52.04 106.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.573 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.018 HD13 ' H ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.33 21.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.737 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 42' ' ' TYR . 50.3 t0 -61.56 -44.27 97.34 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.943 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -108.56 47.75 0.89 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -118.88 -36.92 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.61 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -85.5 -39.43 17.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.696 0.284 . . . . 0.0 111.425 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -60.17 -50.71 84.81 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 48' ' ' LEU . 53.5 Cg_exo -48.99 -44.88 31.06 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.115 1.877 . . . . 0.0 112.295 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.72 67.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -59.46 -42.91 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.97 92.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.814 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -67.61 -44.88 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -65.29 -48.77 71.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 56' ' ' GLY . 21.2 tt -66.43 -40.92 87.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.685 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -65.78 -38.09 94.06 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 tt -65.11 -38.78 91.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.674 0.273 . . . . 0.0 111.366 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.0 m -61.67 -48.46 80.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.918 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.7 tp -66.84 -37.44 79.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -47.78 -32.25 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.262 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -49.52 -28.76 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.662 0.268 . . . . 0.0 111.297 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 59' ' ' ILE . 8.9 tp -67.26 -30.51 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.807 0.337 . . . . 0.0 111.767 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.606 ' NE2' ' CE1' ' A' ' 60' ' ' TYR . 7.1 tt0 -68.03 -45.2 74.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -76.59 -22.94 53.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -28.7 6.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 66' ' ' ARG . 9.7 ptt180 -74.55 -48.65 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.336 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.48 -27.34 37.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.006 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.64 -48.59 72.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.305 0.574 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -67.64 -35.5 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.311 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.1 -40.65 98.26 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.358 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.8 m -86.13 -46.67 10.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.718 0.294 . . . . 0.0 111.189 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.4 p -64.95 -32.61 74.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.071 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 75' ' ' LYS . 34.8 p -139.57 79.24 24.89 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.128 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.81 77.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.575 2.184 . . . . 0.0 111.503 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.59 -42.14 95.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.558 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 77' ' ' ASN . 27.9 p90 -55.6 -47.06 77.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.459 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.561 ' N ' ' CG ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -67.82 -28.34 67.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.88 52.64 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.51 -34.75 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.671 0.272 . . . . 0.0 111.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -67.02 -81.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 tptm . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.445 -179.946 . . . . . . . . 0 0 . 1 stop_ save_